TCR_Public/150813.mbx          T R O U B L E D   C O M P A N Y   R E P O R T E R

              Thursday, August 13, 2015, Vol. 19, No. 225

                            Headlines

22ND CENTURY: Reports $1.3 Million Net Loss for Second Quarter
AEROGROW INTERNATIONAL: Incurs $1.2 Million Net Loss in Q1
AMERICAN APPAREL: Needs to Raise Money or Refinance Debt
AMERICAN INT'L: U.S. to Appeal Ruling in Bailout Dispute
ANACOR PHARMACEUTICALS: Posts $13.2 Million Net Loss for Q2

ARICENT TECHNOLOGIES: S&P Retains 'B' CCR on Proposed Add-On
ASG CONSOLIDATED: S&P Lowers Corporate Credit Rating to 'SD'
BAHA MAR: Files Bankruptcy Rule 2015.3 Report
BERNARD L. MADOFF: Feeder Fund Suit Approved to Move Forward
BIOSCRIP INC: S&P Lowers CCR to 'CCC+', Outlook Negative

CAESARS ENTERTAINMENT: Sued for Paying Creditors for Plan Support
CANCER GENETICS: Incurs $4.9 Million Net Loss in Second Quarter
CARBON ENERGY: U.S. Trustee Seeks Conversion to Ch. 7
CENTRUS ENERGY: Posts Net Loss of $15.1 Million in 2nd Qtr. 2015
CORD BLOOD: Shareholders Elect Five Directors

CUI GLOBAL: Incurs $503,876 Net Loss in Second Quarter
ELEPHANT TALK: Reports $9.5 Million Net Income for Second Quarter
ELITE PHARMACEUTICALS: Posts $16 Million Net Income for Q1
ENERGY FUTURE: Noteholders Unveil Confidentiality Agreements
ERG INTERMEDIATE: Opts to Cancel 363 Sale Process, To File Plan

EXELIXIS INC: FMR LLC Reports 14.9% Equity Stake
EXELIXIS INC: T. Rowe Price Reports 10.9% Stake as of July 31
FINJAN HOLDINGS: Posts $2.6 Million Net Loss for Second Quarter
FREE GOSPEL: US Trustee Unable to Form Creditor's Committee
GELTECH SOLUTIONS: Issues $200,000 Convertible Note

GENESIS HOLDINGS: Trial Court Erroneously Granted Summary Judgment
GLOBALSTAR INC: Posts $204.8-Mil. Net Income for Second Quarter
GLOBALSTAR INC: Signs $75 Million Purchase Agreement with Terrapin
HEALTHWAREHOUSE.COM INC: Incurs $159,600 Net Loss in 2nd Quarter
HOLIDAY MARINAS: Case Summary & 20 Largest Unsecured Creditors

HYDROCARB ENERGY: Sells $1 Million Convertible Note to JMJ
IDERA PHARMACEUTICALS: To Issue 6.2M Shares Under Incentive Plan
IMAGEWARE SYSTEMS: Posts $2.1 Million Net Loss for Second Quarter
INFOR INC: S&P Rates Proposed $400MM Sr. Secured Notes 'B+'
INSITE VISION: Gets Unsolicited Proposal from Pharma Company

INVENTIV HEALTH: Second Quarter Conference Call Set for Aug. 17
JONES ENERGY: Fitch Assigns 'B' Long-term Issuer Default Rating
LOST ACRES: Voluntary Chapter 11 Case Summary
MALIBU ASSOCIATES: Disclosure Statement Hearing Moved to Aug. 27
MALIBU ASSOCIATES: Seeks Jan. 4 Extension of Solicitation Period

MALIBU ASSOCIATES: U.S. Bank Wants Ch. 11 Case Converted to Ch. 7
MARINA BIOTECH: Announces $1.1-Mil. Preferred Stock Financing
MARINA BIOTECH: CEQ508 Granted FDA Fast Track Designation
MARKHAM, IL: S&P Puts 'BB+' GO Debt Rating on CreditWatch Negative
MERRIMACK PHARMACEUTICALS: Incurs $22.9 Million Net Loss in Q2

MIDSTATES PETROLEUM: Amends Credit Agreement with SunTrust Bank
MILLER BRANGUS: Case Summary & 10 Largest Unsecured Creditors
MISSISSIPPI PHOSPHATES: Cancels Auction After Failure to Draw Bids
MOSHAASHAEE: Bid to Reconsider Appointment of Examiner Denied
MOTORS LIQUIDATION: Liquidation of New GM Common Stock Completed

MSAA LV PARTNERS: Case Summary & 20 Largest Unsecured Creditors
MUSCLEPHARM CORP: Posts $7 Million Net Loss for Second Quarter
NEPHROS INC: Posts $1.8 Million Net Loss for Second Quarter
NII HOLDINGS: Reports Financial Results for 2nd Quarter 2015
OWENS-BROCKWAY GLASS: S&P Rates New $1BB Sr. Notes 'BB'

OXFORD RESOURCE: Westmoreland Holds 93.8% Equity Interests
PARKVIEW ADVENTIST: Court Declines Appointment of PCO
PARKVIEW ADVENTIST: Wants Skelton Taintor DQ'd as CMHC Counsel
PARU SELVAM: Default Judgment and Receiver Appointment Upheld
PHOTOMEDEX INC: Posts $6 Million Net Income in Second Quarter

PLY GEM HOLDINGS: Reports $30.4M Net Income for Second Quarter
PROSPECT SQUARE: Court Dismisses Ch. 11
RETROPHIN INC: Incurs $25.5 Million Net Loss in Second Quarter
REYES: Ch. 11 Case Dismissed, Filed in Bad Faith
RICHCOURT EURO: Chapter 15 Case Summary

SABINE OIL: Taps Lazard Freres as Investment Banker
SABINE OIL: U.S. Trustee Forms Five-Member Creditors' Committee
SABLE NATURAL: Jonathan Rich Quits as Director
SAN JUAN RESORT: SJ Beach Declared Successful Bidder
SEMCRUDE: Decision on Kivisto Motion Reversed

SMILE BRANDS: S&P Lowers CCR to 'CCC+', Outlook Negative
STACKPOLE INTERNATIONAL: S&P Puts 'B+' CCR on CreditWatch Positive
STAR BODY EXPERT: Case Summary & 9 Largest Unsecured Creditors
STELLAR BIOTECHNOLOGIES: Reports $464,000 Net Income in Q2
SUMMIT BUILDING: Case Summary & 6 Largest Unsecured Creditors

TELEPHONE AND DATA: Fitch Affirms 'BB+' Issuer Default Ratings
THERAKOS INC: S&P Puts 'B' CCR on CreditWatch Positive
THORNTON & CO: Proposes to Pay Critical Vendors
THORNTON & CO: Seeks to Use PUB's Cash Collateral
THORNTON & CO: Wants Oct. 30 Bar Date for 503(b)(9) Claims

TRISTAR WELLNESS: David Horin Resigns as Chief Financial Officer
TWIN RINKS: Court Approves Aug. 19 Auction for Assets
TWIN RINKS: Files Revised Bid to Employ Greenspan as Accountants
UNI-PIXEL INC: Approves CEO Salary Increase
UNI-PIXEL INC: Posts $15.7 Million Net Loss of Second Quarter

VERMILLION INC: FMR LLC Reports 12.2% Stake as of August 7
VIRTUAL PIGGY: Incurs $2.4 Million Net Loss in Second Quarter
WALTER ENERGY: Has Green Light to Form Retired Employee's Panel
WAYNE COUNTY, MI: Seeks to Avoid Bankruptcy Through Consent Pact
WESTMORELAND COAL: Has 93% Equity Interest in Westmoreland Resource

ZOGENIX INC: Posts $72.4 Million Net Income for Second Quarter

                            *********

22ND CENTURY: Reports $1.3 Million Net Loss for Second Quarter
--------------------------------------------------------------
22nd Century Group, Inc., filed with the Securities and Exchange
Commission its quarterly report on Form 10-Q disclosing a net loss
of $1.3 million on $2.3 million of revenue for the three months
ended June 30, 2015, compared to a net loss of $1.9 million on
$16,114 of revenue for the same period in 2014.

For the six months ended June 30, 2015, the Company reported a net
loss of $5.4 million on $2.9 million of revenue compared to a net
loss of $7.3 million on $463,649 of revenue for the same period
last year.

As of June 30, 2015, the Company had $23.3 million in total assets,
$6.7 million in total liabilities and $16.5 million in total
shareholders' equity.

As of June 30, 2015, the Company had positive working capital of
approximately $9.2 million compared to positive working capital of
approximately $8.0 million at Dec. 31, 2014, an increase of
approximately $1.2 million.  The increase in the Company's working
capital position was mainly the net result of the sale of common
stock during the second quarter of 2015 partially offset by working
capital consumed in our operating activities.

A full-text copy of the Form 10-Q is available for free at:

                        http://is.gd/LnBaSc

                         About 22nd Century

Clarence, New York-based 22nd Century Group, Inc., through its
wholly-owned subsidiary, 22nd Century Ltd, is a plant
biotechnology company using technology that allows for the level
of nicotine and other nicotinic alkaloids (e.g., nornicotine,
anatabine and anabasine) in tobacco plants to be decreased or
increased through genetic engineering and plant breeding.

22nd Century reported a net loss of $15.6 million on $529,000 of
revenue for the year ended Dec. 31, 2014, compared to a net loss of
$26.2 million on $7.27 million of revenue during the prior year.


AEROGROW INTERNATIONAL: Incurs $1.2 Million Net Loss in Q1
----------------------------------------------------------
Aerogrow International, inc. filed with the Securites and Exchange
Commission its quarterly report on Form 10-Q disclosing a net loss
of $1.2 million on $1.5 million of net revenue for the three months
ended June 30, 2015, compared to a net loss of $857,000 on $1.6
million of net revenue for the same period during the prior year.

As of June 30, 2015, the Company had $4.6 million in total assets,
$4.2 million in total liabilities, all current, and $442,000 in
total stockholders' equity.

"The June quarter marks the nadir of our traditional summer slow
period, with sales in the quarter representing less than 10% of our
last year's annual sales," said President and CEO J. Michael Wolfe.
"As such, minor fluctuations in order timing can result in
oversize percentage increases or decreases in the quarterly results
that in fact have little relative impact on annual sales results.
That was the case this quarter in our retail channel due to timing
of reorders.  Moreover, last year nearly 20% of our entire Q1 sales
were from a single counter-seasonal test which was not repeated.
Increased sales to other retailers virtually offset this gap. Our
DR business also experienced headwinds as last year's quarterly
sales benefited from 3/31 backorders for LED gardens that were
shipped during the June quarter, and by our burgeoning business at
Amazon, which creates on-line competition for us."

"Looking forward, our team is working on the key initiatives that
will continue to drive growth in our seasonally strong October to
April time frame.  We've continued to drive product costs down,
while pushing toward major new product introductions this fall.  In
addition, we're planning a major category and brand building
campaign during the holiday season as we look to increase awareness
of the indoor gardening category generally, and AeroGardens
specifically, in the minds of targeted consumers.  As these efforts
come together in our peak selling season beginning this November,
I'm optimistic we'll drive continued substantial top line growth,
with an emphasis on improved bottom line performance."

A full-text copy of the Form 10-Q is available for free at:

                        http://is.gd/Gma8HA

                           About AeroGrow

Boulder, Colo.-based AeroGrow International, Inc., is a developer,
marketer, direct-seller, and wholesaler of advanced indoor garden
systems designed for consumer use and priced to appeal to the
gardening, cooking, and healthy eating, and home and office decor
markets.

AeroGrow reported a net loss attributable to common shareholders of
$1.5 million on $17.9 million of net revenue for the year ended
March 31, 2015, compared with a net loss attributable to common
shareholders of $4.1 million on $9.3 million of of net revenue for
the year ended March 31, 2014.


AMERICAN APPAREL: Needs to Raise Money or Refinance Debt
--------------------------------------------------------
Maria Armental, writing for The Wall Street Journal, reported that
American Apparel Inc. warned it had about $13 million of available
cash and risked default if it didn't raise money or refinance its
debt.

According to the report, the retailer, which also said it would
miss a regulatory deadline to file its June quarter financial
results, toughened its language from a month earlier, when it
disclosed it was running short of cash to meet its obligations over
the next 12 months and said it intended to close several stores as
part of an aggressive cost-cutting plan.  The Journal noted that
American Apparel has staved off bankruptcy through cash infusions.

                     About American Apparel

American Apparel is a vertically-integrated manufacturer,
distributor, and retailer of branded fashion basic apparel based
in downtown Los Angeles, California.  As of Sept. 30, 2014,
American Apparel had approximately 10,000 employees and operated
245 retail stores in 20 countries including the United States and
Canada.  American Apparel also operates a global e-commerce site
that serves over 60 countries worldwide at
http://www.americanapparel.com. In addition, American Apparel     


operates a leading wholesale business that supplies high quality
T-shirts and other casual wear to distributors and screen
printers.

Amid liquidity problems and declining sales, American Apparel in
early 2011 reportedly tapped law firm Skadden, Arps, Slate,
Meagher & Flom and investment bank Rothschild Inc. for advice on a
restructuring.

In April 2011, American Apparel said it raised $14.9 million in
rescue financing from a group of investors led by Canadian
financier Michael Serruya and private equity firm Delavaco Capital
Corp., allowing the casual clothing retailer to meet obligations
to its lenders for the time being.  Under the deal, the investors
were buying 15.8 million shares of common stock at 90 cents
apiece.  The deal allows the investors to purchase additional
27.4 million shares at the same price.

American Apparel reported a net loss of $68.8 million in 2014, a
net loss of $106 million in 2013 and a net loss of $37.3
million in 2012.

As of March 31, 2015, the Company had $271 million in total
assets, $416 million in total liabilities and a $144 million total
stockholders' deficit.

                           *     *     *

The TCR reported on Nov. 21, 2013, that Moody's Investors Service
downgraded American Apparel Inc.'s corporate family rating to
Caa2.  The clothing retailer's probability of default was also
lowered one level and the outlook is negative.

As reported by the TCR on Sept. 2, 2014, Standard & Poor's Ratings
Services lowered its corporate credit rating on Los Angeles-based
American Apparel Inc. to 'CCC-' from 'CCC'.  The outlook is
negative.


AMERICAN INT'L: U.S. to Appeal Ruling in Bailout Dispute
--------------------------------------------------------
Angela Chen, writing for Dow Jones' Daily Bankruptcy Review,
reported that the U.S. government on Aug. 12 filed to appeal a
judge's ruling that it violated the law when it took a controlling
stake in American International Group Inc. in 2008.

According to the report, Judge Thomas C. Wheeler ruled in June that
the government action, during the most dramatic stretch of the
financial crisis, was unlawful.  Still, he accepted the
government's arguments that without a Federal Reserve bank's $85
billion loan to AIG , the company would have filed for bankruptcy
and shareholders likely would have been left with nothing, the
report noted.

The case is Starr International Co. v. U.S., 11-cv-00779, U.S.
Court of Federal Claims (Washington).

                           About AIG

With corporate headquarters in New York, American International
Group, Inc., is an international insurance company, serving
customers in more than 130 countries.  AIG companies serve
commercial, institutional and individual customers through
property-casualty networks of any insurer. In addition, AIG
companies are providers of life insurance and retirement services.

At the height of the 2008 financial crisis, AIG experienced a
liquidity crunch when its credit ratings were downgraded below
"AA" levels by Standard & Poor's, Moody's Investors Service and
Fitch Ratings.  AIG almost collapsed under the weight of bad bets
it made insuring mortgage-backed securities.  The Company,
however, was bailed out by the Federal Reserve, but even after an
initial infusion of $85 billion, losses continued to grow.  The
later rescue packages brought the total to $182 billion, making it
the biggest federal bailout in U.S. history.  AIG sold off a
number of its businesses and other assets to pay down loans
received from the U.S. government.


ANACOR PHARMACEUTICALS: Posts $13.2 Million Net Loss for Q2
-----------------------------------------------------------
Anacor Pharmaceuticals, Inc. filed with the Securities and Exchange
Commission its quarterly report on Form 10-Q disclosing
a net loss of $13.2 million on $21.3 million of total revenues for
the three months ended June 30, 2015, compared to a net loss of
$24.5 million on $2.9 million of total revenues for the same period
in 2014.

For the six months ended June 30, 2015, the Company reported a net
loss of $26.1 million on $36.6 million of total revenues compared
to a net loss of $45.6 million on $7.1 million of total revenues
for the same period during the prior year.

As of June 30, 2015, the Company had $195.7 million in total
assets, $125.5 million in total liabilities, $4.9 million in
redeemable common stock and $65.2 million in total stockholders'
equity.

A full-text copy of the Form 10-Q is available for free at:

                       http://is.gd/3UmzXI

                   About Anacor Pharmaceuticals

Palo Alto, Calif.-based Anacor Pharmaceuticals (NASDAQ: ANAC) is a
biopharmaceutical company focused on discovering, developing and
commercializing novel small-molecule therapeutics derived from its
boron chemistry platform.  Anacor has discovered eight compounds
that are currently in development.  Its two lead product
candidates are topically administered dermatologic compounds -
tavaborole, an antifungal for the treatment of onychomycosis, and
AN2728, an anti-inflammatory PDE-4 inhibitor for the treatment of
atopic dermatitis and psoriasis.

Anacor reported a net loss of $87.1 million on $20.7 million of
total revenues for the year ended Dec. 31, 2014, compared with net
income of $84.8 million on $17.2 million of total revenues for the
year ended Dec. 31, 2013.



ARICENT TECHNOLOGIES: S&P Retains 'B' CCR on Proposed Add-On
------------------------------------------------------------
Standard & Poor's Ratings Services said that its recovery rating on
Aricent Technologies' (B/Stable/--) first-lien credit facility
remains unchanged following the company's announcement of a
proposed $75 million add-on.  The '3' recovery rating indicates
S&P's expectation for meaningful (50% to 70%; in the higher end of
the range) recovery in the event of a payment default.
Subsequently, the issue-level rating on this debt remains at 'B',
in accordance with S&P's notching criteria.  The company will use
proceeds from the proposed add-on for general corporate purposes
and as part of financing to acquire an undisclosed company that
provides semiconductor design and embedded software solutions.  The
transaction is leverage neutral and S&P expects leverage to remain
in the mid-5x area.

The acquisition will provide additional capabilities in
semiconductor design and embedded software solutions, some
diversification to Aricent's core engineering business, and access
to new verticals such as automotive and industrials.

S&P's 'B' corporate credit rating on Aricent remains unchanged. The
outlook is stable and reflects S&P's expectation that the company
will increase annual organic revenues by a rate in the
low-single-digit area while generating consistent profitability and
positive free operating cash flow.

Under Standard & Poor's policies, only a Rating Committee can
determine a Credit Rating Action (including a Credit Rating change,
affirmation or withdrawal, Rating Outlook change, or CreditWatch
action).  This commentary and its subject matter have not been the
subject of Rating Committee action and should not be interpreted as
a change to, or affirmation of, a Credit Rating or Rating Outlook.


RATINGS LIST

Ratings Unchanged

Aricent Technologies Inc.
Corporate credit rating     B/Stable/--
1st-lien cred fac           B
  Recovery rating            3H
2nd-lien cred fac           CCC+
  Recovery rating            6



ASG CONSOLIDATED: S&P Lowers Corporate Credit Rating to 'SD'
------------------------------------------------------------
Standard & Poor's Ratings Services lowered its corporate credit
rating on Seattle-based ASG Consolidated LLC to 'SD' from 'CC'. The
rating action followed the company's transfer of its Holdco
payment-in-kind (PIK) notes at a substantial discount.

"The rating action reflects our assessment of credit quality
following the company's partial exchange of its Holdco PIK notes
due 2017," said Standard & Poor's credit analyst Kim Logan.  "We
lowered the corporate credit rating to 'SD' after the company
completed the transfer of the notes at a substantial discount,
thereby, in our opinion, not meeting the full obligation on the
security that is payable in May 2017.  According to our criteria,
we consider the transfer of the notes as tantamount to default."

The ratings on ASG reflect its highly leveraged financial profile
(including S&P's estimate of debt to EBITDA in excess of 9x as of
June 30, 2015) and near-term potential for declining liquidity due
to tightening financial covenants and pending debt maturities). The
company expects to refinance its senior credit facility and senior
subordinated notes within the next few weeks.

The company has a narrow product focus and participates in the
commodity-oriented, highly regulated, and somewhat volatile
commercial fishing industry, albeit with a strong asset base
including exclusive fishing rights to a significant share of the
North American Bering Sea and several commercial fishing vessels
equipped with on-board processing capacity.  Also, S&P believes
operating performance is subject to supply-and-demand vagaries
related to its products, variable catch volumes, and worldwide
pricing movements that can affect financial performance.



BAHA MAR: Files Bankruptcy Rule 2015.3 Report
---------------------------------------------
Baha Mar Enterprises Ltd. and its affiliated debtors filed a report
with the U.S. Bankruptcy Court in Delaware, disclosing that they
hold 100% interest in these companies:

   Companies                              Interest of Estate  
   ---------                              ------------------  
   Baha Mar Convention Center Company Ltd.       100%
   Baha Mar CHC Ltd.                             100%
   Baha Mar Convention Hotel Company Ltd.        100%
   Baha Mar Luxury Company Ltd.                  100%
   Baha Mar Lifestyle Hotel Company Ltd.         100%

Baha Mar filed the report pursuant to Bankruptcy Rule 2015.3.  The
report dated July 27, 2015, is available for free at
http://is.gd/DIAVMW

                         About Baha Mar

Orlando, Florida-based Northshore Mainland Services Inc., Baha Mar
Enterprises Ltd., and their affiliates sought protection under
Chapter 11 of the Bankruptcy Code on June 29, 2015 (Bankr. D.Del.,
Case No. 15-11402).  Baha Mar owns, and is in the final stages of
developing, a 3.3 million square foot resort complex located in
Cable Beach, Nassau, The Bahamas.

The case is assigned to Judge Kevin J. Carey.

The Debtors are represented by Paul S. Aronzon, Esq., and Mark
Shinderman, Esq., at Milbank, Tweed, Hadley & McCloy LLP, in Los
Angeles, California; and Gerard Uzzi, Esq., Thomas J. Matz, Esq.,
and Steven Z. Szanzer, Esq., at Milbank, Tweed, Hadley & McCloy
LLP, in New York.  The Debtors' Delaware counselare Laura Davis
Jones, Esq., James E. O'Neill, Esq., Colin R. Robinson, Esq., and
Peter J. Keane, Esq., at Pachulski Stang Ziehl & Jones LLP, in
Wilmington, Delaware.  The Debtors' Bahamian counsel is Glinton
Sweeting O'Brien.  The Debtors' special litigation counsel is Kobre
& Kim LLP.  The Debtors' construction counsel is Glaser Weil Fink
Howard Avchen & Shapiro LLP.

The Debtors' investment banker and financial advisor is Moelis
Company LLC.  The Debtors' claims and noticing agent is Prime Clerk
LLC.


BERNARD L. MADOFF: Feeder Fund Suit Approved to Move Forward
------------------------------------------------------------
Jacqueline Palank, writing for Dow Jones' Daily Bankruptcy Review,
reported that a lawsuit seeking to reclaim $825 million from two
major funds that invested with Bernard Madoff may move forward
largely intact, a bankruptcy judge ruled on Aug. 11.

According to the report, Judge Stuart M. Bernstein of the U.S.
Bankruptcy Court in Manhattan largely rejected a bid by the funds,
Kingate Global Fund Ltd. and Kingate Euro Fund Ltd., to dismiss
litigation brought by the Irving Picard, the trustee winding down
Mr. Madoff's investment firm.

                    About Bernard L. Madoff

Bernard L. Madoff Investment Securities LLC and Bernard L. Madoff
orchestrated the largest Ponzi scheme in history, with losses
topping US$50 billion.  On Dec. 15, 2008, the Honorable Louis A.
Stanton of the U.S. District Court for the Southern District of
New
York granted the application of the Securities Investor Protection
Corporation for a decree adjudicating that the customers of BLMIS
are in need of the protection afforded by the Securities Investor
Protection Act of 1970.  The District Court's Protective Order (i)
appointed Irving H. Picard, Esq., as trustee for the liquidation
of
BLMIS, (ii) appointed Baker & Hostetler LLP as his counsel, and
(iii) removed the SIPA Liquidation proceeding to the Bankruptcy
Court (Bankr. S.D.N.Y. Adv. Pro. No. 08-01789) (Lifland, J.).  Mr.
Picard has retained AlixPartners LLP as claims agent.

On April 13, 2009, former BLMIS clients filed an involuntary
Chapter 7 bankruptcy petition against Bernard Madoff (Bankr.
S.D.N.Y. 09-11893).  The petitioning creditors -- Blumenthal &
Associates Florida General Partnership, Martin Rappaport
Charitable
Remainder Unitrust, Martin Rappaport, Marc Cherno, and Steven
Morganstern -- assert US$64 million in claims against  Mr. Madoff
based on the balances contained in the last statements they got
from BLMIS.

On April 14, 2009, Grant Thornton UK LLP as receiver placed Madoff
Securities International Limited in London under bankruptcy
protection pursuant to Chapter 15 of the U.S. Bankruptcy Code
(Bankr. S.D. Fla. 09-16751).

The Chapter 15 case was later transferred to Manhattan.  In June
2009, Judge Lifland approved the consolidation of the Madoff SIPA
proceedings and the bankruptcy case.

Judge Denny Chin of the U.S. District Court for the Southern
District of New York on June 29, 2009, sentenced Mr. Madoff to 150
years of life imprisonment for defrauding investors in United
States v. Madoff, No. 09-CR-213 (S.D.N.Y.).

From recoveries in lawsuits coupled with money advanced by SIPC,
Mr. Picard has commenced  distributions to victims.  As of the end
of May 2015, the SIPA Trustee has recovered more than $10.699
billion and has distributed approximately $7.576 billion.  When
additional settlements awaiting distribution are taken into
account, the recovery in the Madoff liquidation proceeding totals
$10.734 billion.


BIOSCRIP INC: S&P Lowers CCR to 'CCC+', Outlook Negative
--------------------------------------------------------
Standard & Poor's Ratings Services lowered its corporate credit
rating on home infusion services provider BioScrip Inc. to 'CCC+'
from 'B-'.  The rating outlook is negative.

S&P also lowered the issue-level rating on BioScrip's senior
secured term loan to 'B-' from 'B'.  S&P's recovery rating on this
debt remains '2', indicating its expectation for meaningful (50% to
70%; at the lower end of the range) recovery of principal in the
event of a payment default.

In addition, S&P lowered the issue-level rating on the company's
senior unsecured notes to 'CCC-' from 'CCC'.  The recovery rating
on this debt remains '6', indicating S&P's expectations of
negligible (0% to 10%) recovery in the event of default.

"The company's operating performance in the second quarter fell
meaningfully short of our expectations for sequential improvement,"
said Standard & Poor's credit analyst David Kaplan. This follows
weaker-than-expected results in the first quarter in the wake of
significant billing and collection issues in 2014 stemming from the
integration of an acquisition.  This pattern is prompting us to
again reassess our forecast for 2015 and 2016. The company also
announced initiatives to reduce costs, the sale of its PBM
business, and that it plans to explore more divestitures and other
strategic options, including the possible sale of the company.

Given debt levels, S&P believes the company will likely default if
it is unable to improve profitability; moreover, given the
company's pattern of falling short of its guidance S&P's confidence
in the company's ability to execute on its ambitious turnaround
plan is limited.

S&P's negative outlook reflects the downside risk to its revised
base case given its decreased confidence in the company's ability
to execute on its plan to quickly improve profitability in 2016.

S&P would likely lower the rating if it expects adjusted EBITDA
(including recurring "one-time" items) in 2015 or 2016 to fall
short of about $35 million, or if liquidity becomes constrained. In
this scenario, S&P could conclude that BioScrip's capital structure
is unsustainable over the near term.

S&P would consider revising the outlook to stable or an upgrade, if
it develops greater confidence the company can meet its base-case
expectation, including ultimately growing EBITDA to about $50
million.



CAESARS ENTERTAINMENT: Sued for Paying Creditors for Plan Support
-----------------------------------------------------------------
Steven Church, writing for Bloomberg News, reported that creditors
of Caesars Entertainment Operating Co. sued the bankrupt casino
company, accusing it of trying to buy votes for its reorganization
plan.

According to the report, a group of mid-level bondholders said in a
complaint filed in Chicago bankruptcy court that Caesars promised
$200 million in improper payments to other creditors to secure
their support.  The second-lien noteholders, who have been the
company's most vocal opponents, claimed Caesars "has pledged to
continue its illegal vote-buying campaign" to persuade more
creditors to back the proposal, the report related.

The noteholders asked U.S. Bankruptcy Judge A. Benjamin Goldgar to
issue a restraining order preventing Caesars from continuing to
solicit support for the restructuring agreement, the report further
related.

                   About Caesars Entertainment

Caesars Entertainment Corp., formerly Harrah's Entertainment Inc.,
is one of the world's largest casino companies.  Caesars casino
resorts operate under the Caesars, Bally's, Flamingo, Grand
Casinos, Hilton and Paris brand names.  The Company has its
corporate headquarters in Las Vegas.  Harrah's announced its
re-branding to Caesar's in mid-November 2010.

In January 2015, Caesars Entertainment and subsidiary Caesars
Entertainment Operating Company, Inc., announced that holders of
more than 60% of claims in respect of CEOC's 11.25% senior secured
notes due 2017, CEOC's 8.5% senior secured notes due 2020 and
CEOC's 9% senior secured notes due 2020 have signed the Amended
and Restated Restructuring Support and Forbearance Agreement,
dated
as of Dec. 31, 2014, among Caesars Entertainment, CEOC and the
Consenting Creditors.  As a result, The RSA became effective
pursuant to its terms as of Jan. 9, 2015.

Appaloosa Investment Limited, et al., owed $41 million on account
of 10% second lien notes in the company, filed an involuntary
Chapter 11 bankruptcy petition against CEOC (Bankr. D. Del. Case
No. 15-10047) on Jan. 12, 2015.  The bondholders are represented
by Robert S. Brady, Esq., at Young, Conaway, Stargatt & Taylor
LLP.

CEOC and 172 other affiliates -- operators of 38 gaming and resort
properties in 14 U.S. states and 5 countries -- filed Chapter 11
bankruptcy petitions (Bank. N.D. Ill.  Lead Case No. 15-01145) on
Jan. 15, 2015.  CEOC disclosed total assets of $12.3 billion and
total debt of $19.8 billion as of Sept. 30, 2014.

Delaware Bankruptcy Judge Kevin Gross entered a ruling that the
bankruptcy proceedings will proceed in the U.S. Bankruptcy Court
for the Northern District of Illinois.

Kirkland & Ellis serves as the Debtors' counsel.  AlixPartners is
the Debtors' restructuring advisors.  Prime Clerk LLC acts as the
Debtors' notice and claims agent.  Judge Benjamin Goldgar presides
over the cases.

The U.S. Trustee has appointed seven noteholders to serve in the
Official Committee of Second Priority Noteholders and nine members
to serve in the Official Unsecured Creditors' Committee.

The U.S. Trustee appointed Richard S. Davis as Chapter 11
examiner.

                         *     *     *

The Troubled Company Reporter, on April 27, 2015, reported that
Fitch Ratings has affirmed and withdrawn the Issuer Default
Ratings (IDR) and issue ratings of Caesars Entertainment Operating
Company (CEOC).  These actions follow CEOC's Chapter 11 filing on
Jan. 15, 2015.  Accordingly, Fitch will no longer provide ratings
or analytical coverage for CEOC.

In addition, Fitch has affirmed the IDR and issue rating of
Chester Downs and Marina LLC (Chester Downs) and the ratings have
been simultaneously withdrawn for business reasons.


CANCER GENETICS: Incurs $4.9 Million Net Loss in Second Quarter
---------------------------------------------------------------
Cancer Genetics, Inc. filed with the Securities and Exchange
Commission its quarterly report on Form 10-Q disclosing a net loss
of $4.9 million on $4.2 million of revenue for the three months
ended June 30, 2015, compared to a net loss of $4.2 million on $1.5
million of revenue for the same period during the prior year.

For the six months ended June 30, 2015, the Company reported a net
loss of $9.2 million on $8.5 million of revenue compared to a net
loss of $6.6 million on $2.9 million of revenue for the same period
a year ago.

As of June 30, 2015, the Company had $39.8 million in total assets,
$13.1 million in total liabilities and $26.7 million in total
stockholders' equity.

A full-text copy of the Form 10-Q is available for free at:

                       http://is.gd/fcZGiS

                      About Cancer Genetics

Rutherford, N.J.-based Cancer Genetics, Inc., is an early-stage
diagnostics company focused on developing and commercializing
proprietary genomic tests and services to improve and personalize
the diagnosis, prognosis and response to treatment (theranosis) of
cancer.

Cancer Genetics reported a net loss of $16.6 million in 2014, a net
loss of $12.4 million in 2013 and a net loss of $6.66 million in
2012.


CARBON ENERGY: U.S. Trustee Seeks Conversion to Ch. 7
-----------------------------------------------------
Tracy Hope Davis, the United States Trustee for Region 17, asks the
U.S. Bankruptcy Court for the District of Nevada to convert the
Chapter 11 cases of Carbon Energy Holdings, Inc., et. al., to cases
under Chapter 7 of the Bankruptcy Code, or dismiss the cases based
on the Debtors' failure to confirm a plan within the time allowed
for small business cases under the Bankruptcy Code.

The U.S. Trustee explains that it has been more than 300 days since
the petition was filed and the Debtors have not filed a plan.  The
U.S. Trustee has not appointed an unsecured creditors' committee
and no order has been entered to extend the time periods for
confirmation of a plan in a small business case.  In this case, the
deadline for the Debtors to file a plan pursuant to Section
1121(e)(2) was April 23, 2012, and no order was entered prior to
that date extending the time.  It is now too late to file a plan,
the U.S. Trustee adds.

The hearing to consider the conversion request is scheduled for
September 9, 2015, at 02:00 PM.

The U.S. trustee is represented by:

          Nicholas Strozza
          William B. Cossitt
          Justice Department, US Trustees Office
          300 Booth Street, #3009
          Reno NV 89509
          Tel:(775) 784-5335
          Fax:(775) 784-5531
          Email: USTPRegion17.RE.ECF@usdoj.gov

                     About Carbon Energy Holdings

Based in Wickenburg, Arizona, Carbon Energy Holdings LLC and
Carbon Energy Reserve Inc. filed for Chapter 11 bankruptcy (Bankr.
D. Nev. Case Nos. 11-52099 and 11-52101) on June 28, 2011.  Judge
Bruce T. Beesley presides over the cases.  Carbon Energy Holdings
Inc. disclosed $0 in assets and $146,270 in liabilities in its
schedules filed in court.  Carbon Energy Reserve Inc. scheduled
$40,000,000 in assets and $2,009,573 in liabilities.  Kolesar &
Leatham Chtd. acts as the Debtors' general counsel.


CENTRUS ENERGY: Posts Net Loss of $15.1 Million in 2nd Qtr. 2015
----------------------------------------------------------------
Centrus Energy Corp. on Aug. 7 reported a net loss of $15.1 million
or $1.68 per basic and diluted share for the quarter ended June 30,
2015, compared to a net loss of $28.0 million or $5.71 per basic
and diluted share for the second quarter 2014.  For the six months
ended June 30, 2015, Centrus reported a net loss of $30.5 million
compared to a net loss of $78.8 million in the same period of
2014.

Gross profit increased $0.8 million in the three months and $28.6
million in the six months ended June 30, 2015, compared to the
corresponding periods in 2014, reflecting charges in the prior
periods related to the wind-down of the Paducah Gaseous Diffusion
Plant (GDP).

"With our long track record as a reliable supplier and our broad
relationships across the global industry, we are well positioned to
promote reliable and commercially attractive supplies to our
customers," said Daniel B. Poneman, Centrus president and chief
executive officer.  "We are intently focused on securing new
business and diverse sources of supply to support our growth in the
coming years.  We are taking a customer-first approach, since
competitively priced nuclear power will drive Centrus' long-term
success."

"While we are in the early stages of our fresh start following
reorganization and still have a lot of work to do, we believe the
company is on the right trajectory.  Our second quarter results
reflect our declining costs, improving margins, and actions to
manage our order book effectively," Mr. Poneman said.

Revenue

Revenue for the second quarter of 2015 was $63.3 million, a
decrease of $57.9 million or 48 percent compared to the same
quarter of 2014.  In the sixth month period ending June 30, 2015,
revenue was $231.1 million, a decrease of $38.7 million or 14
percent from the same period in 2014.  The volume of separative
work units (SWU) sales declined 63 percent in the three-month
period and 46 percent in the six-month period, reflecting the
variability of timing of customer orders and the expected decline
in SWU deliveries in 2015 compared to 2014.  The average price
billed to customers for sales of SWU increased 9 percent in both
the three- and six-month periods reflecting the particular
contracts under which SWU were sold during the period.

Revenue from the contract services segment increased $4.4 million
or 26 percent in the three months and $22.4 million or 114 percent
in the six months ended June 30, 2015, compared to the
corresponding periods in 2014, reflecting American Centrifuge work
performed under the American Centrifuge Technology Demonstration
and Operations (ACTDO) Agreement beginning May 1, 2014, partially
offset by a decline in contract services work performed for the
Department of Energy (DOE) and DOE contractors.

In a number of sales transactions, Centrus transfers title and
collects cash from customers but does not recognize the revenue
until the LEU is physically delivered.  At June 30, 2015, deferred
revenue totaled $70.3 million compared to $100.9 million at
December 31, 2014.  The gross profit associated with deferred
revenue as of June 30, 2015, was $11.4 million.

Cost of Sales and Gross Profit Margin

Cost of sales for the quarter ended June 30, 2015, was $59.0
million, a decrease of $58.7 million or 50 percent compared to the
corresponding period in 2014.  For the six-month period of 2015,
cost of sales was $219.9 million, a reduction of $67.3 million or
23 percent compared to the same period in 2014 due to lower SWU
sales volume and lower direct charges.  Direct charges to cost of
sales include logistics support and inventory management and
disposition.  In the prior periods, direct charges included costs
associated with the transitioning of the Paducah GDP to DOE. Direct
charges totaled $3.9 million and $8.6 million in the three and six
months ended June 30, 2015, and $14.3 million and $49.2 million in
the corresponding periods in 2014.

Cost of sales per SWU, excluding direct charges, increased 2
percent in the three months and 7 percent in the six months ended
June 30, 2015, compared to the corresponding periods in 2014,
primarily due to the increase to book value of SWU inventories
recorded as of September 30, 2014, as part of the application of
fresh start accounting.  In addition, approximately one-half of our
sales in the prior six-month period were derived from previously
deferred sales, whereby customers made advance payments to be
applied against future deliveries.  The unit cost per SWU for these
sales reflects the average inventory cost when the customer took
title to the SWU. These costs were accumulated in deferred costs
and were then recognized as cost of sales as the SWU is delivered.

Cost of sales for the contract services segment increased $5.4
million or 32 percent in the three months and $22.5 million or 107
percent in the six months ended June 30, 2015, compared to the
corresponding periods in 2014, primarily due to American Centrifuge
work performed under the ACTDO Agreement in the current periods.

Our gross profit margin was 6.8 percent in the three months ended
June 30, 2015 compared to 2.9 percent in the corresponding period
in 2014, and 4.8 percent in the six months ended June 30, 2015
compared to a loss of (6.4 percent) in the corresponding period in
2014.

Advanced Technology, SG&A, Amortization, Special Charges and Other
Income

Advanced technology costs declined $14.0 million in the three
months and $45.5 million in the six months ended June 30, 2015,
compared to the corresponding periods in 2014, reflecting
development work performed in the prior periods under the
Cooperative Agreement with DOE, which expired in accordance with
its terms on April 30, 2014.

American Centrifuge costs incurred by the Company that are outside
of the current ACTDO Agreement are included in advanced technology
costs, including certain demobilization and maintenance costs.
Such costs totaled $4.0 million in the three months and $5.8
million in the six months ended June 30, 2015, and $7.0 million in
May-June 2014.

Selling, general and administrative (SG&A) expenses declined $3.8
million in the three months and $3.2 million in the six months
ended June 30, 2015, compared to the corresponding periods in 2014.
Salaries, benefits and other compensation declined $4.5 million in
the three-month period and $5.4 million in the six-month period,
including a gain of $3.9 million resulting from the remeasurement
of pension obligations under the Employees' Retirement Plan of
Centrus Energy Corp. and the non-qualified supplemental executive
pension plans.  The remeasurements resulted from the level of
lump-sum payments to former employees including those affected by
workforce reductions.  Consulting costs increased $0.3 million and
$1.0 million in the three- and six-month periods, respectively.
Office related expenses increased $0.9 million in the six-month
period.

Amortization commenced in the fourth quarter of 2014 for the
intangible assets resulting from the Company's emergence from
bankruptcy and adoption of fresh start accounting.

The cessation of enrichment at the Paducah GDP and evolving
business needs have resulted in workforce reductions since July
2013.  In the three and six months ended June 30, 2015, special
charges consisted of termination benefits of $2.9 million and $3.8
million, respectively, less $0.3 million in the six-month period
for severance paid by the Company and invoiced to DOE for its share
of employee severance.  In the three and six months ended June 30,
2014, special charges for termination benefits consisted of $4.1
million in the three-month period and $4.2 million in the six-month
period, less amounts paid by the Company and invoiced to DOE of
$1.6 million in the three-month period and $2.2 million in the
six-month period.

In the three and six months ended June 30, 2015, other income
consisted of net gains on sales of assets and property.  DOE and
the Company provided cost-sharing support for American Centrifuge
activities under the Cooperative Agreement, which expired in
accordance with its terms on April 30, 2014.  DOE's cost share of
qualifying American Centrifuge expenditures in the three and six
months ended June 30, 2014 was recognized as other income.

Cash Flow

We ended the second quarter of 2015 with a consolidated cash
balance of $218.5 million.  Cash used in operations in the
six-month period of 2015 was $5.8 million compared to $193.4
million in the same period last year.  Monetization of inventory
purchased or produced in prior periods provided cash flow in the
six months ended June 30, 2015 as inventories declined $118.1
million due to sales deliveries exceeding product received under
SWU purchase agreements.  In addition, accounts receivable declined
$31.8 million due to monetization in the first quarter without
increased sales and billings.  The net reduction of the SWU
purchase payables balance of $116.9 million, due to the timing of
purchase deliveries, was a significant use of cash flow in the
six-month period.  The net loss of $30.5 million in the six months
ended June 30, 2015, net of non-cash charges including depreciation
and amortization, was a use of cash flow.

In the corresponding period in 2014, payment of the SWU purchase
payables balance of $340.7 million, due to the timing of purchase
deliveries, was a significant use of cash flow, as was the net
reduction in accounts payable and accrued liabilities by $34.8
million due to reduced operational activity.  The net loss of $78.8
million, net of non-cash charges including depreciation and
amortization, was a use of cash flow.  Monetization of inventory
purchased or produced in prior periods provided cash flow in the
six-month period as accounts receivable declined $137.9 million and
inventories declined $127.7 million.

2015 Outlook

Centrus will continue its transition during 2015, and we expect to
deliver significantly less SWU to customers than when we began our
transition in 2013.  In 2013, we delivered approximately 8 million
SWU, and during 2014, we delivered approximately 3 million SWU.
The Company expects to deliver approximately 2 million SWU in 2015.
It will also continue to execute our contract with ORNL to conduct
research, development and demonstration of the American Centrifuge
technology under the terms of the ACTDO Agreement.

Specifically, the Company anticipates SWU and uranium revenue in
2015 in a range of $350 million to $375 million and total revenue
in a range of $425 million to $450 million.  It expects to end 2015
with a cash and cash equivalents balance in a range of $175 million
to $200 million.

The Company's financial guidance is subject to a number of
assumptions and uncertainties that could affect results either
positively or negatively.  Variations from the Company's
expectations could cause differences between its guidance and its
ultimate results.  Among the factors that could affect the
Company's results are:

   -- Additional short-term sales;
   -- Timing of customer orders and related SWU deliveries;
   -- The outcome of legal proceedings and other contingencies;
   -- Funding of the ACTDO Agreement or a successor agreement
      beyond its current contract expiration date of September 30,
  
      2015; and
   -- The cost of any American Centrifuge demobilization or
      additional costs related to the overall transition of
      Centrus.

Investor Call

Centrus plans to hold an investor call on August 26, 2015, to
discuss the second quarter results.  Details about the call will be
announced in the near future and will be available on the Company's
website http://www.centrusenergy.com

                    About Centrus Energy Corp.

Centrus Energy Corp. is a supplier of enriched uranium fuel for
nuclear power plants.  Centrus is working to deploy the American
Centrifuge technology for commercial needs and to support U.S.
energy and national security.

Centrus, then known as USEC Inc., filed a Chapter 11 bankruptcy
petition (Bank. D. Del. Case No. 14-10475) on March 5, 2014.  The
Debtor tapped Latham & Watkins LLP, as general counsel; Richards,
Layton & Finger, P.A., as Delaware counsel; Vinson & Elkins as
special counsel; and Lazard Freres & Co. LLC as investment banker.
USEC Inc. won confirmation its reorganization plan and emerged from
Chapter 11 on Sept. 30, 2014, as Centrus Energy Corp.


CORD BLOOD: Shareholders Elect Five Directors
---------------------------------------------
Cord Blood America, Inc., held its annual meeting of shareholders
on Aug. 6, 2015, at which the shareholders:

   (1) elected Joseph Vicente, Timothy McGrath, David Sandberg,
       Adrian Pertierra and Anthony Snow as directors;

   (2) ratified the appointment of De Joya Griffith, LLC as the
       Company's independent registered certified public
       accounting firm for the fiscal year ending Dec. 31, 2015;

   (3) did not approve a proposal to amend the Amended and
       Restated Articles of Incorporation of the Company to
       declassify the Board of Directors and to require that all
       directors stand for annual election;

   (4) did not approve a proposal to amend the Amended and
       Restated Articles of Incorporation to change the
       shareholder vote required to amend Articles III, IV, and V
       of the Articles of Incorporation from a supermajority
       common shareholder vote requirement to a majority vote
       requirement;

   (5) approved an amendment to the Amended and Restated Articles
       of Incorporation to require that, in the case of a
       combination, the authorized shares should be reduced
       commensurately with the reduction in outstanding shares and
       approval to conform cross-references and other immaterial
       clean-up changes in the Amended and Restated Articles of
       Incorporation;

   (6) approve (on an advisory basis) the Company's executive
       compensation; and

   (7) approved a proposal to conduct an advisory vote on the
       frequency of future advisory votes on executive
       compensation every three years.

Adrian Pertierra and Anthony Snow will continue until the 2018
annual meeting of shareholders; Timothy McGrath and Joe Vicente
will continue until the 2017 annual meeting of shareholders; and
David Sandberg will continue until the 2016 annual meeting of
shareholders.

                      About Cord Blood America

Based in Las Vegas, Nevada, Cord Blood America, Inc., is primarily
a holding company whose subsidiaries include Cord Partners, Inc.,
CorCell Co. Inc., CorCell Ltd.; CBA Professional Services, Inc.
D/B/A BodyCells, Inc.; CBA Properties, Inc.; and Career Channel
Inc, D/B/A Rainmakers International.  Cord specializes in
providing private cord blood stem cell preservation services to
families.  BodyCells is a developmental stage company and intends
to be in the business of collecting, processing and preserving
peripheral blood and adipose tissue stem cells allowing
individuals to privately preserve their stem cells for potential
future use in stem cell therapy.  Properties was formed to hold
the corporate trademarks and other intellectual property of CBAI.
Rain specializes in creating direct response television and radio
advertising campaigns, including media placement and commercial
production.

The Company has been the subject of a going concern opinion by its
independent auditors who have raised substantial doubt as to the
Company's ability to continue as a going concern.  De Joya
Griffith, LLC, in Henderson, NV, noted that the Company has
incurred losses from operations, which losses have caused an
accumulated deficit of approximately $53.46 million as of Dec. 31,
2014.

The Company disclosed net income of $240,000 on $4.33 million of
revenue for the year ended Dec. 31, 2014, compared to a net loss of
$2.97 million on $3.82 million of revenue for the year ended Dec.
31, 2013.  As of March 31, 2015, the Company had $3.79 million in
total assets, $4.69 million in total liabilities and a $899,954
total stockholders' deficit.


CUI GLOBAL: Incurs $503,876 Net Loss in Second Quarter
------------------------------------------------------
CUI Global, Inc., filed with the Securities and Exchange Commission
its quarterly report on Form 10-Q disclosing a net loss of $503,876
on $22.9 million of total revenue for the three months ended June
30, 2015, compared to a net loss of $66,462 on $19.2 million of
total revenue for the same period in 2014.

For the six months ended June 30, 2015, the Company reported a net
loss of $4.6 million on $39.8 million of total revenue compared to
a net loss of $554,380 on $36.1 million of total revenue for the
same period during the prior year.

As of June 30, 2015, the Company had $93.3 million in total assets,
$31.1 million in total liabilities and $62.2 million in total
stockholders' equity.

As of June 30, 2015, CUI Global held cash and cash equivalents of
$5.2 million and investments of $4 million.  Operations,
acquisitions, investments, patents, equipment, land and buildings
have been funded through cash on hand.

A full-text copy of the Form 10-Q is available for free at:

                       http://is.gd/MgQj8o

                         About CUI Global

Tualatin, Ore.-based CUI Global, Inc., formerly known as Waytronx,
Inc., is a platform company dedicated to maximizing shareholder
value through the acquisition, development and commercialization
of new, innovative technologies.

CUI Global reported a consolidated net loss of $2.80 million in
2014, a consolidated net loss of $943,000 in 2013 and a
consolidated net loss of $2.52 million in 2012.


ELEPHANT TALK: Reports $9.5 Million Net Income for Second Quarter
-----------------------------------------------------------------
Elephant Talk Communications Corp. filed with the Securities and
Exchange Commission its quarterly report on Form 10-Q disclosing
net income of $9.5 million on $19.2 million of revenues for the
three months ended June 30, 2015, compared to a net loss of $6.4
million on $5 million of revenues for the same period in 2014.

For the six months ended June 30, 2015, the Company reported net
income of $7.4 million on $24.2 million of revenues compared to a
net loss of $11.6 million on $10.4 million of revenues for the same
period during the prior year.

As of June 30, 2015, the Company had $32.2 million in total assets,
$12.8 million in total liabilities and $19.4 million in total
stockholders' equity.

"With a cash balance at June 30, 2015 of $1.2 million, the net
receipt of funding by Atalaya/Corbin of $4.2 million in July 2015
combined with the effects of the expense reduction, the Company
believes it can sustain its operational plans for the coming 12
months.  However, if we are unable to meet our sales objectives and
financing becomes restrictive for our capital expenditures for
growth purposes, we may be required to attract additional
financing.  Although we have previously been able to raise capital
as needed, such capital may not continue to be available to us at
all, or if available, on reasonable terms as required. Further, the
terms of such financing may be dilutive to our existing
stockholders or otherwise on terms not favorable to us or our
existing stockholders.  If we are unable to secure additional
capital, as circumstances require, or do not succeed in meeting our
sales objectives we may be required to change or delay our
operations.

As of June 30, 2015, these conditions raise substantial doubt about
the Company's ability to continue as a going concern."

A full-text copy of the Form 10-Q is available at:

                      http://is.gd/D07LW7

                      About Elephant Talk

Lutz, Fla.-based Elephant Talk Communications, Inc. (OTC BB: ETAK)
-- http://www.elephanttalk.com/-- is an international provider of
business software and services to the telecommunications and
financial services industry.

Elephant Talk reported a net loss of $21.9 million in 2014, a net
loss of $25.5 million in 2013 and a net loss of $23.1 million in
2012.


ELITE PHARMACEUTICALS: Posts $16 Million Net Income for Q1
----------------------------------------------------------
Elite Pharmaceuticals, Inc., filed with the Securities and Exchange
Commission its quarterly report on Form 10-Q disclosing net income
attributable to common shareholders of $16.1 million on $7.1
million of total revenues for the three months ended June 30, 2015,
compared to a net loss attributable to common shareholders of $4.4
million on $1.1 million of total revenues for the same period in
2014.

As of June 30, 2015, the Company had $29.9 million in total assets,
$45.2 million in total liabilities and a $15.3 million total
stockholders' deficit.

As of June 30, 2015, the Company had cash on hand of $11.6 million
and a working capital surplus of $12.5 million.  The Company
believes that those resources, combined with the Company's access
to the remaining $24.6 million available pursuant to the $40
million equity line with Lincoln Park, and approximately $0.6
million available under the Hakim Credit Line are sufficient to
fund operations through the current operating cycle.

A full-text copy of the Form 10-Q is available at:

                       http://is.gd/e5uBL9

                    About Elite Pharmaceuticals

Northvale, New Jersey-based Elite Pharmaceuticals, Inc., is a
specialty pharmaceutical company principally engaged in the
development and manufacture of oral, controlled-release products,
using proprietary technology and the development and manufacture
of generic pharmaceuticals.  The Company has one product,
Phentermine 37.5mg tablets, currently being sold commercially.

Elite Pharmaceuticals reported net income attributable to common
shareholders of $28.9 million on $5 million of total revenues for
the year ended March 31, 2015, compared to a net loss attributable
to common shareholders of $96.5 million on $4.6 million of total
revenues for the year ended March 31, 2014.


ENERGY FUTURE: Noteholders Unveil Confidentiality Agreements
------------------------------------------------------------
Pursuant to the terms of Confidentiality Agreements (the
"Confidentiality Agreements") among Energy Future Holdings Corp,
Energy Future Competitive Holdings Company LLC, Texas Competitive
Electric Holdings Company LLC and Energy Future Intermediate
Holding Company LLC (collectively, the "Company Parties"), on the
one hand, and, individually, certain holders of EFIH Second Lien
Notes (the "Disclosing EFIH Second Lien Noteholders"), on the other
hand, the Disclosing EFIH Second Lien Noteholders on Aug. 3
disclosed certain information received pursuant to the
Confidentiality Agreements.

The Confidentiality Agreements provide that, upon the earliest of
several events, including August 1, 2015, the Company Parties will
publicly disclose certain cleansing materials, and that if,
following the disclosure, the EFIH Second Lien Noteholders believe
the information is insufficient, they may file their own materials.
On August 3, 2015, the Company Parties disclosed certain
information, including financial information about Oncor and a
joint proposal supported by the ad hoc group of EFIH Second Lien
Noteholders and the ad hoc group of EFIH Unsecured Noteholders.
However, the Disclosing EFIH Second Lien Noteholders believe in
good faith that certain additional information, as set for the
below, needs to be disclosed to avoid imposition of material risk
of trading restrictions on the Disclosing Second Lien Noteholders,
and are therefore issuing this press release.

The Disclosing EFIH Second Lien Noteholders understand that an ad
hoc group of TCEH First Lien Creditors (the "TCEH First Lien
Group") and an ad hoc group of TCEH Unsecured Creditors (the "TCEH
Ad Hoc Unsecured Group") are working on a joint plan proposal.  The
Disclosing EFIH Second Lien Noteholders do not have copies of the
latest proposals from the TCEH Ad Hoc Unsecured Group or the TCEH
First Lien Group.  However, on July 15, 2015, advisors to the
Disclosing EFIH Second Lien Noteholders were informed that, at that
point, the joint proposal included a construct where the TCEH Ad
Hoc Unsecured Group would only have until April 30, 2016 (which
such date may be subject to some fluctuation) to implement a REIT
Reorganization and therefore consummate a plan of reorganization
under the Merger Scenario.  During that meeting and subsequent
conversations, it was discussed that if the Merger and the REIT
Reorganization do not occur by April 30, 2016, the TCEH First Lien
Group may be able to proceed with a taxable transaction. (The terms
"REIT Reorganization," "Merger Scenario" and "Merger" are defined
in the Second Amended Plan of Reorganization of Energy Future
Holdings Corp., et al., filed with the bankruptcy court on August
3, 2015.) This information was communicated to the Disclosing EFIH
Second Lien Noteholders.  Counsel to the TCEH Ad Hoc Unsecured
Group has confirmed that, as of Aug. 3, they do not have a signed
agreement with the Company Parties or the Steering Committee of the
TCEH First Lien Group.

The Disclosing EFIH Second Lien Noteholders and their advisors make
no representations or warranties as to the factual accuracy or
reliability of any of the information disclosed in this press
release or of its materiality for any purpose.

                About Energy Future Holdings Corp.

Energy Future Holdings Corp., formerly known as TXU Corp., is
aprivately held diversified energy holding company with a
portfolioof competitive and regulated energy businesses in Texas.
Oncor,an 80 percent-owned entity within the EFH group, is the
largestregulated transmission and distribution utility in Texas.

The Company delivers electricity to roughly three million delivery
points in and around Dallas-Fort Worth.  EFH Corp. was created
inOctober 2007 in a $45 billion leverage buyout of Texas
powercompany TXU in a deal led by private-equity companies
KohlbergKravis Roberts & Co. and TPG Inc.

On April 29, 2014, Energy Future Holdings and 70 affiliated
companies sought Chapter 11 bankruptcy protection (Bankr. D.
Del.Lead Case No. 14-10979) after reaching a deal with some
keyfinancial stakeholders to keep its businesses operating
whilereducing its roughly $40 billion in debt.

The Debtors' cases have been assigned to Judge Christopher S.
Sontchi (CSS).  The Debtors are seeking to have their casesjointly
administered for procedural purposes.

As of Dec. 31, 2013, EFH Corp. reported assets of $36.4 billion in
book value and liabilities of $49.7 billion.  The Debtors have $42
billion of funded indebtedness.

EFH's legal advisor for the Chapter 11 proceedings is Kirkland &
Ellis LLP, its financial advisor is Evercore Partners and its
restructuring advisor is Alvarez & Marsal.  The TCEH first lien
lenders supporting the restructuring agreement are represented by
Paul, Weiss, Rifkind, Wharton & Garrison, LLP as legal advisor, and
Millstein & Co., LLC, as financial advisor.

The EFIH unsecured creditors supporting the restructuring agreement
are represented by Akin Gump Strauss Hauer & Feld LLP, as legal
advisor, and Centerview Partners, as financial advisor.  The EFH
equity holders supporting the restructuring agreement are
represented by Wachtell, Lipton, Rosen & Katz, as legal advisor,
and Blackstone Advisory Partners LP, as financial advisor.  Epiq
Systems is the claims agent.

Wilmington Savings Fund Society, FSB, the successor trustee forthe
second-lien noteholders owed about $1.6 billion, is represented by
Ashby & Geddes, P.A.'s William P. Bowden, Esq., and Gregory A.
Taylor, Esq., and Brown Rudnick LLP's Edward S. Weisfelner, Esq.,
Jeffrey L. Jonas, Esq., Andrew P. Strehle, Esq., Jeremy B. Coffey,
Esq., and Howard L. Siegel, Esq.

An Official Committee of Unsecured Creditors has been appointed
inthe case.  The Committee represents the interests of the
unsecured creditors of ONLY of Energy Future Competitive Holdings
Company LLC; EFCH's direct subsidiary, Texas Competitive Electric
Holdings Company LLC; and EFH Corporate Services Company, and of no
other debtors.  The Committee has selected Morrison & Foerster LLP
and Polsinelli PC for representation in this high-profile
energyrestructuring.  The lawyers working on the case are James M.
Peck, Esq., Brett H. Miller, Esq., and Lorenzo Marinuzzi, Esq., at
Morrison & Foerster LLP; and Christopher A. Ward, Esq., Justin K.
Edelson, Esq., Shanti M. Katona, Esq., and Edward Fox, Esq., at
Polsinelli PC.


ERG INTERMEDIATE: Opts to Cancel 363 Sale Process, To File Plan
---------------------------------------------------------------
ERG Intermediate Holdings LLC and its affiliates ERG Resources Inc.
LLC, ERG Operating Company, LLC, ERG Interests, LLC, and West Cat
Canyon, LLC., all of which filed for Chapter 11 protection in the
Northern District of Texas on April 30, 2015, on Aug. 12 disclosed
that the Companies have cancelled the 363 Sale Process previously
underway and instead will shortly file a Plan of Reorganization.

The Companies did not receive an acceptable bid as required under
the Bidding and Sale Procedures previously approved by the
Bankruptcy Court.  Instead, the Companies' prepetition Lender and
Debtor-in-Possession Financing Lender provided a proposal whereby
the Lenders will support a Plan of Reorganization and provide
significant exit financing to maintain and potentially expand the
Companies' California operations and assets.

Kelly Plato, the Sole Manager of the Companies, said "We believe
that a Plan of Reorganization which provides for significant new
capital in the form of exit financing and which is supported by our
current Lenders provides the best opportunity to maximize the value
of the Companies.  We also appreciate the continuing support of our
vendors and employees as we work to put our plan in place."

Also, on August 7, 2015, the Companies' Unsecured Creditors'
Committee filed a Motion seeking approval for the compromise of
controversies in accordance with a Settlement and Transaction
Support Agreement executed between the Lenders and the Committee.
Among other terms, the settlement provides for the waiver of
certain liens by the Lenders and the establishment of a Liquidation
Trust, which will be initially funded by the Lenders and which will
receive a transfer of the Companies' assets excluding those related
to the Companies' California operations.  The Bankruptcy Court in
the Northern District of Dallas will consider the Committee's
request at a hearing currently scheduled for August 25, 2015.

                      About ERG Resources

ERG Resources, LLC, is a privately owned oil & gas producer that
was formed in 1996.  Since 2010, ERG Resources and ERG Operating
Co. have been primarily engaged in the exploration and production
of crude oil and natural gas in the Cat Canyon Field in Santa
Barbara County, California.  ERG Resources owns 19,027 gross lease
acreage in the Cat Canyon Field.  ERG Resources also owns and
operates oil & gas leases representing 683 gross acres of leasehold
located in Liberty County, Texas.  The Company's corporate
headquarters is located in Houston, Texas.  Scott Y. Wood, through
two of his affiliates, owns 100% of the membership units in ERG
Intermediate Holdings LLC, the parent company.

ERG Intermediate Holdings, ERG Resources and three affiliates
sought Chapter 11 bankruptcy protection (Bankr. N.D. Tex. Case No.
15-31858) on April 30, 2015, in Dallas, Texas.

The Debtors tapped Jones Day as counsel; DLA Piper as co-counsel;
AP Services, LLC, to provide a CRO; and Epiq Bankruptcy Solutions,
LLC.

ERG Intermediate estimated $100 million to $500 million in assets
and debt.

The U.S. Trustee overseeing the Chapter 11 case of ERG Intermediate
Holdings LLC appointed five creditors of the company to serve on
the official committee of unsecured creditors.



EXELIXIS INC: FMR LLC Reports 14.9% Equity Stake
------------------------------------------------
In an amended Schedule 13G filed with the Securities and Exchange
Commission, FMR LLC, Edward C. Johnson 3d and Abigail P. Johnson
disclosed that as of Aug. 7, 2015, they beneficially owned
33,153,128 shares of common stock of Exelixis Inc., which
represents 14.999 percent of the shares outstanding.

Edward C. Johnson 3d is a director and the Chairman of FMR
LLC and Abigail P. Johnson is a director, the vice chairman, the
chief executive officer and the president of FMR LLC.

A copy of the regulatory filing is available at:

                       http://is.gd/gTJpnW

                        About Exelixis Inc.

Headquartered in South San Francisco, California, Exelixis, Inc.,
develops innovative therapies for cancer and other serious
diseases.  Through its drug discovery and development activities,
Exelixis is building a portfolio of novel compounds that it
believes has the potential to be high-quality, differentiated
pharmaceutical products.

Exelixis reported a net loss of $269 million on $25.1 million of
total revenues for the year ended Dec. 31, 2014, compared with a
net loss of $245 million on $31.3 million of total revenues in
2013.

As of March 31, 2015, the Company had $283 million in total assets,
$430 million in total liabilities and a $147 million total
stockholders' deficit.


EXELIXIS INC: T. Rowe Price Reports 10.9% Stake as of July 31
-------------------------------------------------------------
In an amended Schedule 13G filed with the Securities and Exchange
Commission, T. Rowe Price Associates, Inc. disclosed that as of
July 31, 2015, it beneficially owned 24,136,650 shares of common
stock of Exelixis, Inc., which represents 10.9 percent of the
shares outstanding.  A copy of the regulatory filing is available
for free at http://is.gd/RKQ13T

                        About Exelixis Inc.

Headquartered in South San Francisco, California, Exelixis, Inc.,
develops innovative therapies for cancer and other serious
diseases.  Through its drug discovery and development activities,
Exelixis is building a portfolio of novel compounds that it
believes has the potential to be high-quality, differentiated
pharmaceutical products.

Exelixis reported a net loss of $269 million on $25.1 million of
total revenues for the year ended Dec. 31, 2014, compared with a
net loss of $245 million on $31.3 million of total revenues in
2013.

As of March 31, 2015, the Company had $283 million in total assets,
$430 million in total liabilities and a $147 million total
stockholders' deficit.


FINJAN HOLDINGS: Posts $2.6 Million Net Loss for Second Quarter
---------------------------------------------------------------
Finjan Holdings, Inc. filed with the Securities and Exchange
Commission its quarterly report on Form 10-Q disclosing a net loss
of $2.6 million on $700,000 of revenues for the three months ended
June 30, 2015, compared to a net loss of $3.2 million on $0 of
revenues for the same period in 2014.

For the six months ended June 30, 2015, the Company reported a net
loss of $6.8 million on $700,000 of revenues compared to a net loss
of $5.2 million on $0 of revenues for the same period during the
prior year.

As of June 30, 2015, the Company had $14 million in total assets,
$2.3 million in total liabilities and $11.7 million in total
stockholders' equity.

A full-text copy of the Form 10-Q is available for free at:

                        http://is.gd/oT5tyz

                            About Finjan

Finjan, formerly known as Converted Organics, is a leading online
security and technology company which owns a portfolio of patents,
related to software that proactively detects malicious code and
thereby protects end-users from identity and data theft, spyware,
malware, phishing, trojans and other online threats.  Founded in
1997, Finjan is one of the first companies to develop and patent
technology and software that is capable of detecting previously
unknown and emerging threats on a real-time, behavior-based basis,
in contrast to signature-based methods of intercepting only known
threats to computers, which were previously standard in the online
security industry.

Finjan reported a net loss of $10.47 million in 2014 following a
net loss of $6.07 million in 2013.


FREE GOSPEL: US Trustee Unable to Form Creditor's Committee
-----------------------------------------------------------
Judy A. Robbins, the U.S. Trustee for Region 4, told the U.S.
Bankruptcy Court for the District of Maryland that she has not
appointed creditors to serve on the official committee of unsecured
creditors in the Chapter 11 Bankruptcy case of The Free Gospel of
the Apostles Doctrine because the number of persons eligible and
willing to serve on the committee is presently insufficient.  The
U.s. Trustee said it will appoint creditors to the committee upon
the request of an adequate number of eligible unsecured creditors.

The Free Gospel of the Apostles' Doctrine filed a Chapter 11
bankruptcy petition (Bankr. D. Md. Case No. 15-18209) on June 9,
2015.  The petition was signed by Antoinette Green-Snow as
executive administrator.  The Debtor estimated assets of $10
million to $50 million and debts of $1 million to $10 million.

Frank Morris, II, Esq., at Law Office of Frank Morris II, serves as
the Debtor's counsel.


GELTECH SOLUTIONS: Issues $200,000 Convertible Note
---------------------------------------------------
GelTech Solutions, Inc., issued Mr. Reger a $200,000 7.5% secured
convertible note in consideration for a $200,000 loan on Aug. 7,
2015, according to a document filed with the Securities and
Exchange Commission.

The note is convertible at $0.64 per share and matures on Dec. 31,
2020.  Repayment of the note is secured by all of the Company's
assets including its intellectual property and inventory in
accordance with a secured line of credit agreement between the
Company and Mr. Reger.  Additionally, the Company issued Mr. Reger
156,250 two-year warrants exercisable at $2.00 per share.

All of the securities were issued without registration under the
Securities Act of 1933 in reliance upon the exemption provided in
Section 4(a)(2) and Rule 506(b) thereunder.

                           About GelTech
        
Jupiter, Fla.-based GelTech Solutions. Inc., is a Delaware
corporation organized in 2006.  The Company markets four products:
(1) FireIce(R), a water soluble fire retardant used to protect
firefighters, structures and wildlands; (2) Soil2O(R) 'Dust
Control', its new application which is used for dust mitigation in
the aggregate, road construction, mining, as well as, other
industries that deal with daily dust control issues; (3)
Soil2O(R), a product which reduces the use of water and is
primarily marketed to golf courses, commercial landscapers and the
agriculture market; and (4) FireIce(R) Home Defense Unit, a system
for applying FireIce(R) to structures to protect them from
wildfires.

GelTech incurred a net loss of $7.1 million for the year ended June
30, 2014, compared to a net loss of $5.2 million for the year ended
June 30, 2013.

As of March 31, 2015, the Company had $1.47 million in total
assets, $3.93 million in total liabilities, and a $2.46 million
total stockholders' deficit.

Salberg & Company, P.A., in Boca Raton, Florida, issued a "going
concern" qualification on the consolidated financial statements for
the year ended June 30, 2014, citing that the Company has a net
loss and net cash used in operating activities in 2014 of
$7,111,945 and $5,132,019 respectively and has an accumulated
deficit and stockholders' deficit of $35,133,578 and $1,898,315,
respectively, at June 30, 2014.  These matters raise substantial
doubt about the Company's ability to continue as a going concern.


GENESIS HOLDINGS: Trial Court Erroneously Granted Summary Judgment
------------------------------------------------------------------
Judge J. Beach of the Appellate Court of Connecticut granted the
appeal filed by defendant Professional Services Group, Inc.,
finding that the trial court improperly rendered summary judgment
in favor of the plaintiff Astoria Federal Mortgage Corporation.
Judge Beach also concluded that contrary to the Plaintiff's claims,
the Defendant's claims are not barred by the doctrine of collateral
estoppel.

Judge Beach held that the trial court properly concluded that the
doctrine of collateral estoppel was not applicable as the prior
action involved a different debtor, different property, and
different encumbrances.  He says that the court in the prior case
never directly addressed the issues raised in the present case
concerning the scope of the relief from stay granted by the
Bankruptcy Court.

Judge Beach concluded that the trial court erroneously rendered
summary judgment in favor of the plaintiff.  He asserts that the
order of the Bankruptcy Court clearly stated that the relief from
the automatic stay is granted to allow the parties to move forward
with the proceedings in the Connecticut Superior Court for the
limited purpose of determining the extent, validity and priority of
the Defendant's claimed mechanic's lien.  He says that the order
clearly contemplated the Superior Court's deciding only the
specifically referred issues and that further disposition was to
occur in Bankruptcy Court.  He further says that the defendant
could not lawfully have proceeded to foreclose its lien in any
event because no party, nor the court, had the authority to proceed
with foreclosure under the circumstances.

The case is ASTORIA FEDERAL MORTGAGE CORPORATION v. GENESIS
HOLDINGS, LLC, ET. AL., AC 36590.

A full-text copy of Judge Beach's Opinion dated Aug. 4, 2015 is
available at http://is.gd/FnB6Jifrom Leagle.com



GLOBALSTAR INC: Posts $204.8-Mil. Net Income for Second Quarter
---------------------------------------------------------------
Globalstar, Inc., filed with the Securities and Exchange Commission
its quarterly report on Form 10-Q disclosing net income of $204.7
million on $23 million of total revenue for the three months ended
June 30, 2015, compared to a net loss of $433.7 million on $23.9
million of total revenue for the same period in 2014.

For the six months ended June 30, 2015, the Company reported net
income of $75 million on $44 million of total revenue compared to a
net loss of $684.2 million on $44.5 million of total revenue for
the same period last year.

As of June 30, 2015, the Company had $1.2 billion in total assets,
$1 billion in total liabilities and $223.7 million in total
stockholders' equity.

Jay Monroe, Chairman and CEO of Globalstar, commented, "We
continued our principal initiatives in the second quarter including
hitting critical milestones for the deployment of our
second-generation ground infrastructure, continuing our
geographical expansion, introducing new products and continuing to
make progress with the TLPS proceeding before the FCC.  During the
quarter we added 24,000 subscribers and over 72,000 since this time
last year.  We are pleased to announce that the Hughes-based Radio
Access Networks have now been installed at all North American
gateways with additional installations going forward on schedule.
The completion of readiness of the next generation service also
remains on schedule for early 2016, and we are looking forward to
releasing products that take advantage of the full capabilities of
our new infrastructure.  Our operations in Central and South
America have continued the trend over the past few quarters of
producing meaningful new subscriber results, despite currency
headwinds.  The FCC proceeding has also been very active over the
past few months, and we are looking forward to a conclusion."

A full-text copy of the Form 10-Q is available for free at:

                        http://is.gd/cT3rxN

                       About Globalstar, Inc.

Globalstar is a leading provider of mobile satellite voice and
data services.  Globalstar offers these services to commercial and
recreational users in more than 120 countries around the world.
The company's products include mobile and fixed satellite
telephones, simplex and duplex satellite data modems and flexible
service packages.  Many land based and maritime industries benefit
from Globalstar with increased productivity from remote areas
beyond cellular and landline service.  Globalstar customer
segments include: oil and gas, government, mining, forestry,
commercial fishing, utilities, military, transportation, heavy
construction, emergency preparedness, and business continuity as
well as individual recreational users.  Globalstar data solutions
are ideal for various asset and personal tracking, data monitoring
and SCADA applications.

Globalstar reported a net loss of $463 million in 2014, a net loss
of $591 million in 2013 and a net loss of $112.19 million in 2012.


GLOBALSTAR INC: Signs $75 Million Purchase Agreement with Terrapin
------------------------------------------------------------------
Globalstar, Inc., entered into a common stock purchase agreement
dated as of Aug. 7, 2015, with Terrapin Opportunity, L.P. pursuant
to which the Company may, subject to certain conditions, require
Terrapin to purchase up to $75 million of shares of its voting
common stock over the 24-month term following the date of the
agreement.  

The Company may not sell to Terrapin under the Purchase Agreement
any shares of voting common stock which, if aggregated with all
other shares of voting common stock then beneficially owned by
Terrapin and its affiliates, would result in the beneficial
ownership by Terrapin and its affiliates of more than 9.9% of the
number of the Company's shares of voting common stock outstanding
at the date of the sale.  Furthermore, the Company may not sell to
Terrapin under the Purchase Agreement more than 177,944,443 shares
of voting common stock (19.9% of the outstanding shares of the
Company's voting common stock immediately prior to the execution of
the Purchase Agreement) in the aggregate, unless and until the
Company's stockholders approve the transactions contemplated by the
Purchase Agreement in accordance with the rules of the NYSE MKT.

The Company has agreed to pay up to $35,000 of Terrapin's legal
fees and expenses.  No additional legal fees incurred by Terrapin
are payable by the Company in connection with any sale of shares to
Terrapin.

The issuance of the shares of common stock to Terrapin pursuant to
the terms of the Purchase Agreement has been registered by the
Company under a registration statement on Form S-3, Commission File
Number 333-205968, filed by the Company with the U.S. Securities
and Exchange Commission under the Securities Act.

The Company has agreed to indemnify Terrapin and its affiliates for
losses related to a breach of the representations and warranties by
the Company under the Purchase Agreement or any action instituted
against Terrapin or its affiliates due to the transactions
contemplated by the Purchase Agreement, subject to certain
limitations.

Financial West Group, member FINRA SIPC, served as the Company's
placement agent in connection with the financing arrangement
contemplated by the Purchase Agreement.  Pursuant to their
Engagement Letter, the Company has agreed to indemnify and hold
harmless FWG against certain liabilities, including certain
liabilities under the Securities Act.

                       About Globalstar, Inc.

Globalstar is a leading provider of mobile satellite voice and
data services.  Globalstar offers these services to commercial and
recreational users in more than 120 countries around the world.
The company's products include mobile and fixed satellite
telephones, simplex and duplex satellite data modems and flexible
service packages.  Many land based and maritime industries benefit
from Globalstar with increased productivity from remote areas
beyond cellular and landline service.  Globalstar customer
segments include: oil and gas, government, mining, forestry,
commercial fishing, utilities, military, transportation, heavy
construction, emergency preparedness, and business continuity as
well as individual recreational users.  Globalstar data solutions
are ideal for various asset and personal tracking, data monitoring
and SCADA applications.

Globalstar reported a net loss of $463 million in 2014, a net loss
of $591 million in 2013 and a net loss of $112.19 million in 2012.

As of June 30, 2015, the Company had $1.2 billion in total assets,
$1 billion in total liabilities and $223.7 million in total
stockholders' equity.


HEALTHWAREHOUSE.COM INC: Incurs $159,600 Net Loss in 2nd Quarter
----------------------------------------------------------------
HealthWarehouse.com, Inc. filed with the Securities and Exchange
Commission its quarterly report on Form 10-Q disclosing a net loss
attributable to common stockholders of $159,642 on $1.8 million of
net sales for the three months ended June 30, 2015, compared to a
net loss attributable to common stockholders of $439,771 on $1.4
million of net sales for the same period in 2014.

For the six months ended June 30, 2015, the Company reported a net
loss attributable to common stockholders of $440,391 on $3.4
million of net sales compared to a net loss attributable to common
stockholders of $820,142 on $3.1 million of net sales for the same
period during the prior year.

As of June 30, 2015, the Company had $1.2 million in total assets,
$4.7 million in total liabilities and a $3.5 million total
stockholders' deficiency.

Since inception, the Company has financed its operations primarily
through debt and equity financings and advances from related
parties.  As of June 30, 2015, the Company had a working capital
deficiency of $4,102,320 and an accumulated deficit of $30,653,255.
During the six months ended June 30, 2015, and the year ended Dec.
31, 2014, the Company incurred net losses of $280,469 and
$1,783,279, respectively and used cash in operating activities of
$288,043 and $875,769, respectively.  These conditions raise
substantial doubt about the Company's ability to continue as a
going concern.

                         Bankruptcy Warning

"The Company recognizes it will need to raise additional capital in
order to fund operations, meet its payment obligations and execute
its business plan.  There is no assurance that additional financing
will be available when needed or that management will be able to
obtain financing on terms acceptable to the Company and whether the
Company will become profitable and generate positive operating cash
flow.  If the Company is unable to raise sufficient additional
funds, it will have to develop and implement a plan to further
extend payables, attempt to extend note repayments, attempt to
negotiate the preferred stock redemption and reduce overhead until
sufficient additional capital is raised to support further
operations.  There can be no assurance that such a plan will be
successful.  If the Company is unable to obtain financing on a
timely basis, the Company could be forced to sell its assets,
discontinue its operation and /or seek reorganization under the
U.S. bankruptcy code," the Company stated in the Quarterly Report.

A full-text copy of the Form 10-Q is available at:

                        http://is.gd/eVBFY1

                     About HealthWarehouse.com

HealthWarehouse.com, Inc., headquartered in Florence, Kentucky,
is a U.S. licensed virtual retail pharmacy ("VRP") and healthcare
e-commerce company that sells brand name and generic prescription
drugs as well as over-the-counter medical products.

Healthwarehouse.com reported a net loss attributable to common
stockholders of $2.08 million on $6.12 million of net sales for the
year ended Dec. 31, 2014, compared with a net loss attributable to
common stockholders of $7.3 million on $10.23 million of net sales
in 2013.

Marcum LLP, in New York, issued a "going concern" qualification on
the consolidated financial statements for the year ended Dec. 31,
2014, citing that the Company has incurred significant losses and
needs to raise additional funds to meet its obligations and sustain
its operations.  These conditions raise substantial doubt about the
Company's ability to continue as a going concern.


HOLIDAY MARINAS: Case Summary & 20 Largest Unsecured Creditors
--------------------------------------------------------------
Debtor: Holiday Marinas, Incorporated
        14900 Winnwood Road
        Dallas, TX 75254

Case No.: 15-33301

Chapter 11 Petition Date: August 11, 2015

Court: United States Bankruptcy Court
       Northern District of Texas (Dallas)

Judge: Hon. Stacey G. Jernigan

Debtor's Counsel: Rakhee V. Patel, Esq.
                  SHACKELFORD, MELTON, MCKINLEY & NORTON LLP
                  3333 Lee Parkway, Tenth Floor
                  Dallas, TX 75219
                  Tel: 214-780-1400
                  Fax: 214-780-1401
                  Email: rpatel@shacklaw.net

Estimated Assets: $1 million to $10 million

Estimated Liabilities: $100,000 to $500,000

The petition was signed by Jeff Lagow, president.

A list of the Debtor's 20 largest unsecured creditors is available
for free at http://bankrupt.com/misc/txnb15-33301.pdf


HYDROCARB ENERGY: Sells $1 Million Convertible Note to JMJ
----------------------------------------------------------
Hydrocarb Energy Corporation, on July 28, 2015, sold JMJ Financial
a convertible promissory note in the principal amount of up to
$1,000,000, according to a Form 8-K document filed with the
Securities and Exchange Commission.  

The initial amount received in connection with the sale of the JMJ
Convertible Note was $300,000, and the JMJ Convertible Note
currently has a face amount of $330,000, as all amounts borrowed
under the note include a 10% original issue discount.  Moving
forward, JMJ may loan the Company additional funds (up to $900,000
in aggregate) at the Company's request, provided that JMJ has the
right in its sole discretion to approve any future request for
additional funding.  Each advance under the JMJ Convertible Note is
due two years from the date of that advance, with the $330,000
initially owed under the note due on July 28, 2017.

The JMJ Convertible Note is convertible into the Company's common
stock, beginning 180 days after the date the note was sold
(Jan. 24, 2016), at the lesser of $1.23 per share or 60% of the
lowest trading price of the Company's common stock in the 25
trading days prior to the date of any conversion, provided that if
the Company is not DWAC eligible at the time of any conversion an
additional 10% discount applies, and in the event the Company's
common stock is not DTC eligible at the time of any conversion, an
additional 5% discount applies.  The JMJ Convertible Note provides
that unless the Company and JMJ agree in writing, JMJ is not
eligible to convert any amount of the note into common stock which
would result in JMJ owning more than 4.99% of the Company's common
stock.
  
A one-time interest charge of 12% was applied to the principal
amount of the note, which remains payable regardless of the
repayment (or conversion) date of the note.

JMJ agreed to subordinate all amounts owed to it under the JMJ
Convertible Note to the amounts the Company owes to its senior
lender.

For so long as the JMJ Convertible Note is outstanding JMJ agreed
not to effect any "short sales" of the Company's common stock.

The Company agreed to use $190,000 of the amount received in
connection with the sale of the JMJ Convertible Note to repay in
full the Feb. 23, 2015, convertible promissory note sold to JSJ
Investments Inc.  In the event the Company fails to use those funds
for such purpose, the Company is required to pay JMJ liquidated
damages in the amount of $100,000.

                       About Hydrocarb Energy

Hydrocarb Energy, formerly known as Duma Energy Corp, is a
publicly-traded Domestic and International energy exploration and
production company targeting major under-explored oil and gas
projects in emerging, highly prospective regions of the world.
With exploration concessions in Africa, production in Galveston
Bay and Oil Field Services in the United Arab Emirates, the
Company maintain offices in Houston, Texas, Abu Dhabi, UAE and
Windhoek, Namibia.

Hydrocarb Energy reported a net loss of $6.55 million on $5.06
million of revenues for the year ended July 31, 2014, compared to
a net loss of $37.5 million on $7.07 million of revenues for the
year ended July 31, 2013.

As of April 30, 2015, the Company had $27.6 million in total
assets, $24.2 million in total liabilities and $3.4 million in
total equity.

"A decline in the price of our common stock could result in a
reduction in the liquidity of our common stock and a reduction in
our ability to raise additional capital for our operations.
Because our operations to date have been largely financed through
the sale of equity securities, a decline in the price of our
common stock could have an adverse effect upon our liquidity and
our continued operations.  A reduction in our ability to raise
equity capital in the future could have a material adverse effect
upon our business plan and operations, including our ability to
continue our current operations," the Company stated in its
annual report for the year ended July 31, 2014.


IDERA PHARMACEUTICALS: To Issue 6.2M Shares Under Incentive Plan
----------------------------------------------------------------
Idera Pharmaceuticals, Inc. filed a Form S-8 registration statement
with the Securities and Exchange Commission to register the offer
and sale of an additional 6,226,438 shares of the Company's common
stock, $0.001 par value per share, to be issued under its 2013
Stock Incentive Plan, as amended.

The Company separately registered 275,000 shares issuable under its
Inducement Stock Option Award pursuant to a nonstatutory stock
option agreement entered into with Mark Casey on June 29, 2015.

                            About Idera

Cambridge, Massachusetts-based Idera Pharmaceuticals, Inc., is a
clinical stage biotechnology company engaged in the discovery and
development of novel synthetic DNA- and RNA-based drug candidates
that are designed to modulate immune responses mediated through
Toll-like Receptors, or TLRs.  The Company has two drug
candidates, IMO-3100, a TLR7 and TLR9 antagonist, and IMO-8400, a
TLR7, TLR8, and TLR9 antagonist, in clinical development for the
treatment of autoimmune and inflammatory diseases.

Idera Pharmaceuticals reported a net loss attributable to common
stockholders of $39.2 million in 2014, a net loss applicable to
common stockholders of $21.09 million in 2013 and a net loss
applicable to common stockholders of $22.5 million in 2012.

As of June 30, 2015, the Company had $109.8 million in total
assets, $7.3 million in total liabilities and $102.5 million in
total stockholders' equity.


IMAGEWARE SYSTEMS: Posts $2.1 Million Net Loss for Second Quarter
-----------------------------------------------------------------
Imageware Systems, Inc. filed with the Securities and Exchange
Commission its quarterly report on Form 10-Q disclosing a net loss
available to common shareholders of $2.1 million on $1.7 million of
revenues for the three months ended June 30, 2015, compared to a
net loss available to common shareholders of $2.1 million on
$937,000 of revenues for the same period in 2014.

For the six months ended June 30, 2015, the Company reported a net
loss available to common shareholders of $4.6 million on $2.6
million of revenues compared to a net loss available to common
shareholders of $3.7 million on $2 million of revenues for the same
period last year.

As of June 30, 2015, the Company had $11.1 million in total assets,
$3.7 million in total liabilities and $7.4 million in total
shareholders' equity.

At June 30, 2015, the Company's principal sources of liquidity
consisted of cash and cash equivalents of $6,448,000 and accounts
receivable, net of $313,000.  As of June 30, 2015, the Company had
positive working capital of $5,462,000, which included $650,000 of
deferred revenue.  The Company has a history of recurring losses,
and as of June 30, 2015, it has incurred a cumulative net loss of
approximately $140,895,000.

A full-text copy of the Form 10-Q is available for free at:

                       http://is.gd/VRldzy

                     About ImageWare Systems

Headquartered in San Diego, California, ImageWare Systems, Inc.,
is a leader in the emerging market for software-based identity
management solutions, providing biometric, secure credential, law
enforcement and enterprise authorization.  Its "flagship" product
is the IWS Biometric Engine.  Scalable for small city business or
worldwide deployment, the Company's biometric engine is a multi-
biometric platform that is hardware and algorithm independent,
enabling the enrollment and management of unlimited population
sizes.  The Company's identification products are used to manage
and issue secure credentials, including national IDs, passports,
driver licenses, smart cards and access control credentials.  Its
law enforcement products provide law enforcement with integrated
mug shot, fingerprint LiveScan and investigative capabilities.
The Company also provides comprehensive authentication security
software.

Imageware Systems incurred a net loss of $9.84 million in 2013, a
net loss of $10.2 million in 2012 and a net loss of $3.18 million
in 2011.


INFOR INC: S&P Rates Proposed $400MM Sr. Secured Notes 'B+'
-----------------------------------------------------------
Standard & Poor's Ratings Services said that it assigned its 'B+'
issue-level rating and '2' recovery rating to New York City-based
enterprise resource planning (ERP) software provider Infor Inc.'s
proposed $400 million senior secured notes due 2020.  The '2'
recovery rating indicates S&P's expectation for substantial
recovery (70% to 90%; lower half of the range) in the event of
payment default.  These ratings are the same as S&P's ratings on
the company's existing secured debt, but the incremental issuance
results in S&P's recovery expectation for secured lenders shifting
to the lower half of the 70% to 90% range.  S&P's ratings on the
company's unsecured debt and holding company notes are unchanged.
S&P expects Infor to use the proceeds to partly fund the
acquisition of a cloud-based global trade and supply chain
management software provider.

S&P's 'B' corporate credit rating and stable rating outlook on
Infor are unchanged.  The rating reflects S&P's view of the
competitive ERP marketplace with significantly larger players and
meaningful exposure to manufacturing and distribution end-markets,
but also the company's strong position among midmarket customers.
The rating also reflects S&P's view of Infor's leverage, which S&P
expects to peak in the 9x area in fiscal 2016, up from the low 8x
area as of April 30, 2015 pro forma for the acquisition, as EBITDA
declines because of a strengthening U.S. dollar, increased costs to
support software-as-a-service (SaaS) offerings, and SaaS offerings
cannibalizing license sales, which S&P views favorably over the
long term but which will cause revenue to decline over the next
year because of differences in the revenue recognition patterns of
both models.  S&P expects leverage to fall to the mid- to high 8x
area in 2017 on margin expansion as the company benefits from
operating leverage on SaaS offerings.  In fiscal years 2016 and
2017 S&P expects annual free operating cash flow (FOCF) to be above
the low $200 million area and interest coverage to be in the low-2x
area.  S&P's forecast does not include assumptions about
acquisitions, but if the company were to complete tuck-in
acquisitions funded from FOCF, as it has in the past, leverage
would fall more quickly than S&P expects.

The stable outlook reflects S&P's view of Infor's revenue
visibility, good FOCF, and interest coverage that is strong for the
'B' rating.  S&P could lower the rating if increased business
investment in support of the company's SaaS products or more
compelling offerings from competitors result in declines in
profitability, or if the company pursues an acquisition or
shareholder distribution such that it sustains leverage above the
9x area.  S&P is unlikely to raise the rating during the next 12
months because of the company's high leverage and S&P's view that
its private equity ownership structure likely precludes sustained
leverage reduction.

RATINGS LIST

Infor Inc.
Corporate credit rating          B/Stable/--

New Rating

Infor Inc.
$400 mil sr sec nts due 2020     B+
  Recovery rating                 2L



INSITE VISION: Gets Unsolicited Proposal from Pharma Company
------------------------------------------------------------
InSite Vision Inc. announced that it has received an unsolicited
proposal from a multi-national pharmaceutical company
pharmaceutical company to acquire all outstanding shares of its
common stock at a price of $0.25 per share in cash.  The proposal
is non-binding and is subject to further due diligence.

As previously announced, InSite Vision is party to a merger
agreement with QLT Inc. pursuant to which QLT would acquire InSite
in an all-stock transaction in which InSite Vision's stockholders
would receive 0.048 QLT shares for each share of InSite Vision that
they hold.

Consistent with its fiduciary duties and in accordance with its
existing merger agreement with QLT, InSite Vision's Board of
Directors, in consultation with its financial and legal advisors,
will carefully review all aspects of the new proposal and pursue
the course of action that it believes is in the best interests of
InSite's stockholders.  InSite's stockholders do not need to take
any action at this time.

InSite Vision remains subject to its existing merger agreement with
QLT and the InSite Vision Board of Directors, has not changed its
recommendation in support of the QLT transaction, the exiting
merger agreement with QLT or its recommendation that InSite Vision
stockholders adopt the existing merger agreement with QLT.

Guggenheim Securities, LLC is acting as financial advisor to InSite
Vision, Roth Capital Partners provided an independent fairness
opinion and Jones Day is acting as legal advisor to InSite.

                           InSite Vision

Based in Alameda, California, InSite Vision Incorporated (OTCBB:
INSV) -- http://www.insitevision.com/-- is committed to
advancing new and superior ophthalmologic products for unmet eye
care needs.  The company's product portfolio utilizes InSite
Vision's proven DuraSite(R) bioadhesive polymer core technology, a
platform that extends the duration of drug retention on the
surface of the eye, thereby reducing frequency of treatment and
improving the efficacy of topically delivered drugs.

Burr Pilger Mayer, Inc., in E. Palo Alto, California, issued a
"going concern" qualification on the consolidated financial
statements for the year ended Dec. 31, 2014, citing that the
Company's recurring losses from operations, available cash balance
and accumulated deficit raise substantial doubt about its ability
to continue as a going concern.

Insite Vision reported net income of $26.8 million in 2014 compared
to net income of $5.7 million in 2013.

As of March 31, 2015, the Company had $4.09 million in total
assets, $12.23 million in total liabilities and a $8.13 million
total stockholders' deficit.


INVENTIV HEALTH: Second Quarter Conference Call Set for Aug. 17
---------------------------------------------------------------
inVentiv Health, Inc. will hold a conference call at 1:00 p.m.
Eastern Time on Aug. 17, 2015, during which it will discuss the
Company's financial results for the second quarter of 2015.

The U.S. dial-in for the call is (800) 901-5213 ((617) 786-2962 for
non-U.S. callers) and the passcode is 49616487.  A replay of the
conference call will be available until Aug. 24, 2015, by dialing
(888) 286-8010 ((617) 801-6888 for non-U.S. calls) and the passcode
is 70578543.

                       About inVentiv Health

inVentiv Health, Inc., is privately owned by inVentiv Group
Holdings, Inc., an organization sponsored by affiliates of Thomas
H. Lee Partners, L.P., Liberty Lane Partners and members of the
inVentiv Health management team.

inVentiv Health is a top-tier professional services organization
that accelerates the clinical and commercial success of
biopharmaceutical companies worldwide.  The Company's combined
Clinical Research Organization and Contract Commercial Organization
helps clients improve their performance to deliver much-needed
therapies to market.  With 13,000 employees providing services to
clients in 70 countries, inVentiv Health designs best practices,
processes and systems to enable clients to successfully navigate an
increasingly complex environment.
- See more at:
http://www.inventivhealth.com/our-company/investors#sthash.Oi040G6G.dpuf

                            *   *    *

As reported by the TCR on May 22, 2015, Moody's Investors Service
affirmed the Caa1 Corporate Family Rating and Caa1-PD Probability
of Default Rating of inVentiv Health, Inc. as well as all of the
instrument ratings.  The Caa1 rating reflects inVentiv's very high
leverage, history of negative free cash flow and significant
interest burden which will make a default event likely if the
company does not significantly improve its EBITDA performance well
ahead of 2018, when all of the company's debt matures.

The TCR reported on Dec. 12, 2012, that Standard & Poor's Ratings
Services affirmed its 'B-' corporate credit rating on Burlington,
Mass.-based contract research organization (CRO) inVentiv Health
Inc.


JONES ENERGY: Fitch Assigns 'B' Long-term Issuer Default Rating
---------------------------------------------------------------
Fitch Ratings has assigned a Long-term Issuer Default Rating of 'B'
to Jones Energy Holdings, LLC (JEH), a subsidiary of Jones Energy
Inc. (NYSE: JONE).

The Rating Outlook is Stable.

KEY RATING DRIVERS

Ratings for JEH reflect a competitive full-cycle cost structure,
strong hedge positions and defensive hedging philosophy, reasonable
credit metrics for the category, and an adequate liquidity profile
considering the 2015 investment program. Company strengths are
offset by small size, geographic concentration, and the potential
for sustained lower oil and natural gas prices, which places
additional importance on lowering drilling and production costs and
maintaining adequate hedge coverage.

COMPETITIVE FULL-CYCLE COST STRUCTURE

JONE has a long track record in its primary basin (Cleveland Basin,
located in the OK and TX Panhandle), and has developed and improved
drilling & completion techniques specific to the Cleveland. This
allows the company to achieve competitive internal rates of return
(IRRs) by reducing costs in a lower commodity price environment.
JONE has lowered well costs approximately 32% thus far in 2015
(from $3.8 million/well to $2.6 million/well), driven largely by
reductions in frac services and rig rates. JONE generated cash
netbacks of $29/boe in 2014, which is competitive with
liquids-focused peers.

Fitch views the company's focus on returns rather than production
volumes as a credit-positive considering its asset size and
positioning in the context of a challenging commodity price
environment. Over 80% of acreage is held by production, reducing
the need to spend additional capital to hold lease positions. The
company's production mix for the first half of 2015 (1H15) was 30%
oil, 27% NGL, and 43% natural gas.

GOOD HEDGE POSITIONS THROUGH 2016

JONE's hedge positions provide significant cash flow protection and
serve to differentiate JONE from high-yield E&P peers. The company
has a track record of aggressively hedging production volumes
through a variety of commodity price environments. This provides
increased confidence in cash flow and credit metrics forecasts due
to more certainty on top-line forecasts. JONE currently has 100% of
2H15 oil hedged at $84.11/bbl. For 2016, on a barrel of oil
equivalent basis, JONE has 75% of expected oil and natural gas
production hedged at prices of $82.74/bbl for oil and $4.44/mcf for
gas. The mark-to-market value of hedges was $220 million as of the
company's 2Q earnings release on August 6.

REASONABLE CREDIT METRICS

As calculated by Fitch, JONE debt/EBITDA was 3.2x at June 30, 2015.
Fitch expects leverage of 3.5x and 3.7x in 2015 and 2016,
respectively, driven by moderately lower hedge coverage and Fitch's
base case price deck. Interest coverage is expected to remain above
4x in 2015 and 2016. While out-year credit metrics will depend in
part on the path of future commodity prices and the ability of JONE
to economically hedge, Fitch believes that metrics will remain in
line for the rating at our base case price deck (long term: $70/bbl
oil, $3.75/mcf natural gas).

ADEQUATE LIQUIDITY POSITIONING

JONE was active in the capital markets in 1H15, issuing $123
million in equity and selling $250 million in senior notes, terming
out credit facility borrowings, and bolstering liquidity. JONE had
total liquidity of $485.5 million at June 30, consisting of $23
million in cash and $462.5 million available on the credit
facility. The company's liquidity position is adequate relative to
Fitch's cash flow forecasts, which are helped by lower capex in
2015 and cash flow uplift from hedge positions. JONE's borrowing
base was affirmed at $562.5 million in April 2015, indicating that
the bank group is taking a constructive view of JONE's ability to
economically produce the reserve base.

GEOGRAPHIC CONCENTRATION

JONE's single-basis focus in the Cleveland has both positive and
negative credit quality factors. On one hand, a single-asset focus
has allowed the company to eke out production efficiencies and
asset-specific techniques, with lower costs relative to basin
peers. On the other hand, JONE is uniquely exposed to the geology
of the Cleveland, including expected ultimate recoveries, decline
rates, and issues including local rig availability and changes in
service costs. Fitch believes the positives outweigh the negatives
in the case of JONE, but a single-basin focus does serve to limit
ratings upside in the near term.

SMALL SIZE RELATIVE TO PEERS

JONE 2015 YTD production was 25,862 barrels of oil equivalent per
day, which is small relative to Fitch's actively monitored E&P peer
universe. Fitch believes that, while the current rating is
supported by the other factors mentioned, ratings upside will
likely be limited in the near-term due to size and asset diversity
issues.

RECENT FINANCIAL PERFORMANCE

As calculated by Fitch and including the effect of settled
derivative contracts, LTM free cash flow (FCF) was negative $210
million at June 30, 2015, driven by higher capex run rates in the
last half of 2014. Fitch expects that lower capex exit rates in
2015 will lead to a FCF neutral-to modestly negative position, with
leverage under 4x, in the current commodity price environment.
Current hedge positions will provide meaningful amounts of cash
flow protection through 2016, and give the company some flexibility
in managing production growth relative to changes in commodity
prices.

RECOVERY ANALYSIS

JONE recoveries are estimated as outstanding ('RR1' - 100%) at the
first-lien secured level and as average ('RR4' - 31% to 50%) at the
unsecured level. Recovery estimates are influenced by reduced value
estimates for oil and gas reserves. Recovery values are based on
estimated liquidation values of proved (1P) reserves. Fitch begins
with a standard value of $12.50/boe for an average producer based
on our long-term price deck ($70/bbl oil, $3.75/mcf natural gas).
Fitch makes adjustments for location and quality, oil & gas mix, as
well as adjustments related to the recent decline in commodity
prices.

KEY ASSUMPTIONS

-- WTI oil prices of $50/bbl in 2015, $60/bbl in 2016, increasing

    to $70/bbl in 2018;

-- Natural gas prices of $3.00/mcf in 2015, increasing to
    $3.75/mcf in 2018;

-- Production volumes grow at a 4% CAGR through 2018;

-- 2015 capex is consistent with management guidance of $240
    million. In out-years, capex trends in-line with the price
    deck and supports higher YoY production growth in 2017-2018;

-- Existing hedge positions protect cash flow through 2016, with
    more modest protection in 2017 and 2018.

RATING SENSITIVITIES

Positive: Future developments that may lead to positive rating
actions include:

-- Growth in production volumes and EBITDA leading to production
    greater than 50 mboe/day and/or EBITDA over $500 million;
-- Maintenance of debt/EBITDA in the 3.5x-4.0x range and
    debt/Proved Developed in the $14-$16/boe range;
-- Maintenance of a balanced financing policy and an adequate
    hedging program for growth in the face of higher commodity
    prices.

Fitch views positive rating actions as unlikely in the near term.
Pressures from lower commodity prices will likely inhibit
production growth, which will be a key factor in improving credit
quality.

Negative: Future developments that may lead to negative rating
actions include:

-- Debt/EBITDA sustained above 5x, driven by the inability to
    hedge future production at economic prices or increases in
    debt,

-- Debt/PD of $17-$18/boe;

-- Adoption of less conservative hedging policy, leading to
    reduced visibility on cash flows and increased vulnerability
    to sustained lower oil and gas prices;

-- Significant reduction in liquidity following aggressive use of

    revolver for growth, or lower borrowing base redeterminations.

FULL LIST OF RATING ACTIONS

Fitch assigns the following ratings:

Jones Energy Holdings, LLC (JEH)

-- Long-term Issuer Default Rating (IDR) 'B';
-- Senior secured first lien revolver 'BB/RR1';
-- Senior unsecured notes 'B/RR4'.

The Rating Outlook is Stable.


LOST ACRES: Voluntary Chapter 11 Case Summary
---------------------------------------------
Debtor: Lost Acres, LLC
        3148 N. 400 E.
        Monticello, IN 47960

Case No.: 15-40390

Chapter 11 Petition Date: August 11, 2015

Court: United States Bankruptcy Court
       Northern District of Indiana
       (Hammond Division at Lafayette)

Judge: Hon. Robert E. Grant

Debtor's Counsel: David A. Rosenthal (VM), Esq.
                  410 Main Street
                  Lafayette, IN 47901
                  Tel: (765) 423-5375
                  Fax: (765) 423-2597
                  Email: darlaw@nlci.com

Estimated Assets: $100,000 to $500,000

Estimated Liabilities: $1 million to $10 million

The petition was signed by Angela M. Holbrook, member.

The Debtor did not include a list of its largest unsecured
creditors when it filed the petition.


MALIBU ASSOCIATES: Disclosure Statement Hearing Moved to Aug. 27
----------------------------------------------------------------
The United States Bankruptcy Court for the Central District of
California, Northern Division, approved a stipulation under which
Malibu Associates, LLC, and U.S. Bank National Association agreed
to reschedule to Aug. 27, 2015, the hearing on the approval of the
Debtor's disclosure statement explaining its reorganization plan
and U.S. Bank's motion to lift stay and motion to convert the
Chapter 11 case to a Chapter 7 case.

Because of the vacation schedule of Debtor's counsel, and to
coordinate discovery, the parties agreed to reschedule the hearings
on the Proceedings.  The parties agreed to cooperate in good faith
in connection with any other discovery propounded in advance of the
hearings on the Proceedings.  The parties further agreed that the
briefing schedule on the Proceedings shall be set by the Local
Bankruptcy Rules based on the continued hearing date.

The Debtor is represented by:

          David Neale, Esq.
          Lindsey L. Smith, Esq.
          LEVENE, NEALE, BENDER, YOO & BRILL LLP
          10250 Constellation Boulevard  Suite 1700
          Los Angeles, CA  90067
          Tel: (310) 229-1234
          FAX: (310) 229-1244
          Email: dln@lnbyb.com
                 lls@lnbyb.com

U.S. Bank National Association is represented by:

          Joshua D. Wayser, Esq.
          Cristina E. Bautista, Esq
          KATTEN MUCHIN ROSENMAN LLP
          2029 Century California East, Suite 2600
          Los Angeles, California 90067-3012
          Tel: (310)788-4400
          Fax: (310) 788-4471
          Email: joshua.wayser@kattenlaw.com
                 cristina.bautista@kattenlaw.com

                       About Malibu Associates

Headquartered in Malibu, California, Malibu Associates, LLC, owns
the Malibu Golf Club.  The club has a restaurant and clubhouse, in
addition to an 18-hole golf course, on its 650-acre property in
the
Santa Monica Mountains.

Malibu Associates sought Chapter 11 protection (Bankr. C.D. Cal.
Case No. 15-10477) in Santa Barbara, California, on March 10,
2015,
disclosing $76.2 million in total assets and $47.8 million in
total
liabilities.  Thomas Hix, the managing member of the Debtor,
signed
the bankruptcy petition.

The Debtor owns real property located at 901 Encinal Canyon Road,
Malibu, California.  The property secures a $46.8 million debt to
U.S. Bank, National Association, which is secured by a first deed
of trust on the property.  The Los Angeles County Treasurer and
Tax
Collector is also owed $459,800, secured by a tax lien on the
property.

The case is assigned to Judge Deborah J. Saltzman.  David L.
Neale,
Esq., at Levene Neale Bender Rankin & Brill LLP, in Los Angeles,
serves as counsel to the Debtor.

The Debtor previously sought bankruptcy protection on Nov. 3,
2009,
in the Central District of California, San Fernando Valley
Division
(Bankr. C.D. Cal. Case No. No. 9-24625).   That case was assigned
to the Honorable Maureen A. Tighe, but was later dismissed.  The
real property in Malibu was included in the prior filing.


MALIBU ASSOCIATES: Seeks Jan. 4 Extension of Solicitation Period
----------------------------------------------------------------
Malibu Associates, LLC, asks the United States Bankruptcy Court for
the Central District of California, Northern Division, to extend
its exclusive period to obtain acceptances of their plan of
reorganization through and including January 14, 2016.

David Neale, Esq., at Levene, Neale, Bender, Yoo & Brill LLP, in
Los Angeles, California, relates that the Debtor's case has some
complexity to it because its property, which is the Debtor's
primary asset, is a very valuable and unique Property, a sale of
which is bound to be complicated.  Notwithstanding, the Debtor has
already filed the Plan and is solely requesting an extension of the
exclusivity period to obtain acceptance of that Plan.

Thomas C. Hix, the President of the co-managing member of Malibu
Associates, LLC, declared that the Debtor filed a plan of
reorganization and is moving forward with obtaining approval of the
Disclosure Statement and thereafter intends to promptly seek
confirmation of the Plan.

The Debtor is represented by:

          David Neale, Esq.
          Lindsey L. Smith, Esq.
          LEVENE, NEALE, BENDER, YOO & BRILL LLP
          10250 Constellation Boulevard  Suite 1700
          Los Angeles, CA  90067
          Tel: (310) 229-1234
          FAX: (310) 229-1244
          Email: dln@lnbyb.com
                 lls@lnbyb.com

                        About Malibu Associates

Headquartered in Malibu, California, Malibu Associates, LLC, owns
the Malibu Golf Club.  The club has a restaurant and clubhouse, in
addition to an 18-hole golf course, on its 650-acre property in
the
Santa Monica Mountains.

Malibu Associates sought Chapter 11 protection (Bankr. C.D. Cal.
Case No. 15-10477) in Santa Barbara, California, on March 10,
2015,
disclosing $76.2 million in total assets and $47.8 million in
total
liabilities.  Thomas Hix, the managing member of the Debtor,
signed
the bankruptcy petition.

The Debtor owns real property located at 901 Encinal Canyon Road,
Malibu, California.  The property secures a $46.8 million debt to
U.S. Bank, National Association, which is secured by a first deed
of trust on the property.  The Los Angeles County Treasurer and
Tax
Collector is also owed $459,800, secured by a tax lien on the
property.

The case is assigned to Judge Deborah J. Saltzman.  David L.
Neale,
Esq., at Levene Neale Bender Rankin & Brill LLP, in Los Angeles,
serves as counsel to the Debtor.

The Debtor previously sought bankruptcy protection on Nov. 3,
2009,
in the Central District of California, San Fernando Valley
Division
(Bankr. C.D. Cal. Case No. No. 9-24625).   That case was assigned
to the Honorable Maureen A. Tighe, but was later dismissed.  The
real property in Malibu was included in the prior filing.


MALIBU ASSOCIATES: U.S. Bank Wants Ch. 11 Case Converted to Ch. 7
-----------------------------------------------------------------
U.S. Bank National Association asks the United States Bankruptcy
Court for the Central District of California, Northern Division, to
convert the Chapter 11 case of Malibu Associates, LLC, to one under
Chapter 7 of the Bankruptcy Code.

The Banks asserts that the Debtor simply has been unable to manage
its property -- known as 901 Encinal Canyon Road, in Malibu,
California -- and the loans encumbering it.  Thus, a Chapter 7
Trustee should be brought in to promptly dispose of the Property,
the Bank adds.

The Bank also asks the Court to lift the automatic stay to allow it
to foreclose upon and obtain possession of the Malibu property.

The Bank believes that the Debtor lacks equity in its sole asset --
the golf club Property -- as the Property's market value is only
$15,000,000, and there is at least $49,796,422 in secured claims on
the Property.  Meanwhile, the Bank asserts that the value of the
Property is declining, and real property taxes on the Property are
unpaid and continue to accrue penalties and interest.  The Property
is not necessary to an effective reorganization, the Bank adds.

U.S. Bank National Association is represented by:

          Joshua D. Wayser, Esq.
          Cristina E. Bautista, Esq.
          KATTEN MUCHIN ROSENMAN LLP
          2029 Century California East, Suite 2600
          Los Angeles, California 90067-3012
          Tel: (310)788-4400
          Fax: (310) 788-4471
          Email: joshua.wayser@kattenlaw.com
                 cristina.bautista@kattenlaw.com

                     About Malibu Associates

Headquartered in Malibu, California, Malibu Associates, LLC, owns
the Malibu Golf Club.  The club has a restaurant and clubhouse, in
addition to an 18-hole golf course, on its 650-acre property in
the
Santa Monica Mountains.

Malibu Associates sought Chapter 11 protection (Bankr. C.D. Cal.
Case No. 15-10477) in Santa Barbara, California, on March 10,
2015,
disclosing $76.2 million in total assets and $47.8 million in
total
liabilities.  Thomas Hix, the managing member of the Debtor,
signed
the bankruptcy petition.

The Debtor owns real property located at 901 Encinal Canyon Road,
Malibu, California.  The property secures a $46.8 million debt to
U.S. Bank, National Association, which is secured by a first deed
of trust on the property.  The Los Angeles County Treasurer and
Tax
Collector is also owed $459,800, secured by a tax lien on the
property.

The case is assigned to Judge Deborah J. Saltzman.  David L.
Neale,
Esq., at Levene Neale Bender Rankin & Brill LLP, in Los Angeles,
serves as counsel to the Debtor.

The Debtor previously sought bankruptcy protection on Nov. 3,
2009,
in the Central District of California, San Fernando Valley
Division
(Bankr. C.D. Cal. Case No. No. 9-24625).   That case was assigned
to the Honorable Maureen A. Tighe, but was later dismissed.  The
real property in Malibu was included in the prior filing.


MARINA BIOTECH: Announces $1.1-Mil. Preferred Stock Financing
-------------------------------------------------------------
Marina Biotech, Inc., has entered into a definitive agreement with
existing investors, led by Steven T. Newby and James H. Stebbins,
for the issuance of convertible preferred stock at a conversion
price equivalent to $0.40 per share of common stock resulting in
gross proceeds to the company of $1.1 million.  In addition, the
Company will issue to the investors warrants to purchase up to
3,437,500 shares of common stock.  The warrants will have an
exercise price of $0.40 per share and are exercisable for a period
of six years after the date of issuance.  The offering is expected
to close on or about Aug. 7, 2015, subject to the satisfaction of
customary closing conditions.

"Coming on the heels of the FDA's Fast Track designation for
CEQ508, this investment will permit us to focus on business
development related transactions intended to significantly improve
our value and bring in non-dilutive capital," stated J. Michael
French, president and chief executive officer at Marina Biotech.
"We appreciate the continued confidence of our investors and the
future opportunities open to us through this financing."

                       About Marina Biotech

Marina Biotech, Inc., headquartered in Bothell, Washington, is a
biotechnology company focused on the discovery, development and
commercialization of nucleic acid-based therapies utilizing gene
silencing approaches such as RNA interference ("RNAi") and
blocking messenger RNA ("mRNA") translation.  The Company's goal
is to improve human health through the development, either through
its own efforts or those of its collaboration partners and
licensees, of these nucleic acid-based therapeutics as well as the
delivery technologies that together provide superior treatment
options for patients.  The Company has multiple proprietary
technologies integrated into a broad nucleic acid-based drug
discovery platform, with the capability to deliver novel nucleic
acid-based therapeutics via systemic, local and oral
administration to target a wide range of human diseases, based on
the unique characteristics of the cells and organs involved in
each disease.

On June 1, 2012, the Company announced that, due to its financial
condition, it had implemented a furlough of approximately 90% of
its employees and ceased substantially all day-to-day operations.
Since that time substantially all of the furloughed employees have
been terminated.  As of Sept. 30, 2012, the Company had
approximately 11 remaining employees, including all of its
executive officers, all of whom are either furloughed or working
on reduced salary.  As a result, since June 1, 2012, its internal
research and development efforts have been minimal, pending
receipt of adequate funding.

Marina Biotech reported a net loss of $6.47 million on $500,000 of
license and other revenue for the year ended Dec. 31, 2014,
compared to a net loss of $1.57 million on $2.11 million of license
and other revenue in 2013.

As of March 31, 2015, the Company had $8.04 million in total
assets, $11.69 million in total liabilities and a $3.65 million
total stockholders' deficit.

Wolf & Company, P.C., in Boston, Massachusetts, issued a "going
concern" qualification on the consolidated financial statements for
the year ended Dec. 31, 2014, citing the Company has suffered
recurring losses from operations, has a significant accumulated
deficit and has been unable to raise sufficient capital to fund its
operations through the end of 2015.  This raises substantial doubt
about the Company's ability to continue as a going concern, the
auditors noted.


MARINA BIOTECH: CEQ508 Granted FDA Fast Track Designation
---------------------------------------------------------
Marina Biotech, Inc., announced that the U.S. Food and Drug
Administration has granted Fast Track designation to CEQ508, an
investigational RNAi therapeutic for the treatment of Familial
Adenomatous Polyposis.  Currently, there is no pharmaceutical
approach available to treat FAP, which affects an estimated one in
10,000 people worldwide and is associated with a near 100% risk of
colon cancer if untreated.  In addition, the Company announced the
allowance of US 13/196,436 covering the tkRNAi delivery technology
- the delivery technology for CEQ508 - in the U.S.  The patent
broadly covers a wide range of vectors for bacterial mediated gene
silencing, as well as the fundamental invasive bacterium for
delivering RNA therapeutics.


Fast Track is a process designed by the FDA to facilitate the
development, and expedite the review of new drugs to treat serious
conditions and fill an unmet medical need.  Fast Track designated
drugs are eligible for more frequent communication with the FDA and
may receive Accelerated Approval and Priority Review.

"We believe that Fast Track designation, together with Orphan Drug
status previously granted by the FDA for CEQ508, provides Marina a
unique opportunity to address an unmet medical need and bring
CEQ508 to patients with Familial Adenomatous Polyposis as quickly
as possible," said Michael French, president and chief executive
officer.  "The Fast Track designation for CEQ508 can significantly
reduce the review time of a new drug application and therefore
reduce the time to market.  In addition, the recent U.S. patent
allowance for the tkRNAi delivery technology expands the broad
international coverage of this technology, which now includes
related patents granted in Europe, Japan, Korea, Australia and
Canada.  Fast Track designation for CEQ508 and the further
expansion of the intellectual property estate surrounding the
tkRNAi platform continues to build the value of our pipeline and,
in particular, our lead clinical program."

Marina's START-FAP (Safety and Tolerability of An RNAi Therapeutic
in Familial Adenomatous Polyposis) is a single-center, US-based
study to evaluate safety and tolerability of CEQ508 in patients
with FAP.  The study is also evaluating the inhibition of
β-catenin messenger RNA (mRNA), the gene target for CEQ508.  The
first two cohorts in the dose escalation phase of the START-FAP
clinical trial have been completed.  Six patients with FAP
completed the study, three in Cohort 1 at a dose of 1×108 colony
forming units (cfu)/day and three in Cohort 2 at 1×109 cfu/day.
Each patient received once daily CEQ508 orally for 28 days and was
monitored by study staff on a daily basis.  With the support of a
development/marketing partner or the receipt of sufficient direct
funding, the company expects to initiate Cohort 3 in 2016.

"The oral delivery of CEQ508 is unique in the RNAi and nucleic acid
space," said Alan W. Dunton, MD, chief medical officer. "CEQ508 has
been well tolerated and no serious adverse events have been
reported.  The data collected for Cohorts 1 and 2 indicates some
impact on mRNA, an encouraging finding at this stage of
development."

                       About Marina Biotech

Marina Biotech, Inc., headquartered in Bothell, Washington, is a
biotechnology company focused on the discovery, development and
commercialization of nucleic acid-based therapies utilizing gene
silencing approaches such as RNA interference ("RNAi") and
blocking messenger RNA ("mRNA") translation.  The Company's goal
is to improve human health through the development, either through
its own efforts or those of its collaboration partners and
licensees, of these nucleic acid-based therapeutics as well as the
delivery technologies that together provide superior treatment
options for patients.  The Company has multiple proprietary
technologies integrated into a broad nucleic acid-based drug
discovery platform, with the capability to deliver novel nucleic
acid-based therapeutics via systemic, local and oral
administration to target a wide range of human diseases, based on
the unique characteristics of the cells and organs involved in
each disease.

On June 1, 2012, the Company announced that, due to its financial
condition, it had implemented a furlough of approximately 90% of
its employees and ceased substantially all day-to-day operations.
Since that time substantially all of the furloughed employees have
been terminated.  As of Sept. 30, 2012, the Company had
approximately 11 remaining employees, including all of its
executive officers, all of whom are either furloughed or working
on reduced salary.  As a result, since June 1, 2012, its internal
research and development efforts have been minimal, pending
receipt of adequate funding.

Marina Biotech reported a net loss of $6.47 million on $500,000 of
license and other revenue for the year ended Dec. 31, 2014,
compared to a net loss of $1.57 million on $2.11 million of license
and other revenue in 2013.

As of March 31, 2015, the Company had $8.04 million in total
assets, $11.69 million in total liabilities and a $3.65 million
total stockholders' deficit.

Wolf & Company, P.C., in Boston, Massachusetts, issued a "going
concern" qualification on the consolidated financial statements for
the year ended Dec. 31, 2014, citing the Company has suffered
recurring losses from operations, has a significant accumulated
deficit and has been unable to raise sufficient capital to fund its
operations through the end of 2015.  This raises substantial doubt
about the Company's ability to continue as a going concern, the
auditors noted.


MARKHAM, IL: S&P Puts 'BB+' GO Debt Rating on CreditWatch Negative
------------------------------------------------------------------
Standard & Poor's Ratings Services said that it placed its 'BB+'
underlying rating (SPUR) on Markham, Ill.'s previously rated
general obligation (GO) debt on CreditWatch with negative
implications.  This action follows repeated attempts by Standard &
Poor's to obtain timely information of satisfactory quality to
maintain S&P's rating on the securities in accordance with its
applicable criteria and policies.  Failure to receive the requested
information by Aug. 24, 2015 will likely result in S&P's withdrawal
of the affected rating, preceded, in accordance with S&P's
policies, by any change to the rating that it considers appropriate
given available information.


MERRIMACK PHARMACEUTICALS: Incurs $22.9 Million Net Loss in Q2
--------------------------------------------------------------
Merrimack Pharmaceuticals, Inc. filed with the Securities and
Exchange Commission its quarterly report on Form 10-Q disclosing
a net loss of $22.9 million on $36.5 million of collaboration
revenues for the three months ended June 30, 2015, compared to a
net loss of $18.3 million on $27.8 million of collaboration
revenues for the same period during the prior year.

For the six months ended June 30, 2015, the Company reported a net
loss of $57.3 million on $51.4 million of collaboration revenues
compared to a net loss of $46 million on $40.8 million of
collaboration revenues for the same period a year ago.

As of June 30, 2015, the Company had $105 million in total assets,
$248.1 million in total liabilities, $273,000 in non-controlling
interest and a stockholders' deficit of $143.3 million.

As of June 30, 2015, within the Company's unrestricted cash and
cash equivalents, $1.4 million was cash and cash equivalents held
by its majority owned subsidiary, Silver Creek Pharmaceuticals,
Inc., which is consolidated for financial reporting purposes.  This
$1.4 million held by Silver Creek is designated for the operations
of Silver Creek.

A full-text copy of the Form 10-Q is available at:

                        http://is.gd/HB9NmR
     
                          About Merrimack

Cambridge, Mass.-based Merrimack Pharmaceuticals, Inc., a
biopharmaceutical company discovering, developing and preparing to
commercialize innovative medicines consisting of novel
therapeutics paired with companion diagnostics.  The Company's
initial focus is in the field of oncology.  The Company has five
programs in clinical development.  In it most advanced program,
the Company is conducting a pivotal Phase 3 clinical trial.

Merrimack reported a net loss of $83.6 million on $103 million of
collaboration revenues for the year ended Dec. 31, 2014, compared
with a net loss of $131 million on $47.8 million of collaboration
revenues during the prior year.


MIDSTATES PETROLEUM: Amends Credit Agreement with SunTrust Bank
---------------------------------------------------------------
Midstates Petroleum Company, Inc. and Midstates Petroleum Company
LLC ("Midstates Sub"), a wholly owned subsidiary of Midstates,
entered into an Eighth Amendment to its Second Amended and Restated
Credit Agreement dated as of June 8, 2012, among Midstates,
Midstates Sub, as borrower, SunTrust Bank, N.A., as administrative
agent, and the lenders and other parties thereto.

The Eighth Amendment increases the limitation on certain leases and
lease agreements into which Midstates and Midstates Sub may enter
into in any period of 12 consecutive calendar months during the
life of those leases from $2,000,000 to $3,500,000.

A copy of the Eight Amendment to Credit Agreement is available for
free at http://is.gd/5yS7d5

                 About Midstates Petroleum Company

Midstates Petroleum Company, Inc. --
http://www.midstatespetroleum.com/-- is an independent exploration
and production company focused on the application of modern
drilling and completion techniques in oil and liquids-rich basins
in the onshore U.S. Midstates' drilling and completion efforts are
currently focused in the Mississippian Lime oil play in Oklahoma
and Anadarko Basin in Texas and Oklahoma.  The Company's operations
also include the upper Gulf Coast tertiary trend in central
Louisiana.

Midstates reported net income of $117 million on $794 million of
total revenues for the year ended Dec. 31, 2014, compared to a net
loss of $344 million on $470 million of total revenues for the year
ended Dec. 31, 2013.

As of Dec. 31, 2014, the Company had $2.47 billion in total assets,
$2 billion in total liabilities and $466 million in total
stockholders' equity.

The Company's independent auditor, Deloittee & Touche LLP, in
Houston, Texas, issued a "going concern" qualification on the
consolidated financial statements for the year ended Dec. 31, 2014,
citing that Midstates' projected debt covenant violation and
resulting lack of liquidity raise substantial doubt about its
ability to continue as a going concern.

                             *    *    *

Midstates Petroleum carries a 'B' corporate credit rating from
Standard & Poor's Ratings Services.

As reported by the TCR on April 8, 2013, Moody's Investors Service
affirmed Midstates Petroleum's 'B3' Corporate Family Rating.


MILLER BRANGUS: Case Summary & 10 Largest Unsecured Creditors
-------------------------------------------------------------
Debtor: Miller Brangus LLC
        106 Mission Ct Ste 402
        Franklin, TN 37067

Case No.: 15-05524

Chapter 11 Petition Date: August 11, 2015

Court: United States Bankruptcy Court
       Middle District of Tennessee (Nashville)

Judge: Hon. Keith M Lundin

Debtor's Counsel: Griffin S Dunham, Esq.
                  EMERGE LAW PLC
                  2021 Richard Jones Rd
                  Suite 240, Nashville, TN 37215
                  Tel: 615-953-2682
                  Fax: 615-953-2955
                  Email: griffin@emergelaw.net

Estimated Assets: $1 million to $10 million

Estimated Liabilities: $1 million to $10 million

The petition was signed by David Doyle Miller, member.

A list of the Debtor's 10 largest unsecured creditors is available
for free at http://bankrupt.com/misc/tnmb15-05524.pdf


MISSISSIPPI PHOSPHATES: Cancels Auction After Failure to Draw Bids
------------------------------------------------------------------
Mississippi Phosphates Corp. canceled an auction for most of its
assets after it did not receive any bid prior to the July 24
deadline, according to a filing it made in U.S. Bankruptcy Court
for the Southern District of Mississippi.

In February this year, the bankruptcy court approved a bidding
process, which allowed Mississippi Phosphates to solicit offers
from potential buyers.

A hearing to approve the sale was initially scheduled for May 22.
Prior to the hearing, the bankruptcy court issued an order, which
set a new bid deadline of July 24 and a sale hearing for August 6.

The court order also set a deadline of June 1 for the company to
submit a proposed order to reflect a new bidding process approved
by the unsecured creditors' committee, the Environmental Protection
Agency, the Mississippi Department of Environmental Quality and the
lenders' administrative agent STUW LLC.  That date was extended to
June 22, court filings show.

On June 22, Mississippi Phosphates asked the court to approve the
new bidding process, which incorporated key provisions of the
settlement agreements it made with the unsecured creditors'
committee and with government agencies, including the Justice
Department, that resolve environmental issues.

The key provisions included a minimum bid of $15 million in cash
consideration, payment of post-petition financing, closing no later
than Sept. 1, and an alternative transaction.  The alternative
transaction proposed a transfer of the assets of the bankruptcy
estates to two trusts and a sale of those assets.

The new bidding process was opposed by The Chemours Company LLC, a
supplier of the company.  In its objection, Chemours argued that
the proposed sale and the settlement agreements together
"constitute a sub rosa plan" that fails to comply with the
Bankruptcy Code.   

In response, Mississippi Phosphates and the lenders' agent argued
they did not violate the Bankruptcy Code since no distribution of
the company's assets will occur pursuant to the settlements.  They
further said that "no requirements are imposed on any party
regarding a vote on a future plan of reorganization."

The new bidding process was approved on July 24, court filings
show.

                    About Mississippi Phosphates

Mississippi Phosphates Corporation is a major United States
producer and marketer of diammonium phosphate ("DAP"), one of the
most common types of phosphate fertilizer.  MPC, which was formed
is a Delaware corporation in October 1990, owns a DAP facility in
Pascagoula, Mississippi, which was acquired from Nu-South, Inc. in
its 1990 bankruptcy.  Phosphate rock, the primary raw material used
in the production of DAP, is being supplied by OCP S.A., a
corporation owned by the Kingdom of Morocco.

The parent, Phosphate Holdings, Inc., was formed in December 2004
in connection with the bankruptcy reorganization of MPC and its
then-parent Mississippi Chemical Corporation, the first fertilizer
cooperative in the United States.

As of Oct. 27, 2014, MPC has a work force of 250 employees, broken
into 224 regular employees and 26 "nested" third-party contract
employees.

MPC and its subsidiaries, namely Ammonia Tank Subsidiary, Inc., and
Sulfuric Acid Tanks Subsidiary, Inc., sought Chapter 11 bankruptcy
protection (Bankr. S.D. Miss. Lead Case No. 14-51667) on Oct. 27,
2014.  Judge Katharine M. Samson is assigned to the cases.

Mississippi Phosphates disclosed $98.8 million in assets and $141
million plus an unknown amount in liabilities.  Affiliates Ammonia
Tank and Sulfuric Acid Tanks each estimated $1 million to $10
million in both assets and liabilities.

The Debtors have tapped Stephen W. Rosenblatt, Esq., at Butler Snow
LLP as counsel.  The official committee of unsecured creditors
tapped Burr & Forman LLP as its counsel.


MOSHAASHAEE: Bid to Reconsider Appointment of Examiner Denied
-------------------------------------------------------------
Judge David M. Warren of the U.S. Bankruptcy Court for the Eastern
District of North Carolina, Raleigh Division, denied the emergency
motion to reconsider the appointment of Johnny Bass as Chapter 11
examiner in Mehdi Moshaashaee and Leandra Colleen Moshaashaee's
Chapter 11 case.

The Examiner was required to investigate the Debtors' prepetition
and postpetition financial affairs, as well as those of the
Debtors' companies, and report the findings to the court.  The
Court ordered the Debtors to apprise the Examiner of all
anticipated expenditures exceeding $500 and all expenditures of
their companies exceeding $1,000.

The Debtors argued that the Court did not have the authority to
appoint the Examiner because 11 U.S.C. Section 1104(c) requires
that an examiner be appointed only "on the request of a party in
interest or the United States Trustee, after notice and hearing."
The Debtors contend that the cost of the Examiner, which is $125
per hour, did not justify the appointment.  They further contend
that expenditure reporting requirement is unnecessarily burdensome
and will cause irreparable harm.

Judge Warren held that the Court has authority to appoint an
examiner without motion or request by a party in interest.  He
further held that the appointment of the Examiner was not to hinder
or harm the Debtors' efforts in bankruptcy, but to aid them in
proceeding through their case successfully, ultimately to receive a
fresh start.  Judge Warren says that the benefit and protection
that the Examiner can provide to the Debtors, the estate, and the
creditors far outweighs the cost of the Examiner. He further says
that the Court chose the Examiner over appointing a trustee in
order to save costs.

The case is IN RE: MEHDI MOSHAASHAEE, LEANDRA COLLEEN MOSHAASHAEE,
Chapter 11, Debtor, Case No. 15-02941-5-DMW.

A full-text copy of Judge Warren's Order dated Aug. 6, 2015, is
available at http://is.gd/C1G7f9from Leagle.com.



MOTORS LIQUIDATION: Liquidation of New GM Common Stock Completed
----------------------------------------------------------------
Wilmington Trust Company, solely in its capacity as trust
administrator and trustee of the Motors Liquidation Company GUC
Trust, completed sales in the aggregate of 23,748,829 shares of New
GM Common Stock, comprising all of its holdings of New GM Common
Stock, at a weighted average price of $31.2311 per share in the
open market for a total consideration, net of transaction expenses,
of $741,701,486 in cash, according to a document filed with the
Securities and Exchange Commission.

As of Aug. 3, 2015, the GUC Trust had completed sales in the
aggregate of 19,787,128 shares of New GM Common Stock at a weighted
average price of $31.2104 per share in the open market for a total
consideration, net of transaction expenses, of $616,859,891 in
cash.  On August 4 and Aug. 5, 2015, the GUC Trust completed the
liquidation of all of its shares of New GM Common Stock pursuant to
the Liquidation Order, consisting of further sales in the aggregate
of 3,961,701 shares of New GM Common Stock at a weighted average
price of $31.5121 per share in the open market for a total
additional consideration, net of transaction expenses, of
$124,841,595 in cash since the filing of the Current Report on Form
8-K on Aug. 3, 2015.

Pursuant to an order of the Bankruptcy Court for the Southern
District of New York, Wilmington Trust received authority to, among
other actions, liquidate all or substantially all of its holdings
of shares of common stock, par value $0.01 per share, of General
Motors Company into cash.

                     About Motors Liquidation

General Motors Corporation and three of its affiliates filed for
Chapter 11 protection (Bankr. S.D.N.Y. Lead Case No. 09-50026) on
June 1, 2009.  The Honorable Robert E. Gerber presides over the
Chapter 11 cases.  Harvey R. Miller, Esq., Stephen Karotkin,
Esq., and Joseph H. Smolinsky, Esq., at Weil, Gotshal & Manges
LLP, assist the Debtors in their restructuring efforts.  Al Koch
at AP Services, LLC, an affiliate of AlixPartners, LLP, serves as
the Chief Executive Officer for Motors Liquidation Company.  GM
is also represented by Jenner & Block LLP and Honigman Miller
Schwartz and Cohn LLP as counsel.  Cravath, Swaine, & Moore LLP
is providing legal advice to the GM Board of Directors.  GM's
financial advisors are Morgan Stanley, Evercore Partners and the
Blackstone Group LLP.  Garden City Group is the claims and notice
agent of the Debtors.

The U.S. Trustee appointed an Official Committee of Unsecured
Creditors and a separate Official Committee of Unsecured
Creditors Holding Asbestos-Related Claims.  Lawyers at Kramer
Levin Naftalis & Frankel LLP served as bankruptcy counsel to the
Creditors Committee.  Attorneys at Butzel Long served as counsel
on supplier contract matters.  FTI Consulting Inc. served as
financial advisors to the Creditors Committee.  Elihu Inselbuch,
Esq., at Caplin & Drysdale, Chartered, represented the Asbestos
Committee.  Legal Analysis Systems, Inc., served as asbestos
valuation analyst.

The Bankruptcy Court entered an order confirming the Debtors'
Second Amended Joint Chapter 11 Plan on March 29, 2011.  The Plan
was declared effect on March 31.

On Dec. 15, 2011, Motors Liquidation Company was dissolved.  On
the Dissolution Date, pursuant to the Plan and the Motors
Liquidation Company GUC Trust Agreement, dated March 30, 2011,
between the parties thereto, the trust administrator and trustee
-- GUC Trust Administrator -- of the Motors Liquidation Company
GUC Trust, assumed responsibility for the affairs of and certain
claims against MLC and its debtor subsidiaries that were not
concluded prior to the Dissolution Date.

As of March 31, 2015, Motors Liquidation had $1.01 billion in total
assets, $69.23 million in total liabilities and $944.73 million in
net assets in liquidation.


MSAA LV PARTNERS: Case Summary & 20 Largest Unsecured Creditors
---------------------------------------------------------------
Debtor: MSAA LV Partners, LLC
        5299 Alton Pkwy., Suite 216
        Irvine, CA 92602

Case No.: 15-14589

Chapter 11 Petition Date: August 11, 2015

Court: United States Bankruptcy Court
       District of Nevada (Las Vegas)

Judge: Hon. August B. Landis

Debtor's Bankruptcy     HELLER, DRAPER, PATRICK, HORN &
Counsel:                DABNEY, LLC

Debtor's Local Counsel: Talitha B. Gray Kozlowski
                        GARMAN TURNER GORDON, LLP
                        650 White Drive, Suite 100
                        Las Vegas, NV 89119
                        Tel: (725) 777-3000
                        Email: tgray@gtg.legal

Estimated Assets: $1 million to $10 million

Estimated Liabilities: $1 million to $10 million

The petition was signed by Zafar Jafrey, member.

A list of the Debtor's 20 largest unsecured creditors is available
for free at http://bankrupt.com/misc/nvb15-14589.pdf


MUSCLEPHARM CORP: Posts $7 Million Net Loss for Second Quarter
--------------------------------------------------------------
MusclePharm Corporation filed with the Securities and Exchange
Commission its quarterly report on Form 10-Q disclosing a net loss
of $7 million on $50.4 million of net revenues for the three months
ended June 30, 2015, compared to a net loss of $935,000 on $46.7
million of net revenue for the same period in 2014.

For the six months ended June 30, 2015, the Company reported a net
loss of $14.5 million on $91.7 million of net revenue compared to
net income of $1.8 million on $96.9 million of net revenue for the
same peirod during the prior year.

As of June 30, 2015, the Company had $75.1 million in total assets,
$56.9 million in total liabilities and $18.1 million in total
stockholders' equity.

"MusclePharm is a company that has consistently demonstrated strong
growth potential and the ability to capitalize on opportunities,
illustrated by record revenue for the quarter and improved gross
margin," said Brad Pyatt, MusclePharm's chief executive officer.

"Sequentially our revenue has increased primarily due to organic
growth with existing customers and sales from new product
introductions.  We closed the quarter with $8.5 million in sales
backlog, illustrating consumer adoption of our brands resulting in
significant continued growth potential.  Our Adjusted EBITDA was
$1.1 million, for which we expect to see continued improvement as
we move forward in the second half of the year.  We are excited by
this quarter's results, and expect that our business strategy will
continue to grow our top line as we work toward profitability and
long-term shareholder value creation."

A full-text copy of the Form 10-Q is available for free at:

                       http://is.gd/1SpIOt

                        About MusclePharm

Headquartered in Denver, Colorado, MusclePharm Corporation
(OTC BB: MSLP) -- http://www.muslepharm.com/-- is a healthy life-
style company that develops and manufactures a full line of
National Science Foundation approved nutritional supplements that
are 100 percent free of banned substances.  MusclePharm is sold in
over 120 countries and available in over 5,000 U.S. retail
outlets, including GNC and Vitamin Shoppe.  MusclePharm products
are also sold in over 100 online stores, including
bodybuilding.com, Amazon.com and Vitacost.com.

MusclePharm Corporation reported a net loss of $13.8 million in
2014, a net loss of $17.7 million in 2013 and a net loss of $19
million in 2012.


NEPHROS INC: Posts $1.8 Million Net Loss for Second Quarter
-----------------------------------------------------------
Nephros, Inc. filed with the Securities and Exchange Commission its
quarterly report on Form 10-Q disclosing a net loss of $1.8 million
on $567,000 of total net revenues for the three months ended June
30, 2015, compared to a net loss of $5.3 million on $441,000 of
total net revenues for the same period in 2014.

For the six months ended June 30, 2015, the Company reported a net
loss of $1.5 million on $1.1 million of total net revenues compared
to a net loss of $8.8 million on $915,000 of total net revenues for
the same period during the prior year.

As of June 30, 2015, the Company had $3.4 million in total assets,
$9.3 million in total liabilities and a stockholders' deficit of
$5.9 million.

A full-text copy of the Form 10-Q is available for free at:

                       http://is.gd/YUfIzt

                          About Nephros

River Edge, N.J.-based Nephros, Inc., is a commercial stage
medical device company that develops and sells high performance
liquid purification filters.  Its filters, which it calls
ultrafilters, are primarily used in dialysis centers and
healthcare facilities for the production of ultrapure water and
bicarbonate.

Nephros reported a net loss of $7.37 million on $1.74 million of
total net revenues for the year ended Dec. 31, 2014, compared to
net income of $1.32 million on $1.74 million of total net revenues
for the year ended Dec. 31, 2013.

Withum Smith+Brown PC, in Morristown, New Jersey, issued a "going
concern" qualification on the consolidated financial statements for
the year ended Dec. 31, 2014, citing that the Company has incurred
negative cash flow from operations and recurring net losses since
inception.  These conditions, among others, raise substantial doubt
about its ability to continue as a going concern.


NII HOLDINGS: Reports Financial Results for 2nd Quarter 2015
------------------------------------------------------------
NII Holdings, Inc. on Aug. 7 announced its consolidated financial
results for the second quarter of 2015.  The Company reported a net
loss of 64,000 subscribers for the quarter as iDEN subscriber
losses in Brazil and Argentina exceeded 3G net additions in Brazil.
The Company ended the quarter with 6.3 million total subscribers,
a 2 percent increase from a year ago.  For the quarter, the Company
generated consolidated operating revenues of $421 million, a
consolidated adjusted OIBDA loss of $75 million, and a consolidated
operating loss of $179 million. Capital expenditures were $58
million for the quarter.  The Company's consolidated adjusted OIBDA
excludes the impact of non-cash asset impairments, restructuring
charges and other unusual items.  The Company ended the quarter
with $672 million in consolidated cash, cash equivalents and
short-term investments.  The Company's results for the second
quarter of 2015 exclude the Company's operations in Mexico that
were sold to AT&T on April 30, 2015 and reflect the implementation
of fresh start accounting in connection with its emergence from
bankruptcy on June 26, 2015.

"We are disappointed in our performance during the second quarter
including the sequential decline in our adjusted OIBDA, which fell
short of our expectations due to our inability to deliver on our
revenue growth goals," said Steve Shindler, NII Holdings' chief
executive officer.  "Subscriber growth on our 3G network in Brazil
was offset by iDEN subscriber losses in both Brazil and Argentina.
Our results reflect the impact of a challenging macroeconomic
environment that is affecting the entire wireless industry as well
as the deterioration in foreign currency exchange rates that are
expected to continue to affect our businesses in Brazil and
Argentina for the remainder of 2015.  Our results to date and the
negative economic outlook put us well behind the goals we set for
ourselves in the business plan that was developed last year in
connection with our Chapter 11 restructuring process.  We are
implementing contingency plans designed to help us reach our
long-term goals, but our focus for the remainder of this year will
be to build our 3G subscriber base in Brazil and pursue cost saving
strategies to help improve our profitability."

NII Holdings' consolidated average monthly service revenue per
subscriber (ARPU) was $19 for the second quarter of 2015, down from
$25 in the same quarter last year, due to the year over year
decline in local currency values.  The Company's consolidated
average monthly churn rate for the quarter increased to 3.69
percent from 3.30 percent in the second quarter last year due to an
increase in iDEN subscriber churn in both Brazil and Argentina.
Consolidated cost per gross addition (CPGA) was $176 for the second
quarter of 2015, a $34 decrease from the year ago period, primarily
due to an increase in new 3G postpaid subscribers in Brazil who use
their own handsets rather than purchasing a new one from the
Company.

"During the quarter we successfully emerged from bankruptcy as a
more streamlined company focused on creating value through driving
quality subscriber growth," said Juan Figuereo, NII Holdings'
executive vice president and chief financial officer.  "We believe
in the long-term opportunity in Brazil, but anticipate that our
financial results will continue to be volatile in the near-term as
we strive to capture that opportunity in an uncertain economic
environment.  We will deal with that volatility using the same
disciplined process that we used to manage our liquidity during our
restructuring process, prioritizing our investments while
delivering an outstanding customer experience using our high
quality network in Brazil."

The Company will not provide a financial outlook and will not host
financial results conference calls for the remainder of 2015 due to
the challenging economic conditions, foreign currency exchange rate
volatility, and the recently announced transitions in its
management team.  The Company currently expects to be in a position
to provide additional details about its business outlook in
connection with its report of fourth quarter and year-end 2015
results.  

                    About NII Holdings, Inc.

NII Holdings Inc. through its subsidiaries provides wireless
communication services for businesses and consumers in Brazil,
Mexico and Argentina.  NII Holdings has the exclusive right to use
the Nextel brand in its markets pursuant to a trademark license
agreement with Sprint Corporation and offers unique push-to-talk
("PTT") services associated with the Nextel brand in Latin America.
NII Holdings' shares of common stock, par value $0.001, are
publicly traded under the symbol NIHD on the NASDAQ Global Select
Market.

NII Holdings and its affiliated debtors sought bankruptcy
protection (Bankr. S.D.N.Y. Lead Case No. 14-12611) in Manhattan on
Sept. 15, 2014.  The Debtors' cases are jointly administered and
are assigned to Judge Shelley C. Chapman.

The Debtors tapped Jones Day's Scott J. Greenberg, Esq. and Michael
J. Cohen, Esq., as counsel and Prime Clerk LLC as claims and
noticing agent.  NII Holdings disclosed $1.22 billion in assets and
$3.068 billion in liabilities as of the Chapter 11 filing.

The U.S. Trustee for Region 2 appointed five creditors of NII
Holdings to serve on the official committee of unsecured creditors.
The panel is represented by Kenneth H. Eckstein, Esq. and Adam C.
Rogoff, Esq. of Kramer Levin Naftalis & Frankel LLP.  Kurtzman
Carson Consultants LLC is the panel's information agent.

On Jan. 26, 2015, the Debtors reached an agreement for the sale of
their operations in Mexico, operated by non-debtor Comunicaciones
Nextel de Mexico, S.A. de C.V., to an affiliate of AT&T for $1.875
billion, subject to adjustments.  The sale was approved on March
23, 2015, and completed on April 30, 2015.

On June 19, 2015, Judge Shelley C. Chapman confirmed the First
Amended Joint Plan of Reorganization proposed by the Debtors and
the Creditors' Committee.  The Plan embodies the sale transaction.

Under the Plan, approximately 100 million shares of NII Holdings'
new common stock and $745 million in cash will be distributed to
holders of senior notes issued by the Company's subsidiaries, NII
Capital Corp. and NII International Telecom S.C.A.  The Company has
applied to list the shares of NII Holdings' new common stock on the
NASDAQ Stock Exchange.  

The Plan was declared effective on June 26, 2015, signalling the
emergence of NII Holdings, et al., from the bankruptcy
proceedings.


OWENS-BROCKWAY GLASS: S&P Rates New $1BB Sr. Notes 'BB'
-------------------------------------------------------
Standard & Poor's Ratings Services assigned its 'BB' issue-level
rating and '5' recovery rating to Owens-Brockway Glass Container
Inc.'s proposed $1 billion senior notes, which the company will
issue with varying maturities, and placed the issue rating on
CreditWatch with negative implications.  If the Vitro acquisition
is completed as proposed, S&P plans to lower its corporate credit
rating and issue-level ratings on the company by one notch and
remove them from CreditWatch.  The '5' recovery rating indicates
S&P's expectation of modest (10%-30%; upper half of the range)
recovery in the event of a payment default. Owens-Brockway Glass
Container Inc. is a subsidiary of Owens-Illinois Inc.

The company will use the proceeds from this offering, along with
$1.25 billion in proposed term loans, to fund its acquisition of
Vitro S.A.B. de C.V.'s (Vitro) food and beverage glass container
business.

S&P's ratings on Owens-Illinois Inc. remain on CreditWatch, where
S&P placed them with negative implications on May 13, 2015,
following the company's announcement that it has reached a
definitive agreement with Vitro to acquire the firm's food and
beverage glass container business in an all-cash transaction valued
at approximately $2.15 billion.  The acquisition is being financed
with $1.25 billion in proposed term loans and $1 billion in
proposed unsecured notes.

Upon the completion of the Vitro acquisition, which is subject to
regulatory approval and expected to close in the second half of
2015, S&P expects to lower its corporate credit rating on
Owens-Illinois to 'BB' and assign a stable outlook.  Accordingly,
S&P also expects to lower its issue-level ratings on the company's
debt by one notch.

Owens-Illinois is a global leader in glass packaging, with leading
market shares in each of its four regions--North America, Europe,
South America, and Asia-Pacific.

RATINGS LIST

Owens-Illinois Inc.
Corporate Credit Rating           BB+/Watch Neg/--

Ratings Assigned; CreditWatch Action

Owens-Brockway Glass Container Inc.
Proposed $1 Bil. Snr Notes        BB/Watch Neg
  Recovery Rating                  5H



OXFORD RESOURCE: Westmoreland Holds 93.8% Equity Interests
----------------------------------------------------------
Westmoreland Coal Company disclosed in an amended Schedule 13D
filed with the Securities and Exchange Commission that as of
Aug. 1, 2015, it beneficially owned 19,820,008 shares of common
stock of Westmoreland Resource Partners, LP.

On Aug. 1, 2015, pursuant to the terms of the Amended and Restated
Contribution Agreement, dated July 31, 2015, between the Issuer and
WCC, WCC made the Contribution to the Issuer in exchange for
15,251,989 Series A Units of the Issuer and $115 million in cash,
which the Issuer funded with borrowings under its credit facility.

WCC purchased Warrants to acquire a total of 55,519 Common Units in
June 2015, consisting of a Warrant to acquire 11,659 Common Units
from A54 Acquisition-B LLC on June 10, 2015, and a Warrant to
acquire 43,860 Common Units from A54 Acquisition LLC on
June 11, 2015, for a total purchase price of $627,365.  WCC funded
the purchase price for the Warrants with available cash on hand.

Together with the Common Units previously held by WCC, the Series A
Units and the Warrants purchased by WCC represent an aggregate of
93.8% of the Issuer's outstanding equity interests on a fully
diluted basis.

A copy of the regulatory filing is available for free at:

                        http://is.gd/w0bWM4

                       About Oxford Resource

Columbus, Ohio-based Oxford Resource Resource Partners, LP, is a
low-cost producer of high value steam coal, and is the largest
producer of surface mined coal in Ohio.

The Company reported a net loss of $20.2 million on $287 million of
revenues for the nine months ended Sept. 30, 2012, compared with a
net loss of $4 million on $304.1 million of revenues for the same
period of 2011.

The Company's balance sheet at Sept. 30, 2014, showed $203.9
million in total assets, $218 million in total liabilities, and a
partners' deficit of $14.2 million.



PARKVIEW ADVENTIST: Court Declines Appointment of PCO
-----------------------------------------------------
Judge Peter G. Cary of the U.S. Bankruptcy Court for the District
of Maine exercised its discretion and declined to appoint a patient
care ombudsman for Parkview Adventist Medical Center following a
hearing held on July 8, 2015, where Judge Cary found and determined
that his order for the Debtor to show cause why a PCO must not be
appointed in the case has been satisfied by the presentation of
good and sufficient evidence supporting a declination to appoint a
PCO.

The Debtor, in response to the Court's show cause order, explained
that the appointment of a PCO is not necessary for the protection
of patients under the specific facts of its case.  The Debtor said
the additional cost to the estate of an appointed PCO is an
unnecessary expense and would further divert the Debtor's limited
resources from patient care related activities.

Judge Cary said his Order is entered without prejudice to the right
of the United States Trustee to seek the appointment of a PCO in
the future, upon due notice and after hearing, should it determine
that circumstances warrant a request for an appointment.

The Debtor is represented by:

          George J. Marcus, Esq.
          Jennie L. Clegg, Esq.
          David C. Johnson, Esq.
          Andrew C. Helman, Esq.
          MARCUS, CLEGG & MISTRETTA, P.A.
          One Canal Plaza, Suite 600
          Portland, ME 04101
          Tel: (207) 828-8000
          Fax: (207)-773-3210
          Email: gmarcus@mcm-law.com
                 Jclegg@mcm-law.com
                 djohnson@mcm-law.com
                 ahelman@mcm-law.com

                          About Parkview Adventist

Parkview Adventist Medical Center, a Maine non-profit corporation,
operates the Parkview Hospital, a faith-based acute care community
hospital located in Brunswick, Maine, affiliated with the Seventh
Day Adventist Church.  Its mission is to provide services
supporting the physical, emotional and spiritual wellness of its
patients.

Parkview sought Chapter 11 protection (Bankr. D. Maine Case No.
15-20442) in Portland, Maine, on June 16, 2015.  The case is
assigned to Judge Peter G Cary.

The Debtor estimated $10 million to $50 million in assets and
debt.

The deadline for filing claims is Oct. 7, 2015.  The Debtor's plan
and disclosure statement are due Oct. 14,
2015.

The Debtor is represented by George J. Marcus, Esq., at Marcus,
Clegg & Mistretta, PA, in Portlane, Maine.


PARKVIEW ADVENTIST: Wants Skelton Taintor DQ'd as CMHC Counsel
--------------------------------------------------------------
The Parkview Adventist Medical Center asks the U.S. Bankruptcy
Court for the District of Maine to disqualify the law firm of
Skelton, Taintor & Abbott from serving as counsel to Central Maine
Healthcare Corporation and its affiliated entities.

The Debtor explains that ST&A has represented Parkview on a number
of separate occasions, two of which create a conflict of interest
with respect to its continued representation of CMHC.
Specifically, in 2006, Parkview retained ST&A and Michael R.
Poulin, Esq., of that firm to advise it with respect to a potential
unfriendly merger with Midcoast Hospital.  During the course of
that representation ST&A and Mr. Poulin developed a detailed
strategy for defeating any attempt by Midcoast Hospital to form a
combination with Parkview.  In addition, in 2010, while Parkview
was negotiating its loan documents with MHHEFA, Parkview sought and
received advice from ST&A and Mr. Poulin regarding certain
provisions in the MHHEFA loan documents.  The Debtor asserts that
ST&A cannot now advise CMHC on exactly the same issues that were
the subject of the prior representation.

CMHC, in response, argues that ST&A did receive confidential
information from the 2006 representation and that ST&A did not
provide any legal services to Parkview in 2010, thus, there is no
ethical issue raised by ST&A's continued representation of its
longstanding client, CMHC, in the Debtor's bankruptcy proceeding.

The Debtor responded back, arguing that CMHC misapprehends the
import of Maine Rule of Professional Conduct 1.9, which prohibits a
lawyer who has formally represented a client from thereafter
representing another person in the same or substantially related
matter in which that person's interests are materially adverse to
the interests of the former client.  It would be highly prejudicial
to Parkview to allow ST&A to continue to represent CMHC in this
proceeding, the Debtor asserted.

Central Maine Healthcare Corporation is represented by:

          Michael R. Poulin, Esq
          Skelton, Taintor & Abbott
          95 Main Street
          Auburn, ME 04210
          Tel: (207)784-3200
          Email: mpoulin@sta-law.com

The Debtor is represented by:

          George J. Marcus, Esq.
          Jennie L. Clegg, Esq.
          David C. Johnson, Esq.
          Andrew C. Helman, Esq.
          MARCUS, CLEGG & MISTRETTA, P.A.
          One Canal Plaza, Suite 600
          Portland, ME 04101
          Tel: (207) 828-8000
          Fax: (207)-773-3210
          Email: gmarcus@mcm-law.com
                 Jclegg@mcm-law.com
                 djohnson@mcm-law.com
                 ahelman@mcm-law.com

                        About Parkview Adventist

Parkview Adventist Medical Center, a Maine non-profit corporation,
operates the Parkview Hospital, a faith-based acute care community
hospital located in Brunswick, Maine, affiliated with the Seventh
Day Adventist Church.  Its mission is to provide services
supporting the physical, emotional and spiritual wellness of its
patients.

Parkview sought Chapter 11 protection (Bankr. D. Maine Case No.
15-20442) in Portland, Maine, on June 16, 2015.  The case is
assigned to Judge Peter G Cary.

The Debtor estimated $10 million to $50 million in assets and
debt.

The deadline for filing claims is Oct. 7, 2015.  The Debtor's plan
and disclosure statement are due Oct. 14, 2015.

The Debtor is represented by George J. Marcus, Esq., at Marcus,
Clegg & Mistretta, PA, in Portlane, Maine.


PARU SELVAM: Default Judgment and Receiver Appointment Upheld
-------------------------------------------------------------
Judge J. Donovan of the Court of Appeals of Ohio, Second District,
Montgomery County affirmed the granting of default judgment in
favor of Trustee, Lloyd T. Whitaker, as well as the appointment of
Jonathan F. Hung, of the law firm of Green and Green Lawyers, as
Receiver.

Paru Selvam L.L.C., Siddhar Peedham Inc., and Ashok Spiritual
Healing Center contend that the trial court erred in granting the
default judgment in favor of the appellee because the trial court
overlooked the fact that at least one of the Appellants had in fact
appeared, back on July 24, 2013 and defended the case by filing its
objection to the magistrate's decision.  The Appellants  further
contend that the trial court erred in appointing a receiver because
the trial court did not find by clear and convincing evidence that
a receiver was appropriate.

Judge Donovan held that the Court's adjudication of the Appellants'
direct appeal, which affirmed the grant of default judgment in
favor of Appellee, required the denial of their motion to vacate
the default judgment.  Judge Donovan concluded that the Trustee
presented clear and convincing evidence in support of the
appointment of Mr. Hung, namely that the Trustee possessed a
judgment lien of substantial amount, and that the Key Bank Building
lacked utilities and insurance, and was not being taken care of,
such that Hung's appointment was necessary to preserve the
property, ready it for sale, and subject it to the Trustee's claim
pursuant to R.C. 2735.01.

The case is LLOYD T. WHITAKER, TRUSTEE, et. al.,
Plaintiffs-Appellees, v. PARU SELVAM, LLC, et. al.,
Defendants-Appellants, C.A. No. 26555.

A full-text copy of Judge Donovan's Opinion dated Aug. 7, 2015, is
available at http://is.gd/cwgN95from Leagle.com.

Llyod Whitaker, Trustee, is represented by:

          Ronald J. Kozar, Esq.
          Kettering Tower, Suite 2830
          40 N. Main Street
          Dayton, OH 45423
          Telephone: (937)222-6764
          Facsimile: (937)222-6765
          E-mail: ronald.kozar@gmail.com

Paru Selvam, LLC, Ashok Spiritual Healing Center, Siddhar Peedam,
Inc. are represented by:

          Stephen P. Linnen, Esq.
          605 N. High Street, #612
          Columbus, OH 43215
          Telephone: (614)448-5182
          E-mail: spl@linnenlawfirm.com



PHOTOMEDEX INC: Posts $6 Million Net Income in Second Quarter
-------------------------------------------------------------
PhotMedex, Inc. filed with the Securities and Exchange Commission
its quarterly report on Form 10-Q disclosing net income of $6
million on $19.9 million of revenues for the three months ended
June 30, 2015, compared to a net loss of $7.5 million on $31.8
million of revenues for the three months ended June 30, 2014.

For the six months neded June 30, 2015, the Company reported a net
loss of $3.9 million on $40.6 million of revenues compared to a net
loss of $7.8 million on $75.8 million of revenues for the same
period during the prior year.

As of June 30, 2015, the Company had $67.7 million in total assets,
$23.9 million in total liabilities and $43.8 million in total
stockholders' equity.

"With the sale of the XTRAC business on June 23, 2015 enabling the
extinguishment of all our outstanding bank debt, we are now focused
on addressing the challenges that have affected our consumer
business and on implementing the strategies and tactics we believe
will improve its performance.  We are pleased to have held another
successful 24-hour live television home shopping weekday sales
event in the U.S. earlier this month, during which consumers
purchased more than $3 million of retail sales of no!no! Hair.
This event highlighted the unique benefits of no!no! compared with
other home hair removal treatments, and we offered a well-received
summertime animal print special edition.  This most recent
television home shopping sales event builds upon similarly
successful events held in May in the U.S. and in June in the UK,"
said Dr. Dolev Rafaeli, PhotoMedex CEO.

As of June 30, 2015, the Company had cash, cash equivalents and
short-term investments of $4.4 million including $0.8 million of
restricted cash, compared with $10.4 million of unrestricted cash
as of Dec. 31, 2014.

A full-text copy of the Form 10-Q is available for free at:

                       http://is.gd/eUS8hH

                        About PhotoMedex

PhotoMedex, Inc., is a global health products and services company
providing integrated disease management and aesthetic solutions to
dermatologists, professional aestheticians, ophthalmologists,
optometrists, consumers and patients.  The Company provides
proprietary products and services that address skin conditions
including psoriasis, vitiligo, acne, actinic keratosis, photo
damage and unwanted hair, as well as fixed-site laser vision
correction services at our LasikPlus(R) vision centers.

PhotoMedex and its subsidiaries has entered into a second
amended and restated forbearance agreement with the lenders that
are parties to the credit agreement dated May 12, 2014, and with JP
Morgan Chase, as administrative agent for the Lenders pursuant to
which the Lender have agreed to forbear from exercising their
rights and remedies with respect to certain events of default from
Aug. 25, 2014, until April 1, 2016, or earlier if an event of
default occurs, according to a document filed with the Securities
and Exchange Commission in March 2015.

                        Bankruptcy Warning

"If, in the future, PhotoMedex is required to obtain similar
forbearance agreements as a result of our inability to meet the
terms of the credit agreement, there can be no assurance that those
forbearance agreements will be available on commercially reasonable
terms or at all.  If, as or when required, we are unable to repay,
refinance or restructure our indebtedness under those credit
facilities, or amend the covenants contained therein, the lenders
could elect to terminate their commitments under the credit
facilities and institute foreclosure proceedings against our
assets.  Under such circumstances, we could be forced into
bankruptcy or liquidation.  In addition, any additional events of
default or declaration of acceleration under one of those
facilities or the forbearance agreement could also result in an
event of default under one or more of these agreements.  Such a
declaration would have a material adverse impact on our liquidity,
financial position and results of operations," the Company stated
in its 2014 annual report.


PLY GEM HOLDINGS: Reports $30.4M Net Income for Second Quarter
--------------------------------------------------------------
Ply Gem Holdings, Inc. filed with the Securities and Exchange
Commission its quarterly report on Form 10-Q disclosing net income
of $30.4 million on $502.3 million of net sales for the three
months ended July 4, 2015, compared to net income of $11.4 million
on $409.2 million of net sales for the three months ended June 28,
2014.

For the six months ended July 4, 2015, the Company repored a net
loss of $18.5 million on $878.4 million of net sales compared to a
net loss of $40.2 million on $678.6 million of net sales for the
six months ended June 28, 2014.

The Company's balance sheet at July 4, 2015, showed $1.3 billion in
total assets, $1.4 billion in total liabilities and a stockholders'
deficit of $119.5 million.

"I am pleased with our second quarter performance as both business
segments made substantial contributions to adjusted EBITDA," said
Gary E. Robinette, Ply Gem's Chairman and CEO.  "While extreme
winter weather caused a slow start to the spring building season,
volumes rebounded nicely and allowed us to deliver the fifth
consecutive quarterly year-over-year growth of both net sales and
adjusted EBITDA.  While we anticipate the housing market to
continue experiencing near-term choppiness, we remain encouraged by
the macro-economic trends that support the long-term recovery of
the housing industry and Ply Gem is well positioned to participate
in the recovery."

Commenting on the Company's results, Shawn K. Poe, Ply Gem's chief
financial officer added, "Both of our business segments made
significant strides in improving the Company's profitability this
quarter.  Excluding the impact of acquisitions, we achieved a 280
basis point improvement in our gross profit margin as a result of
our improved pricing and operational performance initiatives, which
resulted in our best gross profit margin since the third quarter of
2009.  In addition, our second quarter adjusted EBITDA was at its
highest level since the second quarter of 2007."

"We intend to fund our ongoing capital and working capital
requirements, including our internal growth, through a combination
of cash flows from operations and, if necessary, from borrowings
under our ABL Facility.  We believe that we will continue to meet
our liquidity requirements over the next 12 months.  We believe
that our operating units are positive cash flow generating units
and will continue to sustain their operations without any
significant liquidity concerns.  The performance of these operating
units is significantly impacted by the performance of the housing
industry, specifically single family housing starts and the repair
and remodeling activity.  Any unforeseen or unanticipated downturn
in the housing industry could have a negative impact on our
liquidity position," the Company stated in the Form 10-Q report.

A full-text copy of the Quarterly Report is available at:

                        http://is.gd/Clqdri

                           About Ply Gem

Based in Cary, North Carolina, Ply Gem Holdings Inc. is a
diversified manufacturer of residential and commercial building
products, which are sold primarily in the United States and
Canada, and include a wide variety of products for the residential
and commercial construction, the do-it-yourself and the
professional remodeling and renovation markets.

Ply Gem reported a net loss of $31.3 million on $1.56 billion of
net sales for the year ended Dec. 31, 2014, compared to a net loss
of $79.5 million on $1.36 billion of net sales for the year ended
Dec. 31, 2013.

                            *     *     *

In May 2010, Standard & Poor's Ratings Services raised its
(unsolicited) corporate credit rating on Ply Gem to 'B-' from
'CCC+'.  "The ratings upgrade reflects our expectation that the
Company's credit measures are likely to improve modestly over the
next several quarters to levels that we would consider more in
line with the 'B-' corporate credit rating," said Standard &
Poor's credit analyst Tobias Crabtree.


PROSPECT SQUARE: Court Dismisses Ch. 11
---------------------------------------
Judge Elizabeth E. Brown of the U.S. Bankruptcy Court for the
District of Colorado dismissed the Chapter 11 cases of Prospect
Square  07 A, LLC, et. al., and overruled the Limited Objection
filed by MSCI 2007-IQ 16 Retail 9654.

As previously reported by The Troubled Company Reporter, Patrick S.
Layng, U.S. Trustee for Region 19, asked the Court to dismiss the
Chapter 11 cases of the Debtors as there appears to be no assets
that can be administered for the benefit of unsecured creditors.

Daniel Morse, Assistant U.S. Trustee, told the Court that as a
result of an order granting the motion for relief from stay on the
Debtors' primary asset dated February 17, 2015, there appears to
have been a substantial diminishment of the bankruptcy estate.
Mr.
Morse further told the Court that the continued accrual of
administrative expenses, including U.S. Trustee quarterly fees and
professional fees, is also diminishing the bankruptcy estate.  He
adds that the entry of the Stay Relief Order leaves Debtor unable
to rehabilitate itself.

MSCI 2007-IQ16 did not object to the dismissal of the bankruptcy
case as requested by the U.S. Trustee, but objected to the form of
the order and requested that the Court enter an order specifically
providing that the order approving its Settlement with the Debtors
and the Settlement Agreement survive the dismissal of the
bankruptcy cases.

                       About Prospect Square

Prospect Square 07 A, LLC, and related entities sought Chapter 11
bankruptcy protection from creditors (Bankr. D. Colo. Lead Case
No. 14-10896) in Denver on Jan. 29, 2014.

Prospect Square 07 A is a Single Asset Real Estate as defined in
11 U.S.C. Sec. 101(51B) with principal assets located at 9690
Colerain Avenue, Cincinnati, Ohio.  The Debtor listed $16 million
in assets and more than $12 million in liabilities.  Lee M.
Kutner, Esq., at Kutner Brinen Garber, P.C., in Denver, serves as
the Debtors' counsel.

Lender MSCI 2007-IQ16 Retail 9654, LLC, is represented by James T.
Markus, Esq., and Jeffery O. McAnallen, Esq., at Markus Williams
Young & Zimmermann LLC.

The U.S. Trustee for Region 19 said that no committee of unsecured
creditors for the case was formed since there were too few
creditors who are willing to serve on the committee.


RETROPHIN INC: Incurs $25.5 Million Net Loss in Second Quarter
--------------------------------------------------------------
Retrophin, Inc., filed with the Securities and Exchange Commission
its quarterly report on Form 10-Q disclosing a net loss of $25.5
million on $24 million of net product sales for the three months
ended June 30, 2015, compared to net income of $11.8 million on
$5.7 million of net product sales for the same period a year ago.

For the six months ended June 30, 2015, the Company reported net
income of $14.1 million on $41.4 million of net product sales
compared to a net loss of $63.9 million on $5.7 million of net
product sales for the same period during the prior year.

As of June 30, 2015, the Company had $425.1 million in total
assets, $274.3 million in total liabilities and $150.7 million in
total stockholders' equity.

A full-text copy of the Form 10-Q is available for free at:

                        http://is.gd/9Tsa2B

                         About Retrophin

Retrophin, Inc., develops, acquires and commercializes therapies
for the treatment of serious, catastrophic or rare diseases.  The
Company offers Chenodal(R), a treatment for gallstones;
Vecamyl(R), a treatment for moderately severe to severe essential
hypertension and uncomplicated cases of malignant hypertension;
and Thiola, for the prevention of kidney stone formation in
patients with severe homozygous cystinuria.

Retrophin reported a net loss of $111 million in 2014 following a
net loss of $34.6 million in 2013.

BDO USA, LLP, in New York, issued a "going concern" qualification
on the consolidated financial statements for the year ended
Dec. 31, 2014.  The accounting firm noted that the Company has
suffered recurring losses from operations, used significant amounts
of cash in its operations, and expects continuing future losses.
In addition, at Dec. 31, 2014, the Company had deficiencies in
working capital and net assets of $70.2 million and $37.3 million,
respectively.  Finally, while the Company was in compliance with
its debt covenants at Dec. 31, 2014, it expects to not be in
compliance with these covenants in 2015.  These matters raise
substantial doubt about the Company's ability to continue as a
going concern, the auditors said.


REYES: Ch. 11 Case Dismissed, Filed in Bad Faith
------------------------------------------------
Judge Stuart M. Bernstein of the U.S. Bankruptcy Court for the
Southern District of New York granted the motion to dismiss the
Chapter 11 case, which was filed by Jo Anne Simon, as trustee of
the Gerald Arthur Living Trust.

Ms. Simon argued that Debtor David Francis Charles Reyes filed the
chapter 11 case in "bad faith" as a litigation tactic for the sole
purpose of transferring the state court litigations to the
Bankruptcy Court.  She says that the debtor had few debts, was not
being pressed for payment by the few creditors that he did have and
had no ability to reorganize.  Ms. Simon further argued that
although she was not a creditor, she was nonetheless a
party-in-interest because her rights individually and as a Trustee
were affected by the filing of the bankruptcy case and the removal
of the Surrogate's Court proceedings to which she was a party.

Judge Bernstein held that the Trustee was a party-in-interest
because she was aggrieved by the filing of the chapter 11 case and
the dismissal of the case will relieve her of the harm caused by
the filing of the case.  He adds that Ms. Simon asserted her own
rights as Trustee and satisfied the requirement for prudential
standing.  Judge Bernstein further held that the most significant
badge of bad faith in the case is that the debtor filed the
bankruptcy case solely as a litigation tactic to try the dispute in
a forum he deemed more favorable.  He says that the debtor concedes
that he filed the chapter 11 case in order to litigate his rights
in the Bankruptcy Court instead of the Surrogate's Court.

Judge Bernstein decided against imposing sanctions on the Debtor
and his lawyer, Brian M. DeLaurentis, saying that although the
Debtor and DeLaurentis filed the petition for an improper purpose,
they were not seeking to delay or harass Simon or anyone else.  He
further says that they were trying to expedite the determination of
the Debtor's rights.  Judge Bernstein adds that the Debtor, though
more probably DeLaurentis, clung to the sincere if misguided belief
that Ms. Simon's position as a member of the New York State
Assembly and the Assembly's Judiciary Committee would so affect the
Surrogate as to preclude an impartial decision.  He says that the
fault was not raising the issue with the Surrogate's Court, and
instead, filing the bankruptcy case and removing the litigation to
the Bankruptcy Court as a means of avoiding the perceived bias.

The case is In re: DAVID FRANCIS CHARLES REYES, Chapter 11, Debtor,
Case No. 14-13233 (SMB).

A full-text copy of Judge Bernstein's Memorandum Decision Granting
Motion To Dismiss The Case And Denying Sanctions, dated Aug. 4,
2015, is available at http://is.gd/nRCo0dfrom Leagle.com.

Jo Anne Simon, Trustee of the Gerald Arthur Living Trust, is
represented by:

          Bruce Weiner, Esq.
          ROSENBURG, MUSSO & WEINER LLP
          26 Court St., Suite 2211
          Brooklyn, NY 11242-1125
          Telephone: (718)855-6840
          Facsimile: (718)625-1966

David Francis Charles Reyes is represented by:

          Brian M. DeLaurentis, Esq.
          BRIAN M. DELAURENTIS P.C.
          36 West 44th Street, Suite 911
          New York, NY 10036
          Telephone: (212)354-6300
          Facsimile: (212)954-5081
          E-mail: Brian@DeLaurentisLaw.com

David Carraway is represented by:

          Duncan Peterson, Esq.
          PETERSON DELLECAVE LLP
          233 Broadway, Suite 1800
          New York , NY 10279
          Telephone: (212)240-9075
          E-mail: info@petersondellecave.com



RICHCOURT EURO: Chapter 15 Case Summary
---------------------------------------
Chapter 15 Petitioners: John D. Ayres and Matthew Wright, in their

                       capacity as joint liquidators

   Chapter 15 Debtors                       Case No.
   ------------------                       --------
   America Alternative Investments Inc.     15-12268
   c/o Intertrust Corporate Services Ltd.
   171 Main Street
   P.O. Box 92
   Road Town VG1110
   Tortola, British Virgin Islands

   Optima Absolute Return Fund Ltd          15-12269

   Richcourt Allweather B Inc.              15-12270

   Richcourt Allweather Fund Inc            15-12271

   Richcourt Composite Inc.                 15-12272

   Richcourt Euro Strategies Inc.           15-12273

Type of Business: Open-ended investment companies

Chapter 15 Petition Date: August 12, 2015

Court: United States Bankruptcy Court
       Southern District of New York (Manhattan)

Chapter 15 Petitioners' Counsel: Steven J. Reisman, Esq.
                                 L. P. Harrison 3rd, Esq.
                                 James V. Drew, Esq.
                                 Lauren Tauro, Esq.
                                 CURTIS, MALLET-PREVOST, COLT &
                                   MOSLE LLP
                                 101 Park Avenue
                                 New York, NY 10178
                                 Tel: 212-696-6065
                                 Fax: (212) 697-1559
                                 Email: sreisman@curtis.com
                                        lharrison@curtis.com
                                        jdrew@curtis.com
                                        ltauro@curtis.com

                                    Estimated     Estimated
                                     Assets      Liabilities
                                   -----------   -----------
America Alternative Investments    $100K-$500K   $10MM-$50MM
Richcourt Euro Strategies          $1MM-$10MM    $1MM-$10MM


SABINE OIL: Taps Lazard Freres as Investment Banker
---------------------------------------------------
Sabine Oil & Gas Corporation and its debtor-affiliates ask the
Honorable Shelley C. Chapman of the U.S. Bankruptcy Court for the
Southern District of New York for permission to employ Lazard
Freres & Co. LLC as their investment banker.

The firm will:

     a) review and analyze the Debtors' business, operations, and
financial projections;

     b) evaluate the Debtors' potential debt capacity in light of
its projected cash flows;

     c) assist in the determination of a capital structure for the
Debtors;

     d) assist in the determination of a range of values for the
Debtors on a going concern basis;

     e) advise the Debtors on tactics and strategies for
negotiating with the stakeholders;

     f) render financial advice to the Debtors and participating in
meetings or negotiations with the Stakeholders and rating agencies
or other appropriate parties in connection with any Restructuring;

     g) advise the Debtors on the timing, nature, and terms of new
securities, other consideration, or other inducements to be offered
pursuant to any restructuring;

     h) advise and assist the Debtors in evaluating any potential
Financing transaction by the Debtors, and subject to Lazard's
agreement so to act and, if requested by Lazard, to execution of
appropriate agreements, on behalf of the Debtors, contacting
potential sources of capital as the Debtors may designate and
assisting the Debtors in implementing such Financing;

     i) assists the Debtors in preparing documentation within
Lazard's area of expertise that is required in connection with any
restructuring;

     j) attends meetings of the Debtors' board of directors with
respect to matters on which Lazard has been engaged to advise
pursuant to the engagement letter;

     k) provide testimony, as necessary, with respect to matters on
which Lazard has been engaged to advise pursuant to the engagement
letter in any proceeding before the Bankruptcy Court; and

     l) provide the Debtors with other financial restructuring
advice.

The firm will be paid:

     a) Monthly Fee: A monthly fee of $150,000, payable on the
first day of each month (commencing March 1, 2015) until the
earlier of the consummation of the Restructuring (other than an
amendment or the termination of Lazard's engagement pursuant to the
Engagement Letter.  One-half of the Monthly Fees paid in excess of
$1.8 million shall be credited against any Restructuring Fee,
Amendment Fee, or Financing Fee subsequently payable; provided that
in the event of a chapter 11 filing, such credit shall only apply
to the extent that such fees are approved by the Bankruptcy Court,
if applicable.  Notwithstanding the foregoing, the Debtors may
suspend the Monthly Fee once for a period up to six-months in which
services will not be requested.  If the Debtors do so suspend,
Monthly Fees will be resumed when services are requested.

     b. Restructuring Fee: A fee equal to $7.5 million, payable
upon the consummation of a Restructuring; provided, however, that
if a Restructuring is to be completed through a "pre-packaged" or
"pre-arranged" plan of reorganization, the Restructuring Fee shall
be earned and shall be payable upon the earlier of (i) execution of
definitive agreements with respect to such plan and (ii) delivery
of binding consents to such plan by a sufficient number of
creditors and bondholders, as the case may be, to bind the
creditors or bondholders, as the case may be, to the plan;
provided, further, that in the event that Lazard is paid a fee in
connection with a "pre-packaged" or "pre-arranged" plan and a plan
of reorganization is not consummated, Lazard shall return such fee
to the Debtors.

     c. Amendment Fee: In the event of an amendment, a fee upon the
execution of a binding agreement with respect thereto equal to
$500,000; provided, however, that if multiple Amendments happen
simultaneously, the maximum fee payable for such simultaneous
Amendments shall be $1 million. One-half of any Amendment Fee paid
shall be credited against any Restructuring Fee or Financing Fee
that may be earned.

     d. Financing Fee: A fee payable upon consummation of a
Financing equal to (i) 1.50% of the total gross proceeds raised if
the funds raised in the Financing are through new debt or (ii)
3.00% of the total gross proceeds raised if the funds raised in the
Financing are through new equity; provided, however, that in the
case of any debtor-inpossession, the Financing Fee shall be earned
and shall be payable upon the execution of a definitive agreement
with respect to such Financing; provided, further, that in the
event that Lazard is paid a fee in connection with a Financing and
the Financing is not consummated, Lazard shall return such fee to
the Debtors.  A portion of any Financing Fee(s) paid (and not
returned pursuant to the preceding sentence) shall be credited
(without duplication) against any Restructuring Fee subsequently
payable, as follows:

        -- with respect to any Financing provided by one or more
current lenders under the Debtors’ revolving credit facility, (y)
75.00% of any Financing Fee paid on account of any Financing in an
amount up to the difference between (A) the borrowings outstanding
under the revolving credit facility as of the date of the
Engagement Letter and (B) the total commitments available under the
revolving credit facility as of the Engagement Letter and (z)
50.00% of any Financing Fee paid on account of any Financing to the
extent such Financing exceeds the Available RBL Amount; and

        -- with respect to any Financing provided by a party that
is not a current lender under the Debtors’ revolving credit
facility, 50.00% of the Financing Fee.

     e. In the event of a Restructuring which solely involves one
or more Amendments, the fee payable with respect thereto shall be
determined in accordance with clause (c) above and not clause (b)
and more than one fee may be payable pursuant to each of clauses
(c) and (d) above.  In addition, if at the time of termination of
the engagement Lazard has not been paid at least $2.0 million in
fees, at such time the Debtors will pay Lazard an amount equal to
the difference between $2.0 million and the amount of fees
previously paid.

Brandon Aebersold, managing director of the firm, assures the Court
that the firm is a "disinterested person" within the meaning of
Section 101(14) of the Bankruptcy Code.

Mr. Aebersold can be reached at:

Brandon Aebersold
Lazard Freres & Co. LLC
30 Rockefeller Plaza
New York NY 10112
Tel: +1 212 632 6000
Email: Brandon.aebersold@lazard.com

                       About Sabine Oil & Gas

Sabine Oil & Gas Corp. is an independent energy company engaged in
the acquisition, production, exploration, and development of
onshore oil and natural gas properties in the U.S.  The Company's
current operations are principally located in the Cotton Valley
Sand and Haynesville Shale in East Texas, the Eagle Ford Shale in
South Texas, the Granite Wash in the Texas Panhandle, and the North
Louisiana Haynesville.  The Company operates, or has joint working
interests in, approximately 2,100 oil and gas production sites
(approximately 1,800 operating and approximately 315 non-operating)
and has approximately 165 full-time employees.

Sabine Oil and its affiliated entities sought Chapter 11 protection
(Bankr. S.D.N.Y. Lead Case No. 15-11835) in Manhattan on July 15,
2015.

The Debtors have engaged Kirkland & Ellis LLP and Kirkland & Ellis
International LLP, as counsel; Lazard Freres & Co. LLC, as
investment banker, and Prime Clerk LLC as notice, claims and
balloting agent.  The Debtors also tapped Zolfo Cooper Management,
LLC, to provide Jonathan A. Mitchell as CRO and other additional
personnel.


SABINE OIL: U.S. Trustee Forms Five-Member Creditors' Committee
---------------------------------------------------------------
The U.S. Trustee for Region 2 appointed five creditors of Sabine
Oil & Gas Corp. and its affiliated debtors to serve on the official
committee of unsecured creditors.

The unsecured creditors are:

     (1) The Bank of New York Mellon, N.A.
         101 Barclay Street
         New York, New York 10286
         Attention: Gary S. Bush, Vice President
         Telephone: (212) 815-2747

     (2) Aurelius Capital Partners, LP
         535 Madison Avenue – 22nd Floor
         New York, New York 10022
         Attention: Dan Gropper
         Telephone: ^646) 445-6570

     (3) Farallon Capital Offshore Investors II, L.P.
         One Maritime Plaza, Suite 2100
         San Francisco, California 94111
         Attention: Michael Linn, Managing Member
         Telephone: (415) 421-2132


     (4) AQR Diversified Arbitrage Fund
         2 Greenwich Plaza – 4th Floor
         Greenwich, Connecticut 06830
         Attention: Melinda C. Franek, Vice President
         Telephone: ((203) 742-3007

     (5) Asset Risk Management, LLC
         20329 State Highway 249 - Suite 450
         Houston, Texas 77070
         Attention: Thomas W. Heath, President
         Telephone: (281) 655-3206

Official creditors' committees have the right to employ legal and
accounting professionals and financial advisors, at a debtor's
expense.  They may investigate the debtor's business and financial
affairs.  Importantly, official committees serve as fiduciaries to
the general population of creditors they represent.

                       About Sabine Oil & Gas

Sabine Oil & Gas Corp. is an independent energy company engaged in
the acquisition, production, exploration, and development of
onshore oil and natural gas properties in the U.S.  The Company's
current operations are principally located in the Cotton Valley
Sand and Haynesville Shale in East Texas, the Eagle Ford Shale in
South Texas, the Granite Wash in the Texas Panhandle, and the North
Louisiana Haynesville.  The Company operates, or has joint working
interests in, approximately 2,100 oil and gas production sites
(approximately 1,800 operating and approximately 315 non-operating)
and has approximately 165 full-time employees.

Sabine Oil and its affiliated entities sought Chapter 11 protection
(Bankr. S.D.N.Y. Lead Case No. 15-11835) in Manhattan on July 15,
2015.

The Debtors have engaged Kirkland & Ellis LLP and Kirkland & Ellis
International LLP, as counsel; Lazard Freres & Co. LLC, as
investment banker, and Prime Clerk LLC as notice, claims and
balloting agent.  The Debtors also tapped Zolfo Cooper Management,
LLC, to provide Jonathan A. Mitchell as CRO and other additional
personnel.


SABLE NATURAL: Jonathan Rich Quits as Director
----------------------------------------------
Jonathan Rich resigned as director of Sable Natural Resources
Corporation, effective Aug. 4, 2015.  Mr. Rich's resignation is not
due to any disagreements with the Company or any of its policies or
practices, according to a Form 8-K document filed with the
Securities and Exchange Commission.

                         About Sable Natural

Sable Natural Resources Corporation is an energy holding company
with principal operations centralized in its wholly-owned
subsidiary, Sable Operating Company, Inc.  Sable was formerly known
as NYTEX Energy Holdings, Inc. and Sable Operating was formerly
known as NYTEX Petroleum Inc.  Sable Operating is a development
stage exploration and production company engaged in the
acquisition, development, and production of liquids rich natural
gas and oil reserves from low-risk, high rate-of-return wells in
the Fort Worth Basin of Texas.  On Dec. 31, 2014, the Company's
estimated proved reserves were 669.12 MBOE, of which 100% were
proved developed.  The Company's portfolio of proved developed
natural gas and oil reserves is weighted in favor of liquids rich
natural gas, with the Company's proved reserves consisting of 15%
oil, 38% natural gas liquids and 47% natural gas.  Also, on Dec.
31, 2014, the Company's probable reserves were 565 MBOE consisting
of 17% oil, 2% NGL, and 81% natural gas, and the Company's possible
reserves were 1,231 MBOE consisting of 19% oil, 2% NGL, and 79%
natural gas.

Sable Natural reported a net loss of $4.62 million on $912,000 of
total revenues for the year ended Dec. 31, 2014, compared with a
net loss of $2.67 million on $930,000 of total revenues for the
year ended Dec. 31, 2013.

As of March 31, 2015, the Company had $18.6 million in total
assets, $20.57 million in total liabilities, $3.72 million in
mezzanine equity, and a $5.69 million total stockholders' deficit.

Whitley Penn LLP, in Dallas, Texas, issued a "going concern"
qualification on the consolidated financial statements for the year
ended Dec. 31, 2014, citing that the Company will need additional
working capital to fund operations.  This condition raises
substantial doubt about the Company's ability to continue as a
going concern.


SAN JUAN RESORT: SJ Beach Declared Successful Bidder
----------------------------------------------------
San Juan Resort Owner, Inc., together with Banco Popular de Puerto
Rico, notified the U.S. Bankruptcy Court for the District of Puerto
Rico that SJ Beach PR LLC, which serves as the stalking horse
purchaser, is the successful bidder for the sale of substantially
all of its assets.

As previously reported by The Troubled Company Reporter, Judge
Mildred Caban Flores entered an order approving the asset purchase
agreement, the bidding procedures, and the sale of San Juan Resort
Owner, Inc.'s assets, free and clear, to a stalking horse purchaser
or to the successful bidder.

SJ Beach PR LLC, as the buyer, agrees that the purchase price for
the assets is $9.45 million.  The assets to be sold include all of
the assets of the Debtor that are used in or related to the
operation of the San Juan Beach Hotel.

The parties told the Court that they are working diligently to
close on the Sale to the Stalking Horse Purchaser, as authorized by
the Sale Order, and will inform the Court once the closing occurs.

The Debtor is represented by:

          William M. Vidal-Carvajal
          MCS Plaza Suite 801
          255 Ave. Ponce de Leon Ave
          Hato Rey, Puerto Rico 00918
          Tel: 787 764-6867
          Fax: 787 764-6491
          Email: William.m.vidal@gmail.com

Banco Popular de Puerto Rico is represented by:

          Luis C. Marini
          O'NEILL & BORGES LLC
          American International Plaza
          250 Munoz Rivera Avenue, Suite 800
          San Juan, Puerto Rico 00918-1813
          Tel: (787) 764-8181
          Fax: (787) 753-8944
          Email: luis.marini@oneillborges.com

                     About San Juan Resort

San Juan Resort Owners Inc. sought Chapter 11 bankruptcy
protection (Bankr. D.P.R. Case No. 15-01627) in Old San Juan,
Puerto Rico on March 5, 2015. The petition was signed by Luis A.
Carreras Perez as president.  The Debtor is represented by William
M. Vidal, Esq., at William Vidal Carvajal Law Offices in San Juan,
Puerto Rico.

The Debtor disclosed $12,787,943 in assets and $33,014,219 in
liabilities as of the Chapter 11 filing.

The Debtor owns a parcel of land of 1,637 square meters, with
commercial property known as the San Juan Beach Hotel, a 96-room
hotel.  The hotel is located at 1045, Ashford Avenue, Condado, San
Juan, Puerto Rico.  The company claims the property is worth $11
million based on appraised value.  Banco Popular de Puerto Rico is
owed $17.5 million, of which $6.56 million is unsecured.


SEMCRUDE: Decision on Kivisto Motion Reversed
---------------------------------------------
Judge Fisher of the U.S. Court of Appeals reversed the Bankruptcy
Court's decision denying appellant Thomas L. Kivisto's motion to
enjoin the action brought by SemCrude L.P.'s former limited
partners, known as the Oklahoma Plaintiffs, in state court which
alleged breach of fiduciary duty, negligent misrepresentation, and
fraud.

The Oklahoma Plaintiffs alleged that: (a) they suffered injuries
that were separate and distinct from the injuries suffered by
SemCrude and its other equity holders; and (b) that Kivisto
breached fiduciary duties owed to them as individuals.

Kivisto argued that all SemCrude limited partners suffered the same
loss of capital on a pro rata basis as a result of his alleged
misconduct and that the Oklahoma Plaintiffs respective losses
differ only in amount, not in kind, making their claims derivative.
He further argues that Oklahoma courts have never identified a
violation of a supposed "special duty" to a shareholder as loss "in
addition to" the loss sustained by the corporation.

Judge Fisher held that to the extent the Oklahoma Plaintiffs'
claims are masked claims for a diminution in value of their limited
partner units as a result of Kivisto's mismanagement, their claims
are derivative of the claims released by the Litigation Trust.  He
notes that the Oklahoma Plaintiffs are unable to show that they
experienced any loss "in addition to" the other equity holders or,
equally, the company, who were injured by Kivisto's alleged
misconduct and experienced the same pro rata loss by investing or
failing to divest their units.  Judge Fisher further holds that the
Oklahoma Plaintiffs can show neither that they were injured
separately from the company or all other unitholders on the basis
of Kivisto's misconduct, nor that they were entitled to recovery of
the units they allegedly would not have contributed or would have
sold out but for Kivisto's misconduct. He concluded that the
Oklahoma Plaintiffs' breach of fiduciary duty claim is derivative.

The case is IN RE: SEMCRUDE L.P., et. al., Debtors. THOMAS L.
KIVISTO, Appellant, No. 14-1204.

A full-text copy of Judge Fisher's Opinion of the Court dated
Aug. 5, 2015, is available at http://is.gd/9YK5l1from Leagle.com.

Thomas L. Kivisto is represented by:

          Paul R. Bessette, Esq.
          James P. Sullivan, Esq.
          KING & SPALDING
          401 Congress Avenue, Suite 3200
          Austin, TX 78701
          Telephone: (512)457-2050
          Facsimile: (512)457-2100
          E-mail: pbessette@kslaw.com
                  jsullivan@kslaw.com

The Oklahoma Plaintiffs are represented by:

          Andrew S. Hicks, Esq.
          Adam P. Schiffer, Esq.
          SCHIFFER ODOM HICKS & JOHNSON PLLC
          700 Louisiana, Suite 2640
          Houston, TX 77002
          Telephone: (713)357-5150
          Facsimile: (713)357-5160
          E-mail: ahicks@sohjlaw.com
                  aschiffer@sohlawfirm.com

                    - and -

          Gary F. Seitz, Esq.
          GELLERT SCALI BUSENKELL & BROWN LLC
          601 Walnut Street
          The Curtis Center, Suite 280 South
          Philadelphia, PA 19106
          Telephone: (215)238-0011
          Facsimile: (215)238-0016
          E-mail: gseitz@gsbblaw.com

                       About SemCRUDE L.P.

SemGroup, L.P. -- http://www.semgrouplp.com/-- is a midstream
service company that provides diversified services for end users
and consumers of crude oil, natural gas, natural gas liquids and
refined products.  Services include purchasing, selling,
processing, transporting, terminalling and storing energy. SemGroup
serves customers in the United States, Canada, Mexico and
Wales.

SemGroup L.P. and its debtor-affiliates filed for Chapter 11
protection (Bankr. D. Del. Case No. 08-11525) on July 22, 2008.
John H. Knight, Esq., L. Katherine Good, Esq. and Mark
D. Collins, Esq., at Richards Layton & Finger; Harvey R. Miller,
Esq., Michael P. Kessler, Esq., and Sherri L. Toub, Esq., at Weil,
Gotshal & Manges LLP; and Martin A. Sosland, Esq., and Sylvia A.
Mayer, Esq., at Weil Gotshal & Manges LLP, represented the Debtors
in their restructuring efforts.  Kurtzman Carson Consultants
L.L.C. served as the Debtors' claims agent.  The Blackstone Group
L.P. and A.P. Services LLC acted as the Debtors' financial
advisors.

Margot B. Schonholtz, Esq., and Scott D. Talmadge, Esq., at Kaye
Scholer LLP; and Laurie Selber Silverstein, Esq., at Potter
Anderson & Corroon LLP, represented the Debtors' prepetition
lenders.

SemGroup L.P.'s affiliates, SemCAMS ULC and SemCanada Crude
Company, sought protection under the Companies' Creditors
Arrangement Act (Canada) on July 22, 2008.  Ernst & Young, Inc.,
is the appointed monitor of SemCanada Crude Company and its
affiliates' reorganization proceedings before the Canadian
Companies' Creditors Arrangement Act.

SemGroup LP won confirmation from the Bankruptcy Court of its
Fourth Amended Plan of Reorganization on Oct. 28, 2008.  The
Plan, which distributed more than $2.5 billion in value to
stakeholders, was declared effective on Nov. 30, 2008.

As part of the Plan, the Reorganized Debtors entered into two new
credit facilities aggregating $625 million in financing; entered
into a $300 million Second Lien Term Facility; created a new
corporate structure, including issuing shares of common stock and
warrants; and distributed approximately $500 million of cash and
approximately $1 billion in value of new common stock and warrants
to thousands of creditors in accordance with the Plan.



SMILE BRANDS: S&P Lowers CCR to 'CCC+', Outlook Negative
--------------------------------------------------------
Standard & Poor's Ratings Services removed its ratings on Smile
Brands Group Inc. from CreditWatch, where S&P placed them with
negative implications on Feb. 3, 2015.  At the same time, S&P
lowered its corporate credit and senior secured debt ratings on
Smile Brands to 'CCC+' from 'B-'.  The outlook is negative.

The recovery rating on the senior secured debt remains '3',
indicating expectations of meaningful (50% to 70%; at the lower end
of the range) recovery in a payment default.

"The ratings downgrade reflects the deterioration in Smile Brands'
operating margins and credit measures due to the continued
challenging reimbursement environment in its core markets, and the
noncompliance with its financial covenants in the fourth quarter of
2014 that necessitates a waiver from its lenders and an equity
infusion from the sponsor," said Standard & Poor's credit analyst
Arthur Wong.

Smile Brands has achieved some progress in cost controls and more
optimized patient scheduling at its offices, resulting in slight
margin improvements in the first half of 2015.  However, S&P
believes the company will find it difficult to materially improve
operating performance and generate positive free cash flows in the
next 12 to 18 months.  S&P's assessment of Smile Brands' "highly
leveraged" financial risk profile reflects our expectations of a
leverage ratio above 10x and funds from operations (FFO) to debt of
less than 5.0% for the near term.

Smile Brands and its affiliates operate about 370 dental care
offices in 18 states.  It participates in a highly fragmented and
increasingly competitive dental services industry, which has low
barriers to entry and is susceptible to the growing power of
private insurers which weighs on industrywide prices,
reimbursement, and utilization.  Smile Brands' competitors are
increasingly joining networks of commercial dental insurers and
offering services at discounted prices that are comparable to Smile
Brands' offerings.  This has contributed to the company's weakened
volume and revenue growth over the past two years and, when coupled
with the ongoing industry challenges, result in S&P's "vulnerable"
business risk profile assessment.

S&P's negative rating outlook reflects Smile Brands' need to
reverse operating trends and its constrained liquidity.  Standard &
Poor's will focus on whether management can sustain the positive
momentum achieved in the past two quarters.  S&P is expecting Smile
Brands' revenues and EBITDA to be relatively stable over the next
year, with improvements in margin being key to generating positive
free cash flows.

S&P could lower its rating if free operating cash flow deficits
persist, resulting in ongoing liquidity stress.  This could occur
if revenue growth remains stalled and the company is not able to
improve EBITDA margins to the 8% to 10% range.

S&P could revise the outlook to stable if it concludes that Smile
Brands can reverse operating trends and generate positive free
operating cash flows following an equity contribution.  Free
operating cash flow generation requires a combination of an
improvement in profitability compared with recent quarters,
curtailed capital spending, and reduced cash interest expenses.



STACKPOLE INTERNATIONAL: S&P Puts 'B+' CCR on CreditWatch Positive
------------------------------------------------------------------
Standard & Poor's Ratings Services said it placed its ratings on
Stackpole International group of companies (collectively,
Stackpole), including its 'B+' long-term corporate credit rating on
the company, on CreditWatch with positive implications.

The Stackpole group of companies includes rated entities Stackpole
International EP Holding Ltd., Stackpole International Global
Holding Co., and Stackpole International PM Holding Ltd., as well
as Stackpole International Engineered Products Inc., Stackpole
International Intermediate Co. S.A., and Stackpole International
Powder Metal ULC, which are subsidiaries of the rated entities and
co-issuers of the senior secured notes.

"The CreditWatch placement follows Johnson Electric Holdings Ltd.'s
announcement that it has agreed to acquire Stackpole for C$800
million," said Standard & Poor's credit analyst Jamie Koutsoukis.
"If the transaction closes as planned, we expect Stackpole will
operate as a wholly owned subsidiary of Johnson Electric, which we
rate 'BBB' and therefore in our opinion has a stronger credit
profile," Ms. Koutsoukis added.

Johnson Electric also announced that, in conjunction with the
transaction, it will retire Stackpole's existing high-yield debt.
The transaction is subject to the customary regulatory approvals
and we expect it will close in the fourth quarter of 2015.

S&P's "weak" business risk profile assessment on Stackpole
incorporates the company's relatively limited size and diversity,
as well as the auto parts industry's volatile demand, intense
competition, and constant pricing pressure.  These concerns are
partially mitigated by Stackpole's leading positions in the North
American niche oil pump and powder metal parts industry, where the
company's products are used mostly in long-lived powertrains and
their specialized nature somewhat shields Stackpole from commodity
pressures many other automotive parts makers experience.  S&P views
Stackpole's financial policy as "FS-6," which applies a cap to the
financial risk profile at "highly leveraged."  This assessment
reflects Stackpole's financial sponsor ownership by Crestview
Partners L.P. and CITIC Holdings Ltd.

At year-end 2014, Stackpole's debt leverage, adjusted for capital
leases, was above 5x and funds from operations to debt was in the
mid-single digits.

S&P plans to resolve the CreditWatch placement after the
transaction closes.  At that time, S&P expects to raise the
long-term corporate credit rating on Stackpole by several notches.



STAR BODY EXPERT: Case Summary & 9 Largest Unsecured Creditors
--------------------------------------------------------------
Debtor: Star Body Expert, Inc.
        2 Rd. Km. 20.1
        Candelaria Ward
        TOA Baja, PR 00949

Case No.: 15-06125

Chapter 11 Petition Date: August 11, 2015

Court: United States Bankruptcy Court
       District of Puerto Rico (Old San Juan)

Judge: Hon. Brian K. Tester

Debtor's Counsel: Gerardo L Santiago Puig, Esq.
                  SANTIAGO PUIG LAW OFFICES
                  Doral Bank Plaza Suite 801
                  33 Resolucion St
                  San Juan, PR 00920
                  Tel: 787-777-8000
                  Fax: 787-767-7107
                  Email: gsantiagopuig@gmail.com

Estimated Assets: $500,000 to $1 million

Estimated Liabilities: $1 million to $10 million

The petition was signed by Carlos Olivero Pinero, president.

A list of the Debtor's nine largest unsecured creditors is
available for free at http://bankrupt.com/misc/prb15-06125.pdf


STELLAR BIOTECHNOLOGIES: Reports $464,000 Net Income in Q2
----------------------------------------------------------
Stellar Biotechnologies, Inc. filed with the Securities and
Exchange Commission its quarterly report on Form 10-Q disclosing
net income of $463,986 on $157,748 of revenues for the three months
ended June 30, 2015, compared to net income of $3.4 million on
$72,538 of revenues for the same period during the prior year.

For the nine months ended June 30, 2015, the Company reported a net
loss of $1.3 million on $558,036 of revenues compared to a net loss
of $3.6 million on $245,734 of revenues for the same period in
2014.

As of June 30, 2015, the Company had $11.2 million in total assets,
$1.7 million in total liabilities and $9.4 million in total
shareholders' equity.

"Our working capital position at June 30, 2015 was $8,944,753,
including cash and cash equivalents of $10,161,458 and noncash
current portion of our warrant liability of $1,235,905.  Management
believes the current working capital is sufficient to meet our
present requirements, including all contractual obligations and
anticipated research and development expenditures for at least the
next 12 months.  We expect to finance our future expenditures and
obligations through revenues from product sales, contract services
income, grant revenues, and sales of our equity and debt
securities.  We expect to continue incurring losses for the
foreseeable future and may need to raise additional capital to
pursue our business plan and continue as a going concern.  We may
raise additional capital through the sale of our equity or debt
securities in the public or private markets or through strategic
collaborations.  We cannot provide any assurances that we will be
able to raise additional capital on commercially acceptable
terms."

"Market demand for high-quality, sustainable sources of GMP-grade
KLH increases as many biotechnology companies expand their
pipelines of immunotherapies based on KLH protein.  These companies
are seeing success in their ongoing clinical trials in a wide
variety of disease indications - like our collaborator Neovacs
targeting lupus, and others in the industry such as Axon and its
recent progress with a KLH-based Alzheimer's vaccine to name
another," said Frank Oakes, chief executive officer of Stellar
Biotechnologies.

"Our strategic collaboration with Ostiones Guerreros SA de CV,
which we believe has transformative potential for the Company, was
spurred in part by this increasing demand.  With this agreement in
place, we look forward to being the only company with a reliable
and scalable supply of KLH as an ever-growing roster of customers
and new clients with successful therapeutic candidates approach FDA
approval, and eventually, commercialization."

A full-text copy of the Form 10-Q is available for free at:

                        http://is.gd/bnURew

                           About Stellar

Port Hueneme, Cal.-based Stellar Biotechnologies, Inc.'s
business is to commercially produce and market Keyhole Limpet
Hemocyanin ("KLH") as well as to develop new technology related to
culture and production of KLH and subunit KLH ("suKLH")
formulations.  The Company markets KLH and suKLH formulations to
customers in the United States and Europe.

KLH is used extensively as a carrier protein in the production of
antibodies for research, biotechnology and therapeutic
applications.

Stellar Biotechnologies reported a net loss of $8.43 million for
the year ended Aug. 31, 2014, a net loss of $14.5 million for the
year ended Aug. 31, 2013, and a net loss of $5.52 million for the
year ended Aug. 31, 2012.


SUMMIT BUILDING: Case Summary & 6 Largest Unsecured Creditors
-------------------------------------------------------------
Debtor: Summit Building and Development, LLC
        A New Mexico Limited Liability Company
           aka Summit Development of Las Cruces, LLC
        7805 Arroyo Rd
        Las Cruces, NM 88012

Case No.: 15-12138

Chapter 11 Petition Date: August 11, 2015

Court: United States Bankruptcy Court
       New Mexico (Albuquerque)

Judge: Hon. Robert H. Jacobvitz

Debtor's Counsel: R. Trey Arvizu, III, Esq.
                  ARVIZULAW.COM, LTD.
                  PO Box 1479
                  Las Cruces, NM 88004-1479
                  Tel: 575-527-8600
                  Fax: 575-527-1199
                  Email: trey@arvizulaw.com

Estimated Assets: $1 million to $10 million

Estimated Liabilities: $1 million to $10 million

The petition was signed by Harlo J Dynek, managing member.

A list of the Debtor's six largest unsecured creditors is available
for free at http://bankrupt.com/misc/nmb15-12138.pdf


TELEPHONE AND DATA: Fitch Affirms 'BB+' Issuer Default Ratings
--------------------------------------------------------------
Fitch Ratings has affirmed the Issuer Default Ratings (IDR) and
senior unsecured debt ratings for Telephone and Data Systems, Inc.
(TDS) and its subsidiary United States Cellular Corp. (USM) at
'BB+'. In addition, Fitch has assigned an 'RR4' recovery rating to
the senior unsecured debt for both companies. USM's ratings
consider the consolidated ratings at TDS. The Rating Outlook
remains Stable.

KEY RATING DRIVERS

Wireless Market Position: Fitch's current ratings reflect the
challenges faced by TDS's main operating business -- USM -- which
is the fifth-largest wireless operator in a market dominated by
four national wireless operators. This concern is mitigated by
TDS's financial flexibility arising from its healthy liquidity
position and relatively low leverage for the rating. USM's
subscriber trends in core markets improved in the second half of
2014; however, operating profitability in 2014 was suppressed due
to billing system issues early in the year as well as higher losses
on equipment driven by strong smartphone sales. Positive, though
modest, net additions have continued in 2015 owing to much improved
churn rates.

Leverage: TDS's gross leverage was 2.33x at March 31, 2015,
including a portion of partnership distributions received from
noncontrolled entities (2.6x without). Partnership distributions
will be temporarily lower in 2015 and 2016, due to a one-time
charge at the Los Angeles partnership related to a capital lease
for AWS-3 spectrum covering the partnership's market.

Spectrum: USM participated in the Federal Communications
Commission's (FCC) spectrum auction for AWS-3 spectrum through its
limited partnership interest in Advantage Spectrum. Advantage
Spectrum won 124 licenses with a total value of $338 million, net
of the 25% designated entity discount. To fund the loans to
Advantage Spectrum and its general partners and the capital
contributions to Advantage Spectrum, USM issued $275 million of
senior unsecured notes due 2063.

Solid Financial Profile: The ratings at TDS and USM reflect the
current strong liquidity position owing to substantial cash
balances, conservative balance sheet, long-dated maturities and
unused revolving credit facility capacity of $399 million and $282
million at TDS and USM, respectively.

Cable Strategy: TDS has targeted the cable industry as an avenue of
growth. The company acquired BendBroadband in September 2014 for
$261 million in cash. BendBroadband was the second major cable
acquisition for TDS, following the acquisition of Baja Broadband
for $267 million in August 2013.

Noncore Assets: The sale of noncore assets has mitigated the effect
of negative FCF on USM and TDS. USM has sold wireless towers
located in the Chicago and St. Louis markets for approximately $159
million. Of this amount, the balance of approximately $142 million
was received in January 2015, following an initial amount received
in 2014. The customers in these markets had been sold to Sprint in
2013. In 2015, the company has received $145 million in cash from
spectrum exchanges. While Fitch believes TDS considers USM's 5.5%
stake in the Los Angeles partnership and its tower portfolio as
core assets, Fitch also recognizes these assets provide the company
with financial flexibility should the need arise as it pursues
growth in the cable industry.

FCF Expectations Pressured: Fitch expects free cash flow (FCF)
levels in 2015 to be negative due to the continued high level of
capital investment and low margins in the wireless business. In
2015, Fitch expects negative FCF in the range of $300 million to
$375 million, a material improvement relative to negative FCF of
$463 million in 2014. Capital spending is estimated by TDS to
approximate $830 million in 2015, up from approximately $800
million in 2014.

KEY ASSUMPTIONS

-- Fitch assumes a low single digit decline in wireless service
    ARPUs during 2015 to 2017, which is offset by moderate gross
    subscriber additions and growth in equipment revenues under
    equipment instalment plans. Churn is expected to remain around

    1.4% to 1.5%, in line with levels seen in 2015 and slightly
    below the 1.6% rate during 2H'14.

-- Wireless EBITDA margins improve to the low double digits from
    the 8.7% level in 2014. Higher sales on equipment installment
    sales are helping margins, as the loss on equipment sales
    decreased by $152 million in 1H'15 alone.

-- TDS Telecom demonstrates revenue growth due to cable
    acquisitions and growth in Hosted and Managed Services. Fitch
    expects 2015 EBITDA in the segment to decline in a 0% to 2%
    range, before returning to nominal growth in the years ahead.

-- Fitch estimates leverage could increase to the 2.7x to 2.9x
    range in 2016 (2.5x to 2.7x including a portion of partnership

    distributions), as USM explores the opportunity to bid on
    additional spectrum assets. USM's plans are not known but for
    forecasting purposes, Fitch assumes USM spends a similar
    amount to what they spent on the AWS-3 auction.

RATING SENSITIVITIES

Positive Rating Action: Positive actions are not contemplated at
this time.

Negative Rating Action: Longer term, Fitch believes TDS's and USM's
ability to grow revenues and cash flows while competing effectively
against much larger national operators is key to maintaining their
'BB+' Issuer Default Ratings (IDRs). In addition, if gross leverage
? calculated including partial credit for material wireless
partnership distributions in EBITDA ? approaches 3.5x, a negative
action could be contemplated.

LIQUIDITY

Strong Liquidity Profile: In relation to its total outstanding debt
of $1,994 million at June 30, 2015, TDS has relatively high
balances of cash, which amounted to $632 million. The ratings at
TDS and USM reflect the current strong liquidity position owing to
substantial cash balances, conservative balance sheet, available
revolving credit facility capacity and generally long-dated
maturities.

Debt Maturities: At TDS, a $400 million ($399 million of capacity)
revolving credit facility matures in December 2017, as does a $300
million ($282 million of capacity) revolving credit facility at
USM. The only material near-term maturity is the $225 million
CoBank loan, which matures in 2022. The loan was drawn in July
2015. The earliest notes at TDS are due in 2045 ($116 million) and
at USM the earliest note maturity is in 2033 ($544 million face
value).



THERAKOS INC: S&P Puts 'B' CCR on CreditWatch Positive
------------------------------------------------------
Standard & Poor's Ratings Services placed its 'B' corporate credit
rating and issue-level ratings on Therakos Inc. on CreditWatch with
positive implications. "The CreditWatch placement follows
Mallinckrodt PLC's announced plans to acquire Therakos," said
Standard & Poor's credit analyst Tahira Wright.

Therakos, a leading manufacturer of immunotherapy products and
integrated systems for administering autologous immune cell
therapy, is being acquired by pharmaceutical company Mallinckrodt
PLC from its sponsor The Gores Group in a $1.3 billion all-stock
transaction. The acquisition will aid Mallinckrodt's strategy of
further diversifying its specialty brands portfolio.

S&P's ratings on Mallinckrodt are unchanged following the
announcement.  The outlook on Mallinckrodt was revised to
negative.

S&P will resolve the CreditWatch placement once the transaction is
closed in the latter part of the third quarter of 2015 and
Therakos' outstanding debt is redeemed.  S&P will likely raise its
'B' corporate credit rating on Therakos to match the 'BB-' rating
on Mallinckrodt.  S&P will subsequently withdraw the corporate
credit and issue-level ratings on Therakos following the close of
the transaction.  S&P assumes the Therakos debt will be retired by
Mallinckrodt at transaction close.



THORNTON & CO: Proposes to Pay Critical Vendors
-----------------------------------------------
Thornton & Co., Inc., is asking the U.S. Bankruptcy Court for the
District of Connecticut for approval to pay the prepetition claims
of critical vendors.

Jeffrey M. Sklarz, Esq., at Green & Sklarz LLC, explains that it
will not be possible for the Debtor to liquidate effectively
without the ongoing support and participation of the Critical
Vendors.  If the critical vendors refuse to do business with the
Debtor, then the Debtor will be unable to ship inventory for sale.
This will eliminate approximately $10 million of value for the
Debtor and its estate, Mr. Sklarz tells the Court.

                       About Thornton & Co.

Thornton & Co., Inc. is an international distributor, trader and
wholesaler of plastic resins, providing a full offering of
polyethylene and polypropylene products.  J. Paul Thornton, Jr.
founded TCI in 1994.  As of Aug. 1, 2015, TCI had 20 employees,
consisting of 12 people at its Southington, Connecticut
headquarters, and 8 sales representatives who work in various
locations.

Thornton & Co. sought Chapter 11 protection (Bankr. D. Conn. Case
No. 15-21416) on Aug. 10, 2015, in Hartford, Connecticut.  Judge
Ann M. Nevins presides over the case.

The Debtor estimated $10 million to $50 million in assets and
debt.

The Debtor has tapped Green & Sklarz LLC as counsel, and Gordian
Group as financial advisor.

There's a meeting of creditors under 11 U.S.C. Sec. 341(a) on Sept.
4, 2015.  Proofs of claim are due by Dec. 3, 2015.


THORNTON & CO: Seeks to Use PUB's Cash Collateral
-------------------------------------------------
Thornton & Co., Inc., is asking the U.S. Bankruptcy Court for the
District of Connecticut to enter preliminary and final orders
authorizing the use of cash collateral and providing adequate
protection to secured creditors.

People's United Bank ("PUB"), pursuant to a UCC-1 financing
statement recorded on April 4, 2011 with the Secretary of the State
of Delaware, may claim an interest in the Debtor's cash
collateral.

In April 2011, TCI and PUB entered into a $30 million revolving
loan and credit facility (the "PUB Loan").  By way of multiple
amendments and restatements, the PUB Loan was ultimately increased
to a $40 million revolving credit facility.  Beginning in 2014, PUB
began requesting modification to the PUB Loan, including: requiring
personal guarantees, posting of collateral, modification of
borrowing base requirements, etc.  At this time, PUB is owed
approximately $21 million.  The approximate market value TCI's
inventory and accounts receivable are currently approximately $28
million.

The Debtor proposes to grant PUB a replacement lien in all after
acquired cash collateral, limited, however, to the same extent,
priority and validity as each possessed valid, duly enforceable
liens on the Petition Date and excluded from the replacement lien
on post-petition assets will be bankruptcy causes of action
available to the estate under 11 U.S.C. Sec. 544, 545, 547, 548,
549, 550, 551 and 553.

                       About Thornton & Co.

Thornton & Co., Inc. is an international distributor, trader and
wholesaler of plastic resins, providing a full offering of
polyethylene and polypropylene products.  J. Paul Thornton, Jr.
founded TCI in 1994.  As of Aug. 1, 2015, TCI had 20 employees,
consisting of 12 people at its Southington, Connecticut
headquarters, and 8 sales representatives who work in various
locations.

Thornton & Co. sought Chapter 11 protection (Bankr. D. Conn. Case
No. 15-21416) on Aug. 10, 2015, in Hartford, Connecticut.  Judge
Ann M. Nevins presides over the case.

The Debtor estimated $10 million to $50 million in assets and
debt.

The Debtor has tapped Green & Sklarz LLC as counsel, and Gordian
Group as financial advisor.

There's a meeting of creditors under 11 U.S.C. Sec. 341(a) on Sept.
4, 2015.  Proofs of claim are due by Dec. 3, 2015.


THORNTON & CO: Wants Oct. 30 Bar Date for 503(b)(9) Claims
----------------------------------------------------------
Thornton & Co., Inc., is asking the U.S. Bankruptcy Court for the
District of Connecticut to establish Oct. 30, 2015, as the deadline
for all creditors who assert an administrative priority claim
pursuant to 11 U.S.C. Sec. 503(b)(9) to file requests for payment
and/or proofs of claim asserting those claims.

Jeffrey M. Sklarz, Esq., at Green & Sklarz LLC, explains that the
Debtor desires to ascertain the nature and extent of any Sec.
503(b)(9) claims of which it may presently be unaware.  This will
not only aid the Debtor in formulating a plan of reorganization by
creating certainty with regard to any Sec. 503(b)(9) claims, but it
will also assure that any issues concerning such claims are
resolved before the plan confirmation process is underway.

                       About Thornton & Co.

Thornton & Co., Inc. is an international distributor, trader and
wholesaler of plastic resins, providing a full offering of
polyethylene and polypropylene products.  J. Paul Thornton, Jr.
founded TCI in 1994.  As of Aug. 1, 2015, TCI had 20 employees,
consisting of 12 people at its Southington, Connecticut
headquarters, and 8 sales representatives who work in various
locations.

Thornton & Co. sought Chapter 11 protection (Bankr. D. Conn. Case
No. 15-21416) on Aug. 10, 2015, in Hartford, Connecticut.  Judge
Ann M. Nevins presides over the case.

The Debtor estimated $10 million to $50 million in assets and
debt.

The Debtor has tapped Green & Sklarz LLC as counsel, and Gordian
Group as financial advisor.

There's a meeting of creditors under 11 U.S.C. Sec. 341(a) on Sept.
4, 2015.  Proofs of claim are due by Dec. 3, 2015.


TRISTAR WELLNESS: David Horin Resigns as Chief Financial Officer
----------------------------------------------------------------
Mr. David Horin resigned from his position as Tristar Wellness
Solutions, Inc.'s chief financial officer effective Aug. 4, 2015,
according to a Form 8-K filed with the Securities and Exchange
Commission.

                      About TriStar Wellness

TriStar Wellness Solutions, Inc., offers products and technologies
in the areas of wound care, women's health and therapeutic skin
care.  The Company is based in Westport, Connecticut.

TriStar Wellness reported a net loss of $8.87 million on $5.54
million of sales revenue for the year ended Dec. 31, 2014, compared
to a net loss of $12.6 million on $3.77 million of sales revenue
for the year ended Dec. 31, 2014.

As of March 31, 2015, the Company had $2.69 million in total
assets, $14.9 million in total liabilities and a $12.2 million
total stockholders' deficit.

M&K CPAS, PLLC, in Houston, TX, issued a "going concern"
qualification on the consolidated financial statements for the year
ended Dec. 31, 2014, citing that the Company has suffered
reoccurring losses from operations, and has an accumulated deficit
and working capital deficit as of Dec. 31, 2014.  These conditions
raise substantial doubt about its ability to continue as a going
concern.


TWIN RINKS: Court Approves Aug. 19 Auction for Assets
-----------------------------------------------------
Twin Rinks At Eisenhower, LLC, sought for and obtained from Judge
Robert E. Grossman of the U.S. Bankruptcy Court for the Eastern
District of New York, approval of its bidding procedures in
connection with the sale of substantially all of its assets.

The Bidding Procedures provide, among others, these terms:

     (a) Assets to be Sold: The auction will permit bidders to bid
on some or all of the Twin Rinks Assets.  The Twin Rinks Assets
generally constitute all of the operating assets owned or leased by
the Debtor including, but not limited to, a license with the County
of Nassau.  The Debtor may consider offers that contemplate a Sale
Transaction.

     (b) Participation Requirements: In order to participate in the
bidding process or otherwise be considered for any purposes
hereunder, a person interested in entering into a Sale Transaction
for some or all of the Twin Rinks Assets must first deliver an
executed confidentiality agreement in form and substance
satisfactory to the Debtor and its counsel.

     (c) Bid Deadline: Bids musts be received no later than Aug.
13, 2015 at 5:00 p.m.

     (d) Auction: If more than one Qualified Bid by a Qualified
Bidder is received by the Bid Deadline, an Auction with respect to
a sale of the Twin Rinks Assets will take place on Aug. 19, 2015 at
10:00 a.m.

     (e) Sale Hearing: The Court will conduct a hearing to approve
the sale on Aug. 26, 2015 at 1:30 p.m.

The County of Nassau sought changes to the Bidding Procedures to
reflect the critical role the County must play in the sale process,
which is a direct result of the terms of the its License Agreement
with the Debtor.

The County sought these changes:

     (1) The assumption of the License Agreement is a requirement
for any bid on the Twin Rinks Assets to constitute a Qualified
Bid;

     (2) At all stages of the sale process which the Debtor
formerly agreed to consult with the Committee and the Secured
Creditor, it now agrees to consult with the County in addition to
the Committee and the Secured Creditor;

     (3) Although the Debtor, in consultation with the Committee,
the Secured Creditor and the County may waive one or more defects
which would otherwise cause a bid not to be a Qualified Bid, the
requirement that a Qualified Bidder agree to an assignment of the
License Agreement cannot be waived;

     (4) The Debtor will provide to the County of Nassau, as they
are received by the Debtor or its financial advisor, (a) the names
of those persons or entities that entered into non-disclosure
agreements with the Debtor with respect to the proposed sale and
(b) copies of all information provided by Potential Bidders.  The
County of Nassau will hold such information confidential pending
the sale hearing; and

     (5) The Debtor may not exclude the License Agreement from the
list of Executory Contracts and Unexpired Leases to be assumed and
assigned if the Court determines that the applicable Cure Amount is
greater than the Cure Amount proposed by the Debtor.

The County's proposed changes to the bidding procedures were
adopted by the Court in its order approving the bidding
procedures.

Twin Rinks At Eisenhower, LLC, is represented by:

          Harold D. Jones, Esq.
          JONES & SCHWARTZ, P.C.
          One Old Country Road, Suite 384
          Carle Place, NY 11514
          Telephone: (516)873-8700

The County of Nassau is represented by:

          Stephen A. Donato, Esq.
          Thomas L. Kennedy, Esq.
          BOND, SCHOENECK & KING PLLC
          One Lincoln Center
          Syracuse, NY 13202
          Telephone: (315)218-8000
          Facsimile: (315)218-8100
          E-mail: sdonato@bsk.com
                  tkennedy@bsk.com

                         About Twin Rinks

Twin Rinks At Eisenhower, LLC, an East Meadow, New York-based ice
skating rink operator and entertainment business, sought
Chapter 11 bankruptcy protection (Bankr. E.D.N.Y. Case No.
15-72466) on June 8, 2015, with plans to sell its business and its
assets as a going concern.

The Debtor disclosed $52.4 million in assets and $55.2 million in
debt as of May 25, 2015.  

The Debtor tapped Jones & Schwartz, P.C., as counsel, and Greenspan
Associates, CPAs, as accountants.

The U.S. Trustee appointed three creditors to serve on the official
committee of unsecured creditors.   The Committee tapped Meyer,
Suozzi, English & Klein, P.C., as its general counsel.



TWIN RINKS: Files Revised Bid to Employ Greenspan as Accountants
----------------------------------------------------------------
Twin Rinks At Eisenhower, LLC, filed with the U.S. Bankruptcy Court
for the Eastern District of New York an amended request to employ
Greenspan Associates, CPAs, PC, as accountants, under a general
retainer, pursuant to Section 327(a) of the Bankruptcy Code.

As reported in the Troubled Company Reporter on June 12, 2015,
Greenspan will be required to render, among other things, these
services to the Debtor:

  (a) to give accounting advice with respect to the Debtor's powers
and duties;

  (b) to analyze all transfers pre- and post-petition that may be
avoidable by the Debtor;

  (c) to analyze all claims filed against the Debtor's estate;

  (d) to prepare all necessary operating statements, schedules and
tax documents for filing and reviewing proposed transactions
concerning any tax consequences; and

  (e) to perform any other accounting services for the Debtor in
connection with the Chapter 11 cases.

The current hourly rates which Greenspan has informed the Debtor it
charges for the accounting services of its professionals are:

                                       Hourly Rate
                                       -----------
         Principals                       $275
         Senior Staff                 $100 to $200

The Debtor says it will pay the firm an amount not to exceed 75% of
its invoices for fees and expenses in full on a monthly basis, with
such payment and the balance of those invoices subject to an
appropriate application for compensation.  The firm estimates its
fees will be in the amount of $30,000 for the entire case, the
Debtor notes.

Greenspan has informed the Debtor that it is a "disinterested
person" as defined by Section 101(14), and used in Section 327(a)
of the Bankruptcy Code.

                         About Twin Rinks

Twin Rinks At Eisenhower, LLC, an East Meadow, New York-based ice
skating rink operator and entertainment business, sought Chapter 11
bankruptcy protection (Bankr. E.D.N.Y. Case No. 15-72466) on June
8, 2015, with plans to sell its business and its assets as a going
concern.

The Debtor disclosed $52.4 million in assets and $55.2 million in
debt as of May 25, 2015.  

The Debtor tapped Jones & Schwartz, P.C., as counsel, and Greenspan
Associates, CPAs, as accountants.

The U.S. Trustee appointed three creditors to serve on the official
committee of unsecured creditors.   The Committee tapped Meyer,
Suozzi, English & Klein, P.C. as its general counsel.


UNI-PIXEL INC: Approves CEO Salary Increase
-------------------------------------------
The Compensation Committee of Uni-Pixel, Inc. increased, as of Aug.
1, 2015, the annual salary of Jeff A. Hawthorne, the Company's
chief executive officer, from $250,000 to $305,000.  

Also on Aug. 4, 2015, Mr. Hawthorne, Christine Russell, the
Company's chief financial officer, and Jalil Shaikh, the Company's
chief operating officer, each agreed, for the payroll period
beginning on Aug. 1, 2015, through the payroll period ending on
Dec. 31, 2015, to take a portion of his or her salary in shares of
the Company's common stock.  The common stock will be issued from
the Company's 2011 Stock Incentive Plan.  On an annual basis, the
cash portion of Mr. Hawthorne's salary was reduced from $305,000 to
$230,000, the cash portion of Ms. Russell's salary was reduced from
$280,000 to $230,000 and the cash portion of Mr. Shaikh's salary
was reduced from $300,000 to $230,000.  The cash reduction during
the Stock Compensation Period will total $31,250 for Mr. Hawthorne,
$20,833 for Ms. Russell and $29,167 for Mr. Shaikh.

                       About Uni-Pixel Inc.

The Woodlands, Tex.-based Uni-Pixel, Inc. (OTC BB: UNXL)
-- http://www.unipixel.com/-- is a production stage company       

delivering its Clearly Superior(TM) Performance Engineered Films
to the Lighting & Display, Solar and Flexible Electronics market
segments.

Uni-Pixel incurred a net loss of $25.7 million in 2014, a net loss
of $15.2 million in 2013 and a net loss of $9.01 million in 2012.

As of March 31, 2015, Uni-Pixel had $30.4 million in total assets,
$7.69 million in total liabilities and $22.7 million in total
shareholders' equity.


UNI-PIXEL INC: Posts $15.7 Million Net Loss of Second Quarter
-------------------------------------------------------------
Uni-Pixel, Inc., filed with the Securities and Exchange Commission
its quarterly report on Form 10-Q disclosing a net loss of $15.7
million on $1.3 million of revenue for the three months ended
June 30, 2015, compared to a net loss of $6 million on $0 of
revenue for the same period in 2014.

For the six months ended June 30, 2015, the Company reported a net
loss of $21.4 million on $1.3 million of revenue compared to a net
loss of $12.2 million on $0 of revenue for the same period during
the prior year.

As of June 30, 2015, the Company had $33.3 million in total assets,
$13.5 million in total liabilities and $19.7 million in total
shareholders' equity.

Jeffrey A. Hawthorne, president and chief executive officer of
UniPixel, said, "The second quarter of 2015 was an important
quarter in the history of the Company.  We have transitioned from a
technology development company to a fully integrated sales and
marketing organization with a focus on driving consistent revenue
growth.  Revenue for the second quarter was substantially higher
than the first quarter as we shipped a significantly larger number
of our sensors for use by our Tier 1 OEM customers.  Our
manufacturing facility in Colorado Springs is operational and we
expect that it will become increasingly more efficient in the
coming quarters as we fully integrate the new manufacturing
technology."

A full-text copy of the Form 10-Q is available for free at:

                        http://is.gd/W3IEUH

                        About Uni-Pixel Inc.

The Woodlands, Tex.-based Uni-Pixel, Inc. (OTC BB: UNXL)
-- http://www.unipixel.com/-- is a production stage company       

delivering its Clearly Superior(TM) Performance Engineered Films
to the Lighting & Display, Solar and Flexible Electronics market
segments.

Uni-Pixel incurred a net loss of $25.7 million in 2014, a net loss
of $15.2 million in 2013 and a net loss of $9.01 million in 2012.


VERMILLION INC: FMR LLC Reports 12.2% Stake as of August 7
----------------------------------------------------------
FMR LLC, Edward C. Johnson 3d and Abigail P. Johnson disclosed in a
Schedule 13G filed with the Securities and Exchange Commission that
as of Aug. 7, 2015, they beneficially owned 6,175,000 shares of
common stock of Vermillion Inc., which represents 12.198% of the
shares outstanding.

Edward C. Johnson 3d is a director and the chairman of FMR
LLC and Abigail P. Johnson is a director, the vice chairman, the
chief executive officer and the president of FMR LLC.

A copy of the regulatory filing is available at:

                        http://is.gd/UaHLX4

                          About Vermillion

Vermillion, Inc., is dedicated to the discovery, development and
commercialization of novel high-value diagnostic tests that help
physicians diagnose, treat and improve outcomes for patients.
Vermillion, along with its prestigious scientific collaborators,
has diagnostic programs in oncology, hematology, cardiology and
women's health.

The Company filed for Chapter 11 bankruptcy protection (Bankr. D.
Del. Case No. 09-11091) on March 30, 2009.  Vermillion's legal
advisor in connection with its successful reorganization efforts
wass Paul, Hastings, Janofsky & Walker LLP.  Vermillion emerged
from bankruptcy in January 2010.  The Plan called for the Company
to pay all claims in full and equity holders to retain control of
the Company.

Vermillion reported a net loss of $19.2 million in 2014, a net loss
of $8.81 million in 2013 and a net loss of $7.14 million in 2012.

As of March 31, 2015, the Company had $18.67 million in total
assets, $3.48 million in total liabilities and $15.19 million in
total stockholders' equity.


VIRTUAL PIGGY: Incurs $2.4 Million Net Loss in Second Quarter
-------------------------------------------------------------
Virtual Piggy, Inc., filed with the Securities and Exchange
Commission its quarterly report on Form 10-Q disclosing a net loss
attributable to common stockholders of $2.4 million on $5,277 of
sales for the three months ended June 30, 2015, compared to a net
loss attributable to common stockholders of $5.3 million on $1,253
of sales for the same period during the prior year.

For the six months ended June 30, 2015, the Company reported a net
loss attributable to common stockholders of $5.8 million on $9,386
of sales compared to a net loss attributable to common stockholders
of $13.5 million on $1,678 of sales for the same period in 2014.

As of June 30, 2015, the Company had $1.6 million in total assets,
$5.2 million in total liabilities, all current, and a stockholders'
deficit of $3.5 million.

A full-text copy of the Form 10-Q is available for free at:

                      http://is.gd/z6w4Ot

                 About Oink (Virtual Piggy, Inc.)

Virtual Piggy is the provider of Oink, a secure online and in-store
teen wallet.  Oink enables teens to manage and spend money within
parental controls, while gaining valuable financial management
skills.  The technology company also delivers payment platforms
designed for the Under 21 age group in the global market, and
enables online businesses the ability to function in a manner
consistent with the Children's Online Privacy Protection Act and
similar international children's privacy laws.  The company, based
in Hermosa Beach, CA, is on the Web at: http://www.oink.com/and
holds three technology patents, US Patent No. 8,762,230, 8,650,621
and 8,812,395.

Virtual Piggy reported a net loss of $9.65 million in 2014, a net
loss of $16 million in 2013 and a net loss of $12.03 million in
2012.

Morison Cogen LLP, in Bala Cynwyd, PA, issued a "going concern"
qualification on the consolidated financial statements for the year
ended Dec. 31, 2014, citing that the Company's losses from
development stage activities raise substantial doubt about its
ability to continue as a going concern.


WALTER ENERGY: Has Green Light to Form Retired Employee's Panel
---------------------------------------------------------------
The Chapter 11 cases of Walter Energy Inc. and its
debtor-affiliates can have an official committee to represent
retired employees pursuant to Section 1114(c)(2) and 1114(d) of the
Bankruptcy Code, the U.S. Bankruptcy Court for the Northern
District of Alabama ruled.

The Debtors sought appointment of a retirees committee.  They
explained that, as of the petition date, they employ approximately
2,300 employees in the United States.  These employees include
about 700 salaried and 1,600 hourly individuals. Of these,
approximately 1,285 and 160 hourly employees are represented by the
United Mine Workers of America ("UMWA") and the United Steelworkers
("USW") respectively.  The employees perform a variety of functions
critical to the Debtors' operations, including coal and methane gas
extraction, sales, marketing, accounting, administration and
management.

The Debtors provide healthcare, life-insurance and other
post-retirement benefits to their retirees including:

     a) UMWA Retiree Medical Plan.  This company-sponsored plan is
maintained pursuant to the Debtors' collective bargaining agreement
with the UMWA.  As of Dec. 31, 2014, the Debtors have approximately
3,274 participants under the UMWA Retiree Medical Plan, of which
approximately 609 are active, and approximately 2,665 are retired
or disabled.  As of Dec. 31, 2014, the Debtors have approximately
$579.1 million in unfunded liabilities with respect to the UMWA
Retiree Medical Plan.

     b) Taft Retiree Medical Plan.  This company-sponsored plan is
maintained pursuant to the Debtors' legacy collective bargaining
agreement with the USW.  As of Dec. 31, 2014, the Debtors have
approximately 27 participants under the Taft Retiree Medical Plan,
all of whom are currently retired.  As of Dec. 31, 2014, the
Debtors have approximately $3.4 million in unfunded liabilities
with respect to the Taft Retiree Medical Plan.

     c) Walter Coke Retiree Medical Plan.  This company-sponsored
plan is maintained pursuant to the Debtors' collective bargaining
agreement with the USW.  As of Dec. 31, 2014, the Debtors have
approximately 423 participants under the Walter Coke Retiree
Medical Plan, of which approximately 170 are active, and
approximately 253 are retired.  As of Dec. 31, 2014, the Debtors
have approximately $10.9 million in unfunded liabilities with
respect to the Walter Coke Retiree Medical Plan.

     d) Walter Coke Retiree Life Plan.  This company-sponsored plan
is maintained pursuant to the Debtors' collective bargaining
agreement with the USW.  As of Dec. 31, 2014, the Debtors have
approximately 330 participants under the Walter Coke Retiree Life
Plan, of which approximately 170 are active, and approximately 160
are retired.  As of Dec. 31, 2014, the Debtors have approximately
$0.5 million in unfunded liabilities with respect to the Walter
Coke Retiree Life Plan.

     e) Salaried Post-Retiree Medical Plan.  The Salaried
Post-Retiree Medical Plan is not maintained pursuant to any
collective bargaining agreement.  As of Dec. 31, 2014, the Debtors
have approximately 348 participants under the Salaried Post-Retiree
Medical Plan, of which approximately 246 are active, and
approximately 102 are retired.  As of Dec. 31, 2014, the Debtors
have approximately $4.2 million in
unfunded liabilities with respect to the Salaried Post-Retiree
Medical Plan.

According to the Debtors, their Retiree Benefits -- as defined in
section 1114(a) of the Bankruptcy Code -- total approximately
$598.1 million in unfunded liabilities as of Dec. 31, 2014.  As
part of their restructuring efforts and to return to profitability,
the Debtors must, as a first step, substantially delever their
balance sheets through the Chapter 11 Cases.  A successful
restructuring, however, demands more than just the elimination of
funded debt.  Confirmation of a chapter 11 plan depends on the
Debtors' ability to materially reduce their legacy and existing
labor costs.  Towards that end, the Debtors will engage in
negotiations with the UMWA, the USW and non-unionized retirees,
among others, to obtain cost-savings in respect of the Company's
OPEB Obligations.  While the Company will strive to reach a
consensual resolution with its retirees, the UMWA and the USW
regarding these essential concessions, the Company may need to seek
judicial relief to obtain such relief through the procedures and
processes provided for in sections 1113 and 1114 of the Bankruptcy
Code if no consensual resolution results.

                       About Walter Energy

Walter Energy -- http://www.walterenergy.com/-- is a publicly   
traded "pure-play" metallurgical coal producer for the global steel
industry with strategic access to steel producers in Europe, Asia
and South America.  The Company also produces thermal coal,
anthracite, metallurgical coke and coal bed methane gas.  Walter
Energy employs approximately 2,700 employees, with operations in
the United States, Canada and the United Kingdom.

For the year ended Dec. 31, 2014, the Company reported a net loss
of $471 million following a net loss of $359 million in 2013.  

Walter Energy, Inc., and its affiliates sought Chapter 11
protection (Bankr. N.D. Ala. Lead Case No. 15-02741) in Birmingham,
Alabama on July 15, 2015.  The Debtors tapped Paul, Weiss, Rifkind,
Wharton & Garrison as counsel; Bradley Arant Boult Cummings LLP, as
co-counsel; Ogletree Deakins LLP, as labor and employment counsel;
Maynard, Cooper & Gale, P.C., as special counsel; Blackstone
Advisory Services, L.P., as investment banker; AlixPartners, LLP,
as financial advisor, and Kurtzman Carson Consultants LLC, as
claims and noticing agent.

Walter Energy disclosed total assets of $5.2 billion and total debt
of $5 billion as of March 31, 2015.


WAYNE COUNTY, MI: Seeks to Avoid Bankruptcy Through Consent Pact
----------------------------------------------------------------
Elizabeth Campbell, writing for Bloomberg News, reported that Wayne
County completed a consent agreement with the Michigan Department
of Treasury, moving the home of Detroit a step closer to state
oversight in a bid to mend its finances.

The report related that the pact, which keeps local officials in
charge, is an alternative to bankruptcy and becomes effective after
the 15-member county commission approves it, according to an
e-mailed statement dated Aug. 11 from the office of County
Executive Warren Evans.  Once it is approved by the commission and
signed, the county executive's office has 30 days to keep
negotiating with unions before Evans can use his powers under the
pact to impose pay or benefit cuts, the Bloomberg report noted.

                         *     *     *

The Troubled Company Reporter, on June 26, 2015, reported that
Moody's Investors Services has affirmed the Ba3 rating on the
general obligation limited tax (GOLT) debt of Wayne County, MI.
The county has a total of $654 million of long-term GOLT debt
outstanding, of which $336 million is rated by Moody's.  An
additional $144 million of short-term GOLT delinquent tax
anticipation notes (DTANs) are outstanding, with a sale for an
additional $186.9 million of short-term DTANs.

The TCR, on March 16, 2015, reported that Fitch Ratings has
downgraded the ratings for the following Wayne County, Michigan
bonds:

-- $186.3 million limited tax general obligation (LTGO) bonds
    issued by Wayne County to 'B' from 'BB-';

-- $51.3 million building authority (stadium) refunding bonds,
   series 2012 (Wayne County LTGO) issued by Detroit/Wayne County
   Stadium Authority to 'B' from 'BB-';

-- $203.5 million building authority bonds issued by Wayne County
   Building Authority to 'B' from 'BB-';

-- Wayne County unlimited tax general obligation (ULTGO) (implied)
   to 'B' from 'BB'.

On Feb. 10, 2015, the TCR reported that Moody's Investors Services
has downgraded to Ba3 from Baa3 the rating on the general
obligation limited tax (GOLT) debt of Wayne County, MI. The county
has a total of $695 million of long-term GOLT debt outstanding, of
which $336 million is rated by Moody's.  An additional $302
million
of short-term GOLT delinquent tax anticipation notes are
outstanding. The outlook remains negative.

The TCR, on Feb. 9, 2015, also reported that Fitch Ratings has
placed the following Wayne County ratings on Rating Watch
Negative:

  -- $190.9 million limited tax general obligation (LTGO) bonds
     issued by Wayne County 'BB-';

  -- $54.9 million building authority (stadium) refunding bonds,
     series 2012 (Wayne County LTGO) issued by Detroit/Wayne
     County Stadium Authority 'BB-';

  -- $207.2 million building authority bonds issued by Wayne
     County Building Authority 'BB-';

  -- Wayne County unlimited tax general obligation (ULTGO)
     (implied) 'BB'.


WESTMORELAND COAL: Has 93% Equity Interest in Westmoreland Resource
-------------------------------------------------------------------
Westmoreland Coal Company disclosed in an amended Schedule 13D
filed with the Securities and Exchange Commission that as of
Aug. 1, 2015, it beneficially owned 19,820,008 Common Units
Representing Limited Partner Interests of Westmoreland Resource
Partners, LP.

On Aug. 1, 2015, pursuant to the terms of the Amended and Restated
Contribution Agreement, dated July 31, 2015, between the Issuer and
WCC, WCC made the Contribution to the Issuer in exchange for
15,251,989 Series A Units of the Issuer and $115 million in cash,
which the Issuer funded with borrowings under its credit facility.

WCC purchased Warrants to acquire a total of 55,519 Common Units in
June 2015, consisting of a Warrant to acquire 11,659 Common Units
from A54 Acquisition-B LLC on June 10, 2015, and a Warrant to
acquire 43,860 Common Units from A54 Acquisition LLC on
June 11, 2015, for a total purchase price of $627,365.  WCC funded
the purchase price for the Warrants with available cash on hand.

Together with the Common Units previously held by WCC, the Series A
Units and the Warrants purchased by WCC represent an aggregate of
93.8% of the Issuer's outstanding equity interests on a fully
diluted basis.

A full-text copy of the regulatory filing is available at:

                       http://is.gd/w0bWM4

                   About Westmoreland Resource

Oxford Resource Partners, LP, now known as Westmoreland Resource
Partners, LP, is a producer of high value steam coal, and is the
largest producer of surface mined coal in Ohio.

Westmoreland Resource reported a net loss of $28.6 million on $322
million of total revenues for the year ended Dec. 31, 2014,
compared with a net loss of $23.7 million on $347 million
of total revenues for the year ended Dec. 31, 2013.

As of June 30, 2015, Westmoreland Resource had $289.9 million in
total assets, $234.7 million in total liabilities and $55.2 million
in total partners' capital.


ZOGENIX INC: Posts $72.4 Million Net Income for Second Quarter
--------------------------------------------------------------
Zogenix, Inc. filed with the Securities and Exchange Commission its
quarterly report on Form 10-Q disclosing net income of $72.4
million on $7.3 million of total revenue for the three months ended
June 30, 2015, compared to net income of $62.8 million on $6.7
million of total revenue for the same period a year ago.

For the six months ended June 30, 2015, the Company reported net
income of $49.6 million on $11.9 million of total revenue compared
to net income of $41.9 million on $14.1 million of total revenue
for the same period a year ago.

As of June 30, 2015, the Company had $246.7 million in total
assets, $138.6 million in total liabilities and $108.1 million in
total stockholders' equity.

"With further positive data from the Belgian study of low-dose
fenfluramine in Dravet syndrome, a clear development path for Phase
3 that now includes significant input from the FDA and the
successful execution of a Dravet syndrome-focused KOL event, we
have generated significant momentum over the past several months,"
said Stephen J. Farr, Ph.D., president and CEO.  "From a clinical
development standpoint, we are well-positioned to begin our Phase 3
program for ZX008 in the fourth quarter of 2015.  In addition,
following our recent capital raise, Zogenix is now in the strongest
financial position in our company's history, and our cash should be
sufficient to take us through the regulatory submissions, and
potential approvals, of ZX008 in the U.S. and Europe."

A full-text copy of the Form 10-Q is available for free at:

                        http://is.gd/sbUhDD

                         About Zogenix Inc.

Zogenix, Inc. (NASDAQ: ZGNX), with offices in San Diego and
Emeryville, California, is a pharmaceutical company
commercializing and developing products for the treatment of
central nervous system disorders and pain.

Zogenix reported net income of $8.58 million in 2014 following a
net loss of $80.85 million in 2013.

Ernst & Young LLP, in San Diego, California, issued a "going
concern" qualification on the consolidated financial statements
for the year ended Dec. 31, 2014, citing that the Company's
recurring losses from operations and negative cash flows from
operating activities raise substantial doubt about its ability to
continue as a going concern.


                            *********

Monday's edition of the TCR delivers a list of indicative prices
for bond issues that reportedly trade well below par.  Prices are
obtained by TCR editors from a variety of outside sources during
the prior week we think are reliable.  Those sources may not,
however, be complete or accurate.  The Monday Bond Pricing table
is compiled on the Friday prior to publication.  Prices reported
are not intended to reflect actual trades.  Prices for actual
trades are probably different.  Our objective is to share
information, not make markets in publicly traded securities.
Nothing in the TCR constitutes an offer or solicitation to buy or
sell any security of any kind.  It is likely that some entity
affiliated with a TCR editor holds some position in the issuers
public debt and equity securities about which we report.

Each Tuesday edition of the TCR contains a list of companies with
insolvent balance sheets whose shares trade higher than $3 per
share in public markets.  At first glance, this list may look like
the definitive compilation of stocks that are ideal to sell short.
Don't be fooled.  Assets, for example, reported at historical cost
net of depreciation may understate the true value of a firm's
assets.  A company may establish reserves on its balance sheet for
liabilities that may never materialize.  The prices at which
equity securities trade in public market are determined by more
than a balance sheet solvency test.

On Thursdays, the TCR delivers a list of recently filed
Chapter 11 cases involving less than $1,000,000 in assets and
liabilities delivered to nation's bankruptcy courts.  The list
includes links to freely downloadable images of these small-dollar
petitions in Acrobat PDF format.

Each Friday's edition of the TCR includes a review about a book of
interest to troubled company professionals.  All titles are
available at your local bookstore or through Amazon.com.  Go to
http://www.bankrupt.com/books/to order any title today.

Monthly Operating Reports are summarized in every Saturday edition
of the TCR.

The Sunday TCR delivers securitization rating news from the week
then-ending.

                            *********

S U B S C R I P T I O N   I N F O R M A T I O N

Troubled Company Reporter is a daily newsletter co-published
by Bankruptcy Creditors Service, Inc., Fairless Hills,
Pennsylvania, USA, and Beard Group, Inc., Washington, D.C., USA.  
Jhonas Dampog, Marites Claro, Joy Agravante, Rousel Elaine
Tumanda, Valerie Udtuhan, Howard C. Tolentino, Carmel Paderog,
Meriam Fernandez, Joel Anthony G. Lopez, Cecil R. Villacampa,
Sheryl Joy P. Olano, Psyche A. Castillon, Ivy B. Magdadaro, Carlo
Fernandez, Christopher G. Patalinghug, and Peter A. Chapman,
Editors.

Copyright 2015.  All rights reserved.  ISSN: 1520-9474.

This material is copyrighted and any commercial use, resale or
publication in any form (including e-mail forwarding, electronic
re-mailing and photocopying) is strictly prohibited without prior
written permission of the publishers.  Information contained
herein is obtained from sources believed to be reliable, but is
not guaranteed.

The TCR subscription rate is $975 for 6 months delivered via
e-mail.  Additional e-mail subscriptions for members of the same
firm for the term of the initial subscription or balance thereof
are $25 each.  For subscription information, contact Peter A.
Chapman at 215-945-7000 or Nina Novak at 202-362-8552.

                   *** End of Transmission ***